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StmARy
The metabolism of the mammalian form of Leishmania mexicana
mexicana has been investigated by comparing the amastigote activities
of a number of enzymes involved in the glycolytic sequence, tri-
carboxylic acid cycle and associated pathways with those of the
promastigote. Initial studies suggested that there are only
quantitive differences between the two forms with the greatest
of the differences found in the area of CO2-fixation. Phosphoenol-
pyruvate carboxykinase (PEP carboxykinase) was detected at much
higher activity in amastigotes than promastigotes. This enzyme was
found to be ADP specific and to have an absolute requirement for
M 2+n • There appeared to be no regulation of the amastigote enzyme in
crude homogenates by ATP, GTP, ITP or the end products malate and
succinate~ Pyruvate carboxylase was undetectable in either parasite
form and malic enzyme (carboxylating) was detected only at low
activity in promastigotes. Amastigotes had low pyruvate kinase but
high malate dehydrogenase activities in comparison to prom~stigotes.
This suggests that in amastigotes the main catabolic route for PEP is
to succinate, a major end-product of metabolism, by way of carboxy-
lation and reduction involving malate dehydrogenase and fumarate
reductase. In contrast, the high activity of pyruvate kinase in
promastigotes suggests that, in this parasite form, PEP is more
likely to be converted to pyruvate which either enters the TCA cycle
or is transaminated to alanine. Promastigotes had a high NADH-linked
glutamate dehydrogenase activity in comparison to amastigotes and may
reflect the higher glutamate utilization by the insect form of the
parasi teo A low NADPH-linked glutamate dehydrogenase acti vi ty was
found in amastigotes, whereas none was detected in promastigotes.
Isoci trate lyase could not be detected in either form, suggesting
vi
that the glyoxylate cycle plays no part in L. m. mexicana metabolism.
The theory that the glycolytic kinases, and in particular
phosphofructokinase, are primary targets in the action of pentavalent
antimonial drugs against Leishmania was investigated with L. m.
mexicana. Pentostam (sodium stibogluconate), active in vivo against
Leishmania, had no effect on promastigote growth in vi tro even at
concentrations of 100}Jg/ml. In contrast, Triostam, the trivalent
analogue of Pentostam, inhibited the growth in vi tro of L. m.
mexicana promastigotes with an L050 of 20}Jg/ml and an MLC of
400}Jg/ml. It was found to be almost as effective on a weight/weight
basis as the trivalent arsenical melarsen oxide (LD50, 20}Jg/ml; MLC,
10~g/ml). The leishmanicidal effect of Triostam, however, could not
be correlated with any enzyme inhibitory activity. Neither Pentostam
(110}JM) n~r Triostam (600}-lM)inhibited hexokinase, phosphofructo-
kinase, pyruvate kinase, malate dehydrogenase or PEP carboxykinase
from either amastigote or promastigote. In contrast, melarsen oxide
was a potent inhibitor of all leishmanial enzymes tested except
hexokinase. The action of Triostam was antagonised by cysteine
indicating that the drug's action may involve thiol groups in some
way. Triostam, but not Pentostam, inhibited phosphofructokinase of
adult Schistosoma mansoni with an 150 of 200~M, suggesting that
antimonials may act in different ways against schistosomes and
Leishmania.
The subcellular organisation of L. m. mexicana promastigotes was
investigated using di fferenti al and isopycnic centrifugation.
Glycosomes and mitochondrial vesicles from culture promastigotes were
separated on linear sucrose gradients. Hexokinase, glucose
phosphate isomerase, phosphofructokinase, glyceraldehyde-3-phosphate
dehydrogenase and PEP carboxykinase were recovered largely in
association with glycosomes (density; 1.215 g/ml). Phosphoglycerate
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kinase and glucose-6-phosphate dehydrogenase had some glycosomal
activity but were mostly recovered in the soluble fractions. Pyruvate
kinase was totally cytosolic. Malate dehydrogenase showed a broad
peak corresponding to that of the mitochondrial marker oligomycin-
sensitive ATPase (density; 1.190g/ml). Glutamate dehydrogenase and
alanine aminotransferase both showed small mitochondrial peaks, but
most of the activities were recovered elsewhere on the gradient and
in the soluble fractions. Amastigotes of L. m. mexicana were not
successfully fractionated using the technique developed for
promastigotes, therefore the subcellular location of enzymes in
amastigotes was investigated by following the release of soluble
enzymes from digitonin-treated amastigotes. This revealed distinct
cytosolic, mitochondrial and glycosomal compartments. The findings
give an insight into the organisation of L. m. mexicana promastigote
and amastigote energy metabolism.
The importance of PEP carboxykinase and malate dehydrogenase to
the metabolism of the amastigote prompted a more detailed investi-
gation of these two enzymes. Isoelectric focusing studies showed that
amastigotes possessed particulate malate dehydrogenase isoenzymes
apparently absent from promastigotes. The particulate activities of
amastigote malate dehydrogenase and PEP carboxykinase were purified
to apparent electrophoretic homogeneity by hydrophobic interaction
chromatography using Phenyl-Sepharose CL-4B, affinity chromatography
using 5' AMP-Sepharose 4B and gel filtration using Sephadex G-100.
Malate dehydrogenase was purified 150-fold overall with a final
specific activity of 1230 units/mg protein and a recovery of 63%.
PEP carboxykinase was purified 132-fold with a final specific
activity of 30.3 units/mg protein and a recovery of 20%. Molecular
weights determined by gel filtration and SOS gel electrophoresis were
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39,BOO and 33,300 for malate dehydrogenase and 63,100 and 65,100 for
PEP carboxykinase, respectively. Kinetic studies with malate dehyd-
rogenase assayed in the direction of oxaloacetic acid reduction
showed a Km NAOH of 41f-1Mand a Km oxaloacetic acid of 39j-lM. For
malate oxidation there was a Km malate of 3.6mM and a Km NAO+ of
0.79mM. Oxaloacetic acid exhibited substrate inhibition at concen-
trations greater than O.B3mM and malate was found to be a product
inhibitor at high concentrations, however there was no modification
of enzyme activity by a number of glycolytic intermediates and
cofactors suggesting that malate dehydrogenase is not a major
regulatory enzyme in L. m. mexi cana. The resu lts show that these
L. m. mexicana amastigote enzymes are in several ways similar to
their mammalian counterparts, nevertheless their apparent importance
and unique subcellular organisation in the parasite make them
potential targets for chemotherapeutic attack.
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1.0 INTRODUCTION
1.1. LEISHMANIA AND THE LEISHMANIASES
The leishmanias are parasitic protozoa that cause a group of
diseases, the leishmaniases, that are widespread throughout the
tropics and sub-tropics and affect many millions of people (Chance
1981). The medical, economic and biological importance of the
diseases was emphasised by their inclusion in the UNDP/World
Bank/WHO Special Program for Research and Training in Tropical
Diseases.
1.1.1. Taxonomy of Leishmania
The classification of the genus Leishmania is outlined in table
1. It is a member of the order Kinetoplastida and the family
Trypanosomatidae, which also contains the genera Crithidia and
Trypanosoma (Honigberg et al. 1964, Kudo 1966). There are eight
species of Leishmania known to infect man, and two of the species,
L. mexicana and L. braziliensis, are subdivided into subspecies
(Molyneux and Ashford 1983) (Tables 2 and 3). In the majority of
cases these species cannot be distinguished by their morphology alone
and so have been classified according to their geographical
locations, clinical manifestations and biochemical characteristics.
Isoenzyme electrophoresis and the measurement of the buoyant density
of nuclear and kinetoplast DNA are the biochemical techniques
generally used to distinguish the species and sub-species. This is
the current classification for Leishmania at the time of writing,
however to avoid confusion in nomenclature for Leishmania species
mentioned in papers that predate this classification, the species
na~es used by the authors in the original papers will be given
throughout this thesis.
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Table 1. Classification of Leishmania
Kingdom
Subkingdom
Phylum
Subphylum
Class
Order
Suborder
Family
Genus
Protista
Protozoa
Sarcomastigophora
Mastigophora
Zoomastigophorea
Kinetoplastida
Trypanosomatina
Trypanosomatidae
Leishmania
From Molyneux and Ashford 1983
--------------------------------------------------------------------
Table 2. Species of Leishmania that infect man in the Old World
Speciesa Distribution--------------------------------------------------------------------
L. donovani Africa,
Asia
L. aethiopica Ethiopia,
Kenya
L. major Asia,
Africa
L. tropica Europe, Asia
North Africa
L. infantum Mediterranean
Disease
Main
Reservoir Host
Visceral,
"Kala-azar"
Dry cutaneous;
diffuse,
"Oriental sore"
Wet cutaneous;
rural
Dry cutaneous;
urban
Infantile
visceral
Many
Rock hyrax
Rodents
Man
Dogs, foxes
--------------------------------------------------------------------
a From Molyneux and Ashford 1983
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Table 3. Species of Leishmania that infect man in the New World
Speciesa Distribution Disease
L. braziliensis Brazil Mucocutaneous
braziliensis "Espundia"
L. b. gU:ianensis South Cutaneous
Jl.rrerica
L.b. ~anamensis Panama Cutaneous
L. b. ~eruviana South Cutaneous
Jl.rrerica
L. donovani South Visceral
Jl.rrerica
L. chagasi South Visceral
Jl.rrerica
L. mexicana Central Cutaneous
mexicana America "Chiclero
ulcer"
L. m. amazonensis Brazil Cutaneous
L. m. ~ifanoi Venuzuela Cutaneous
Main
Reservoir Host
Rodents
Sloths
Sloths
Dogs
Dogs
Dogs
Rodents
Rodents
Unknown
--------------------------------------------------------------------
a From Molyneux and Ashford 1983
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1.1.2. Life-cycle of Leishmania
There are two major stages in the life-cycle of Leishmania: The
promastigote living in the gut of the sandfly vector and the
amastigote which resides in a parasitophorous vacuole of a host
macrophage (Bray 1974). The promastigote is elongated, approximately
20~m in length, with the kinetoplast and single flagellum at the
anterior end, whereas the amastigote is ovoid in shape, with a length
of 4-6jJm, and a flagellum that hardly protrudes from the flagellar
pocket (Vickerman 1976, Vickerman and Preston 1976). A simplified
life-cycle of Leishmania is shown in fig. 1.
Only phlebotomine sandflies (Oiptera: Psychodidae: Phlebotomine)
are known to be insect vectors for Leishmania, there being two genera
that infect man; Phlebotomus in the Old World and Lutzomyia in the
New World (Williams and Coelho 1978). Following the ingestion of a
blood meal from an infected host by female phlebotomine sandflies,
the Leishmania amastigotes taken into the midgut transform into
promastigotes, usually within 24-36 hours (Strang ways-Oixon and
Lainson 1966). In all the mammalian species of Leishmania except the
L. braziliensis complex, promastigotes multiply in the abdominal
midgut until, after as little as 4-6 days, there is a spread of
infection through the thoracic midgut to the oesophagus, pharynx and
finally the proboscis ready for infection of a mammal (Strang ways-
Dixon and Lainson 1966, Hertig and McConnell 1963, Killick-Kendrick
1979). Several different morphological forms of Leishmania have been
recognised as being present in different parts of the sandfly gut
(Killick-Kendrick 1979), however the significance of these variations
in morphology has not been established. Promastigotes of the
L. brazi liensis complex have a different pattern of development as
they become established in the pylorus and ileum of the sandfly
before moving forward with subsequent infection of the proboscis.
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Fig 1. A simplified life-cycle of Leishmania
transform to promastigotes ~ ..~ some promastigotes move
in midgut forward and live in the
proboscis
IN SANDFLY
infected macrophages
ingested by sandfly
promastigotes pass
from insect proboscis
during blood meal into mammalian host
liberation and
reinfection -
IN MAMMAL
promastigotes ingested
by macrophages and
transform to amastigotes
amastigotes multiply
within a parasitophorous
vacuole of a macrophage
.... amastigotes live withina parasi tophorous vacuole
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The transformation of amastigote to promastigote has been
followed successfully in vitro using both light and electron
microscopy (Rudzinska et al. 1964, Brun and Krassner 1976, Hart
et al. 1981a). Rudzinska et al. (1964) showed with L. donovani that
there was an increase in the mitochondrial volume which appeared to
be formed by the kinetoplast, whereas Brun and Krassner (1976)
reported a small decrease in relative mitochondrial volume. It was
shown with L. m. mexican a that division occurred during the
transformation process (Hart et al. 1981a). The changes that occur
have also been studied biochemically with it being shown in different
studies with various species of Leishmania that carbohydrates
(Simpson 1968), L-proline (Krassner and Flory 1972), and non-
esterified fatty acids (Hart et al. 1981a) are important nutritional
requirements for parasite transformation. In addition, the in vitro
transformation process has been used to test the effect of inhibitors
on amastigotes, giving information on amastigote metabolism as well
as its sensitivity to drugs (Hart et al. 1981a, Coombs et al. 1983).
The transmission of Leishmania into the mammalian host occurs
during the bite of an infected sandfly when promastigotes are
probably inoculated during the probing of the insect. Parasite entry
may possibly also occur later if the bi te is scratched and the skin
broken (Williams 1966, Williams and Coelho 1978). The cell damage
caused by penetration of the proboscis at the site of the bite,
together wi th the residual saliva from the sand fly, are thought to
attract white cells including mononuclear phagocytes. These latter
cells are presumed to take up the promastigote which transforms into
the amastigote within the parasitophorous vacuole. The amastigotes
divide within the macrophages by binary fission (Vickerman 1980) and
reinfect other cells after the progeny are released. The different
species of Leishmania can infect cells from different organs of the
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body, thereby producing the characteristic clinical symptoms of each
disease. Leishmania donovani mainly parasitizes the phagocytic cells
of the liver and spleen to produce the appropriately named visceral
leishmaniasis. In cutaneous leishmaniasis the parasites infect
macrophages of the skin, whereas in mucocutaneous leishmaniasis the
parasite can spread from the skin to the palate and pharynx.
1.1.3.The interaction of Leishmania with macrophages
1.1.3.1.Entry of Leishmania into macrophages
One of the most fascinating aspects of Leishmania is its ability
to survive and multiply within a macrophage - a host cell that
specialises in microbicidal activity. The parasite lives in a
potentially hostile environment the properties of which include low
pH, an ion'ic free radicals, and a large number of digestive enzymes
(Silverstein et al. 1977). The first step in the establishment of an
infection is parasite-macrophage recognition. In vitro studies have
shown that promastigotes bind strongly to macrophages, weakly to
lymphocytes and not at all to erythrocytes (Benoliel et al. 1980,
Chang 1983). This binding has been shown with L. donovani to occur
at multiple sites on both the cell body and the flagellum of the
promastigote (Chang 1983), whereas for L. tropica and
L. b. braziliensis attachment has been reported to be predominantly
via the flagellum (Zenian et al. 1979, Merino et al. 1977). It has
been suggested that surface membrane pr-ot.eins of Leishmania may be
involved in forming ligand-receptor complexes on the macrophage
surface (Benoliel et al. 1980, Chang 1981, Chang 19B3). Macrophages
have a system of retrieval and recycling of extracellular acid
hydrolases (Stahl et al. 1978, Stahl and Schlessinger 1980) and one
such enzyme, acid phosphatase, whi ch is an enzyme usually found in
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lysosomes of eukaryotic cells, has been found on the surface of
L. donovani promastigotes (Gottlieb and Dwyer 1981). This enzyme may
therefore be an important ligand involved in binding and entry of
Leishmania into the macrophage (Dwyer and Gottlieb 1983).
Macrophages are naturally phagocytotic in vivo, therefore it is
unlikely the Leishmania needs to release substances that would
promote entry into the cell as may be the case with
Plasmodium lophurae. This distantly related protozoan releases a
histidine-rich protein that reacts with the erythrocyte membrane and
may help penetration by the merozoite (Kilejian 1976). Phagocytosis
is implicated as the mechanism of parasite entry as the uptake of
Leishmania by macrophages is inhibited by cytochalasin B, suggesting
involvement of actin filaments (Alexander 1975, Zenian et al. 1979,
Chang 1983), and iodoacetate, suggesting an energy requirement
(Benoliel et al. 1980).
1.1.3.2. Survival of Leishmcmia within macrophages
Intracellular parasites have different mechanisms of avoiding or
resisting the microbicidal activities of the host macrophages.
Toxoplasma gondii appears to prevent fusion of the secondary
lysosomes thereby protecting itself from proteolytic digestion (Jones
and Hirsch 1972) and there is evidence that this is mediated through
its active penetration into vacuoles rather than being phagocytosed
into normal phagosomes. Trypanosoma cruzi can cross the membrane of
the original phagosome and live in the cytoplasmic matrix (Dvorak and
Hyde 1973), whilst Mycobacterium lepraemurium forms a physical
protective barrier in the form of a thick enveloping capsule (Draper
and Rees 1970). Although secondary lysosomes fuse with the
parasitophorous vacuoles of Leishmania-infected macrophages, the
parasites not only survive but multiply in this environment
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(Alexander and Vi ckerman 1975, Chang and Dwyer 1976, Berman et a1.
1979, Brazil 1984).
The ability of the promastigote to transform and differentiate
into the amastigote is vital for continued leishmanial survival
within the macrophage (Lewis and Peters 1977). New antigens appear
on the amastigote surface after transformation and may signify a
molecular reorganisation of the plasma membrane which may be
important in preferential amastigote survival (Chang and Fong 1983).
In addition, the two forms of Leishmania may have differing abilities
to survive the oxidative response of phagocytes to invasion. The
ability of phagocytes to destroy intracellular parasites is partly
dependent on their capacity for generating toxic oxygen metabolites,
namely superoxide (02-), hydrogen peroxide (H202), hydroxyl radicals
(OH·) and singlet oxygen (102) (Klebanoff et ale 1983, Locksley and
Klebanoff 1983). Resident macrophages have a weak respiratory burst
and intracellular parasites such as Leishmania can survive within
these cells, whereas activated macrophages have both an increased
respiratory burst and a more effective antiparasitic activity.
Although with L. donovani and L. tropica both promastigotes and
amastigotes induce a respiratory burst, the response to promastigotes
is far greater than amastigotes (Murray 1981, Murray and Cartelli
1983). This correlates well with the greater susceptibility of the
promastigote to the microbial activity of phagocytes. The levels of
endogenous scavengers of oxygen metabolites may also playa part in
intracellular survival. L. donovani amastigotes have been shown to
have a 3-fold higher activity of superoxide dismutase and catalase,
and a 14-fold higher glutathione peroxidase activity than the
promastigote, which could make the amastigote more resistant to the
toxic activity of macrophages (Murray 1982). Catalase and
glutathione peroxidase were not detected in L. m. mexicana
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amastigotes ,however, and superoxide dismutase was found to have
similar activi ty in both forms of the parasi te (Ghafoor and Coombs
1980).
There are a number of other ways that Leishmania may survive
macrophage attack. A number of cell surface components from both
Leishmania amastigotes and promastigotes have been shown to be
resistant to degradation by isolated rat liver lysosomes and these
may form a barrier that protects the cell (Chang and Dwyer 1978,
Chang and Fong 1983). Another possible mechanism for amastigote
survival is the excretion into the parasitophorous vacuole of
substances that could antagonise the microbicidal activity of the
macrophages. Leishmania m. mexicana amastigotes contain high
cysteine proteinase activity which, if released into the
parasitophorous vacuole, could protect the parasite by degrading host
digestive enzymes (Coombs 1982). There is no evidence as yet however
to suggest that there is secretion of proteinases either in vivo or
in vitro. It has been reported that the intravacuolar pH does not
seem to be affected by the presence of the parasite (Chang 1980),
however high concentrations of amines and ammonia are produced, by
proteolysis and amino-acid metabolism, and these could inactivate
host enzymes by raising the pH of the lysosomal vacuoles (Coombs
1982, Coombs and Sanderson 1984). Leishmania also produce excreted
factors that have been shown to inhibit ~-galactosidase activity (El-
On et al. 1980). These factors have been characterised as
glycosylated proteins containing galactose and may playa role in
amastigote survival wi thin the parasi toporous vacuole of the
macrophage by inhibiting lysosomal enzymes (Zehaui et al. 1983).
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1.2. ULTRASTRUCTURE OF LEISHMANIA
Trypanosomatids contain a number of subcellular structures that
are common to all eukaryotic cells as well as some organelles
apparently unique to this group of Protozoa (Vickerman and Preston
1976). A transmission electron micrograph of some L. m. mexicana
amastigotes showing the major structural features of the cells is
gi ven in fig. 2.
The plasma membrane is a typical unit membrane 2-4nm in width,
and is associated with a complex array of sub-pellicular microtubules
that completely surrounds the organism except for a gap at the point
of attachment of the flagellum to the parasite body (Vickerman 1974).
These microtubules, which are found in both the vertebrate and
invertebrate stages of Leishmania, give internal support to the cell
and conseguently makes the parasite very difficult to lyse without
drastic breakage methods such as grinding with abrasive powders or
incubating with detergents.
The endomembrane systems of trypanosomatid flagellates have not
been well studied, although some information has been derived from
electron microscopy studies. The nucleus, which is typically
eukaryotic, is surrounded by a nuclear envelope with two membranes
both of which contain pores which link the matrix to the cytoplasm.
There is an endoplasmic reticulum consisting of flattened, ramifying
cisternae and tubules, and a Golgi apparatus with stacks of smooth
flattened membranes; neither show striking differences from the
generalized eukaryote (Vickerman and Preston 1976). The endoplasmic
reticulum is in part rough, with attached ribosomes, and in part
smooth, without ribosomes, and is usually concentrated around the
nucleus and between the nucleus and flagellar pocket. The Golgi
apparatus is usually associated with the flagellar pocket and is
attached by a limb to smooth endoplasmic reticulum (Vickerman and
12
Fig. 2. A transmission electron micrograph of Leishmania mexicana
mexicana amastigotes ( x 25,000). Key to subcellular structures:
Nucleus (n), mitochondrion (m), megasomes (mg), glycosomes (g), sub-
pellicular microtubules Isprnl , flagellum (f) wi thin the flagellar
pocket (fp). Micrograph couptesy of L. Tetley.
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Preston 1976).
The characteristic feature of the organisms that gives the order
Kinetoplastida its name is the kinetoplast-mitochondrion complex.
The kinetoplast, which is found close to the basal body from which
the flagellum arises, is located wi thin the uni tary mi tochondrion
which is branched and forms a reticulum of canals running the length
of the organism (Simpson 1972, Vickerman and Preston 1976). The
kinetoplast is not associated, as its name implies, to the movement
of the organism and the reason for its position so close to the basal
bodies of the flagellum is unknown. The central part of the concave
disk-like kinetoplast capsule contains DNA that is comprised of a
gigantic network of catenated circles (See section 1.4.1.).
There is considerable cyclical variation in the kinetoplast-
mitochondrion complex during the life-cycle of salivarian
trypanosomes, but this does not occur to the same extent in other
trypanosomatids such as T. cruzi and Leishmania species (Rudzinska
et al. 1964, Vickerman 1974, Vickerman and Preston 1976). In
T. brucei long slender bloodstream form, there is a simple
unbranched mitochondrion with few tubular cristae. In the subsequent
short stumpy bloodstream form there is an increased mi tochondrial
volume and the presence of a number of tubular ,5cr-i ..tae. On
transformation to the insect procyclic form, there is the formation
of a well developed mitochondrion containing plate-like cristae.
These large morphological changes are associated with the development
of an active TCA cycle and respiratory chain together with a change
in the energy metabolism of the parasite (Vickerman 1974, Vickerman
and Preston 1976, Bowman and Flynn 1976). In Leishmania, however,
cristae are present in the mitochondrion of both amastigotes and
promastigotes which, together with the available information on the
respiration of the two stages, suggests that there is little
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variation in mitochondrial function between the two forms (Vickerman
and Preston 1976, Hart et al. 1961c).
Another unique feature of trypanosomatid subcellular structure
is the presence of microbody-like organelles known as glycosomes.
These were first discovered in bloodstream forms of T. brucei and
contain a number of glycolytic enzymes (Dpperdoes and Borst 1977,
Dduro et al. 196Da) (See section 1.4.3.1.). These organelles have
since been found in all trypanosomatids studied including T. cruzi
and C. fasciculata (Taylor et al. 1960, Cannata et al. 1962) and
L. m. mexicana (Coombs et al. 1962, Tetley et a1. 1963). The
dglycosomes of bloostream T. brucei have been studied in the most
A
detail, including purification to near homogeneity by differential
and isopycnic centrifugation (Dpperdoes et a1. 1964). The
organelles, which are bound by a single membrane, appear to be
remarkably homogeneous with an average diameter of 0.27J-lmand
containing a dense core displayi ng a lamellar structure, but
apparently no DNA. From in situ analysis, the number of glycosomes
in each T. brucei cell was found to be approximately 230, which
represents 4.3% of the total cell volume (Opperdoes et a1. 1964). 3-
dimensional reconstruction of L. m. mexicana amastigotes from
electron micrographs of serial thin sections has revealed that there
are only 9 to 10 glycosomes per amastigote (Tetley et al. 1963).
This is considerably less than the number found in bloodstream
T. brucei and, although Leishmania amastigotes are considerably
smaller, the low number of glycosomes may reflect a smaller reliance
on glycolysis by the cell. Leishmania m. mexicana amastigotes also
contain a number of lysosome-like organelles given the name
"Megasomes" (Alexander and Vickerman 1975) which are interestingly
not found in promastigotes. They were shown to be concentrated at
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the posterior end of the cell away from the flagellar pocket (Tetley
et al. 19B3). The "Megasomes", which vary considerably in size, are
thought to contain a number of lysosomal enzymes and may play a part
in the survival of the mammalian form of the parasite within the host
macrophage (Coombs 19B2).
1.3. CONTROL OF LEISHMANIASIS
The control of leishmaniasis through the interruption of its
life-cyc18 is a long term aim that is proving very difficult to
achieve (Chance 19B1). The control of the insect vector by spraying
with insecticides has faced insurmountable problems in areas such as
tropical rain forests and has also provided a major ecological and
environmental problem (Lainson and Shaw 197B). Although there are a
number of drugs suitable for treating patients with leishmaniasis,
there are no chemoprophylactic drugs or effective multivalent
vaccines which could be used in the eradication of the disease
through interruption of the parasite life-cycle in the mammalian
host.
1.3.1. Immunisation
Immunisation has been extremely successful as a method of
control and even eradication of many bacterial and viral diseases,
but has so far proved almost totally unsuccessful as a method for
treating the three major groups of diseases caused by parasitic
protozoa; trypanosomiasis, malaria and leishmaniasis. The reasons
for this are many fold, but in particular the parasites have evolved
complex ways of evading the immune response. In the mammaliam forms
of african trypanosomes the plasma membrame is totally covered with a
glycoprotein surface coat that is responsible for the way in which
the parasite evades the immune response by antigenic variation
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(Vickerman and Luckins 1969, Vickerman 1978). The prospect of a
vaccine against trypanosomes is sti 11 remote, but with increasing
knowledge of the molecular biology relating to antigenic variation an
effective cocktail pf variable surface antigens produced through
genetic engineering is a possibility for the future (Diggs 1982,
Vickerman and Barry 1982). There are also many problems associated
wi th vaccination against Leishmania, largely due to the parasi te
evading the immune system by becoming intracellular and living in the
parasi tophorous vacuole of rnacrophages, cells of the immune system
itself (Mauel and Behin 1981). There has been some success using
vaccines of attenuated promastigotes of L. major in the U.S.S.R. and
Israel, but due to the di fferences in host response and the lack of
cross-immunity with different species of Leishmania the possibility
of a multIvalent Leishmania vaccine appears to be very remote (Chance
1981) •
1.3.2. Chemotherapy
Chemotherapy is still the only effective form of treatment for
leishmaniasis. The drugs of choice are the pentavalent antimonials
sodium stibogluconate (Pentostam) and methylglucamine antimoniate
(Glucantime) which have been in use for over thirty years (See Steck
1972, 1974). The lack of response to these drugs of Leishmania
species from various geographical locations, however, together with
the variable host immune responses that occur, make the drugs
unsuitable for use in many instances (Peters 1974). Drug resistance
to antimonials has not become a major problem in leishmaniasis,
although resistance to Pentostam does occasionally occur in a few
types of the disease, especially post kala-azar dermal and diffuse
cutaneous leishmaniasis (Peters 1974). There is, however, frequent
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unresponsiveness to antimonials amongst other types of Leishmania,
although this is not apparently attributable to aquired drug
resistance (WHO Bulletin 1982). In cases where pentavalent
antimonial treatment fails, the drugs pentamidine, allopurinol or
amphotericin B are generally used (Steck 1981a). These drugs,
however, can be toxic and frequently have only poor activity.
Consequently there is an urgent requirement for new antileishmanial
agents, not only for treating drug-resistant cases but also to avoid
the toxic side effects of those in current clinical use.
1.3.2.1. The search for new drugs
A number of different strategies are employed in the search for
new chemotherapeutic agents (Steck 1981b). There is random screening
of available chemicals, many of which are produced as part of
research into other diseases. Chemotherapeutic studies with
Leishmania have been hindered by the lack of effecti veness of many
antileishmanial agents against promastigotes growing in vitro
(Beverage 1963). Amastigotes have not so far been successfully grown
axenically in vitro, however the development of other in vitro
methods to assess drug sensitivities against both Leishmania-infected
monocyte-deri ved macrophages (Berman and Wyler 1980) and also
amastigotes transforming in vitro (Hart et al. 1981a, Coombs et al.
1983) has allowed screening of new potential drugs against the target
form of the parasite, the amastigote. The former method has the
advantage that it involves the complete host-parasite system in which
the amastigotes multiply, whereas the latter method has the potential
advantage that interference from host cells that might process the
drug is avoided.
A significant advance in the treatment of visceral leishmaniasis
appears to have been achieved with the developement of liposome-
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entrapped antileishmanial drugs with which the efficacy of treatment
has been increased several hundred fold (Black et al. 1977, New
et al. 1978, Alving et al. 1978). The liposomes containing the drugs
are taken up by Kupffer cells of the liver and spleen, the cells in
which Leishmania resides in visceral infections, and then fuse with
the parasitophorous vacuole thus bringing the drug into close
proximity with the parasites (Heath et al. 1984). The specific
targeting of the drug to cells in which the Leishmania lives, such
that it is kept isolated from the general circulation, shows great
promise in reducing toxicity and increasing efficacy in the treatment
of leishmaniasis.
Another approach in the search for new drugs is target-directed
biochemical rationale, that is the selection of an enzyme system only
found in the parasite and the design of inhibitors specific for that
enzyme system (Steck 1981b, Wang 1984). Unfortunately, there has
been little biochemical research on the amastigote of Leishmania, the
form that is the causati ve agent of the disease in man, but initial
work has indicated that there are significant differences between the
amastigote and promastigote. The unique subcellular organisation of
trypanosomatid flagellates, including the arrangement of various
glycolytic and associated enzymes in glycosomes, provides several
aspects of metabolism that are potential targets for chemotherapy.
Biochemical investigations into the organisation and control of
pathways associated with the glycosomes and other subcellular
organelles could reveal major differences between the parasite and
host cells and it is this approach that forms the overall basis for
the research carried out in this project.
Compartmentation has been suggested as a major factor in the
antitrypanosomal effect of melarsen oxide. Pyruvate kinase has been
shown to be the likely target of the drug in vivo (Flynn and Bowman
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1974, Bowman and Flynn 1976), although a number of other trypanosomal
enzymes were inhibi ted to a greater extent than pyruvate kinase in
crude homogenates (Bowman and Flynn 1976, Fairlamb and Bowman 1977).
An explanation is that pyruvate kinase is a cytosolic enzyme, freely
available to inhibition by the drug, whereas the other enzymes are
located in organelles that may be impermeable to melarsen oxide
(Fairlamb 1982).
Polyamine function and biosynthesis have also been investigated
as potential chemotherapeutic targets in trypanosomatids for which
these compounds appear to be especially important (Bacchi et al.
1980, Bachrach et al. 1981, Bacchi 1981). Polyamine metabolism has
been implicated with the activity of a number of cationic
trypanocides such as ethidium bromide and antrycide (Bachrach et al.
1979). ~ specific inhibitor of polyamine biosynthesis is ~-
difluoromethylornithine (<<-OMFO) which is an enzyme-activated
irreversible inhibitor of ornithine decarboxylase, one of the key
enzymes of polyamine biosynthesis (Bacchi et al. 1980,1982). This
drug has potent antitrypanosomal activity against T. brucei in mice
(Bacchi et al. 1982), is non-toxic to mammals (Seiler et al. 1978)
and may have some future therapeutic potential. Other new analogues
of ornithine such as sinefungin also show some promise as
antileishmanials (Bachrach et al. 1980).
Ketoconazole is a N-substituted imidazole derivative that was
first shown to have antifungal properties but is also active against
L. tropica and L. mexicana amastigotes infecting human monocyte-
derived macrophages (Berman 1981,1982). Ketoconazole appears to have
a similar mechanism of action in both yeast and Leishmania by
disturbing sterol biosynthesis and function in membranes (Berman
et al. 1984). In studies on L. mexicana promastigotes it was found
that the removal of the 14 Q(.-methyl group of lanesterol was
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inhibi ted, thereby preventing the formation of ergosterol, an
important sterol of Leishmania membranes. The mode of action of the
polyene antibiotic Amphotericin B, which also has both antifungal and
antileishmanial properties, is also thought to involve interaction
with ergosterol resulting in membrane damage (Kobayashi and Medoff
1977)•
All trypanosomatids so far studied have been shown to be
deficient in the de novo synthesis of purine nucleotides (Marr et al.
1978, Ceron et al. 1979) (See section 1.4.1.1.) and consequently
purine salvage enzymes are essential for parasite growth and survival
(Gutteridge and Coombs 1977). Leishmania species possess an unusual
purine salvage enzyme, purine nucleoside phosphotransferase, which
catalyses phosphorylation of purine nucleosides (Nelson et al. 1979).
A number, of purine nucleoside analogues such as allopurinol,
allopurinol riboside and formycin B have been synthesised (Nelson
et al. 1979, Carson and Chang 1981) and shown to have antileishmanial
activity in both in vivo and in vitro tests (See Marr and Berens
1983). The drugs are believed to be metabolised to the nucleotides
by the parasite and are then leishmanicidal either due to
incorporation into nucleic acids or by inhibition of other purine
salvage enzymes (Nelson et al. 1979, Rainey and Santi 1983, Marr and
Berens 1983). These compounds are relatively non-toxic to mammalian
cells which do not possess the nucleos ide phosphotransferase that
metabolises the nucleoside analogues (Nelson et al. 1979, Wang 1984).
Initial clinical trials shows some efficiacy for allopurinol in
antimony-resistant cases of Leishmania (Kager et al. 1981), although
clinical trials on the more active ribonucleoside analogues are still
to be completed (Marr and Berens 1983). The results so far, however,
have emphasised the potential of a rational approach to parasite
chemotherapy.
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1.3.2.2. The mode of action of antileishmanial antiroonialdrugs
Pentavalent antimonials, such as Pentostam, are the most
important group of drugs for treating leishmaniasis (Steck 1981a).
There are, however, no reports on the mechanism of action of these
antileishmanial antimonials, although it has been suggested that
glycolytic kinases, especially phosphofructokinase, may be involved
(Gutteridge and Coombs 1977). This idea probably arose from the
report that the activity of antischistosomal trivalent antimonials,
such as Stibophen, are thought to be mediated through inhibition of
phosphofructoki nase (Mansour and Bueding 1954, Buedi ng 1969).
Pentostam was shown to be effective against leishmanial amastigotes
growing in human monocyte-derived macrophages in vitro (Berman and
Wyler 1980) and against amastigotes transforming in vitro (Coombs
et al. 1983) but it had no acti vity against cultured promastigotes
(Mattock and Peters 1975, Berman and Wyler 1980, Coombs et al. 1983).
It has been suggested that pentavalent antimonials, like the
pentavalent antitrypanosomal arsenicals, must be reduced to the
trivalent form to be active (Goodwin and Page 1943, Crawford 1947,
Flynn and Bowman 1974) and the inhibition of transforming
amastigotes by Pentostam suggests that prior metabolism by the host
cell is not required for activi ty (Coombs et al. 1983). Pre-dosing
of host cells growing in vitro wi th antimonials before their
infection by amastigotes increased significantly the antileishmanial
activity of the drugs and it was suggested that these compounds exert
their main effects on the amastigotes, during the brief
extracellular phase of their existence in the vertebrate host, when
infecting other host cells (Mattock and Peters 1975). Nevertheless,
the drugs do exert a significant antileishmanial effect on
intracellular amastigotes (Berman and Wyler 1980).
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1.4 INTERMEDIARY METABOLISM OF LEISHMANIA
Leishmania is similar to many other unicellular parasites in
that it multiplies relatively rapidly, approximately once every 12
hours in the case of L. m. mexicana promastigotes in culture, and
once every 24 hours for amastigotes growing in macrophages in vitro.
Consequently the parasites are dependent upon the production of large
quantities of new cellular materials and the formation of sufficient
energy to meet this requirement (Von Brand 1979). The amastigote and
promastigote of Leishmania have contrasting morphology and live in
very different environments, therefore it is to be expected that
their metabolism differs to some extent. The biochemistry of the
promastigote has been extensively studied, as it can be cuItivated
easily axenically in vitro, but it is only recently, since a
procedure-was developed to isolate amastigotes essentially free from
host cell contamination (Hart et al. 1981b), that sufficient material
has been available for detailed biochemical study of this stage of
the parasite. This development has allowed the comparative studies
on the two forms that are essential for the elucidation of both the
changes that occur during transformation of the amastigote to
promastigote (and vice-versa) and also the relationship between the
amastigote and its host cell, the macrophage. It should also be
noted that all the biochemical studies performed on the promastigote
have been done on those cells grown in culture, from amastigotes
transformed in vitro, and not on promastigotes isolated from the
sandfly, as far too few promastigotes can be isolated from the insect
vector to allow extensive biochemical study. It has been generally
assumed. however. that the biochemistry of culture promastigotes is
similar to that found in the insect gut.
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1.4.1. Biosynthetic processes
The basis for the growth and functioning of any cell is the
formation of complex molecules from low molecular weight precursors
and metabolic intermediates and the subsequent incorporation of these
macromolecules into supramolecular assemblies and finally organelles.
The metabolic pathways and molecular mechanisms whereby these
precursors are converted into macromolecules can vary greatly between
species. even though the major classes of macromolecules. nucleic
acids. proteins. lipids and polysaccharides all have similar
functions in different types of cell. Polysaccharides have two major
functions. Some serve as energy stores. e.g. starch and glycogen
whilst others. e.g. cellulose. are structural components of the cell.
Leishmania apparently contain no polysaccharide energy stores
(Cutt.er-Ldgeand Coombs 1977) or complex carbohydrates used in cell
structure. therefore no further mention will be made of these
macromolecules. Nucleic acid. protein and lipid metabolism. however.
are important areas of Leishmania biochemistry as they have some
unique features which are the basis for the mode of action of a
number of antiparasitic agents (Gutteridge and Coombs 1977. Von Brand
1979) •
1.4.1.1. Nucleic acids
Nucleic acids are synthesised from purine and pyrimidine
nucleotides. In mammalian cells purines can either be synthesised de
novo from glycine. formate. CO2, glutamine and aspartate or. in
certain tissues. salvaged from the bloodstream. Most trypanosomatid
protozoa are unable to synthesise the purine ring de ~ and rely
totally on salvage for their purine requirements (Jaffe and
Gutteridge 1974). The one known exception to this is C. oncopelti.
which has been shown to incorporate radioactively labelled glycine
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into nucleic acid purines (Jaffe and Gutteridge 1974). This
organism, however, as unusual as it contains »bipolar bodies», which
are thought to be endosymbiotic bacteria that may synthesise the
purine ring de novo for the protozoan (Gutteridge and Macadam 1971,
Gutteridge and Coombs 1977). Purine metabolism has been studied
extensively in promastigotes of Leishmania (Marr et al. 1976, Tuttle
and Krenitsky 1960, Lafon et al. 1962), but only recently in
amastigotes of L. donovani (Looker et al. 1963) and L. m. mexicana
(Hassan and Coombs 1964). The purine salvage pathways of L. donovani
have been shown to be similar in both forms of the parasite with the
ex cept ion 0fad enos ine met abo lis m (Loo ker eta 1. 1963 )• In
amastigotes of L. donovani, adenosine is deaminated to inosine by
adenosine deaminase before it is subsequently cleaved to
hypoxanthine. In contrast, promastigotes, which do not contain
adenosine deaminase, metabolise adenosine to adenine, which is
subsequently converted to hypoxanthine, by adenine deaminase (Looker
et al. 1963). Adenine deaminase is not found in amastigotes of
L. donovani (Looker et al. 1963). This stage specific adenosine
metabolism in L. donovani has not been found with L. m. mexicana
(Hassan and Coombs 1964). Both amastigotes and promastigotes of
L. m. mexicana contain adenosine and adenine deaminases and it has
been suggested that adenosine is converted either to AMP by adenosine
kinase or to hypoxanthine via adenosine deaminase and inosine
nucleosidase. Purine bases are salvaged by purine
phosphoribosyltrarisferases(PRTases). which have been found in high
activity in both L. donovani (Looker et al. 1963) and L. m. mexicana
(Hassan and Coombs 1964). Both hypoxanthine and guanine are believed
to be metabolised by the same enzyme, hypoxanthine-guanine PRTase
(Tuttle and Kreni tsky 1960, Looker et al•• 1963, Hassan and Coombs
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1984) which together with xanthine PRTase is found in glycosomes
(Hassan and Coombs 1984). Adenine PRTase is cytosolic. The PRTases
of Leishmania have been shown to be very different from mammal ian
isofunctional enzymes as they have a higher affinity for various
purine analogues, such as allopurinol, than the mammalian enzyme
(Marr and Berens 1983) (See secti on 1.3.2.1.). Promastigotes of
L. donovani have also been shown to have a unique purine nucleoside
phosphotransferase activity that converts allopurinol ribonucleoside
to its monophosphate nucleotide (Nelson et al. 1979). Although no
physiological substrates or phosphate donors have been discovered for
this enzyme (its only activity being with allopurinol ribonucleoside
and formycin B), it has great potential as a target for
antileishmanial drugs (Looker et al. 1983).
In contrast to purines, pyrimidines can be synthesised de ~
by parasitic protozoa (Gutteridge and Coombs 1977, Hammond and
Gutteridge 1982). All the enzymes involved in de novo synthesis have---
been detected in homogenates of L. m. amazonensis promastigotes
(Hammond and Gutteridge 1982). The first three enzymes of the
pathway, carbomyl phosphate synthase, aspartate carbomyltransferase
and dihydro-orotase, are cytosolic in Leishmania. In mammalian cells
these three enzymes are thought to be found in a multienzyme complex
in the cytosol (Jones 1980), but there is no evidence to suggest that
this occurs in Leishmania or any other trypanosomatid. In all
eukaryotic cells other than trypanosomatids in which it is found, the
fourth enzyme of the pyrimidine biosynthetic pathway, dihydro-orotate
dehydrogenase is a particulate mitochondrial enzyme that is linked to
the respiratory chain at the Ubiquinone level (Miller 1975). In
Leishmania, however, the isofunctional enzyme is soluble, utilizes
oxygen but is not linked to the respiratory chain (Gero and Coombs
1982, Hammond and Gutteridge 1982). Studies with amastigotes and
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promastigotes of L. m. mexicana suggested that the enzyme does not
have a hydroxylase mechanism that requires the involvement of an
unconjugated reduced pteridine (Gero and Coombs 1982) as had
originally been suggested for C. fasciculata and other
trypanosomatids (Kidder et al. 1976, Gutteridge et al. 1979). Recent
data on the enzyme purified from C. fasciculata and T. brucei
supported the previous work on L. m. mexicana and showed that the
enzyme exhibited a characteristic flavin electronic spectrum
suggesting that dihydroorotate oxidation in trypanosomatids is
mediated by flavoprotein oxidases rather than pteridine-linked
hydroxylases (Pascal et al. 1983). The last two enzymes of de novo
pyrimidine biosynthesis, orotate phosphoribosyl transferase and
orotidine-5'-phosphate carboxylase, have also been found to have
unusual properties in trypanosomatids in comparison to mammalian
enzymes. In mammals the enzymes are cytosolic whereas in the
trypanosomatids they have been shown to be particulate (Gero and
Coombs 1980, Hammond and Gutteridge, 1980, 1982, 1983) and associated
with glycosomes (Hammond et al. 1981, Hammond and Gutteridge 1982).
Pyrimidines may be produced not only by synthesis de novo but
also via salvage pathways and a number of the enzymes involved in the
salvage of uracil have been detected in L. m. amazonensis (Hammond
and Gutteridge 1982).
Another important area of nucleotide metabolism in parasitic
protozoa is the production of deoxyribonucleotides for DNA synthesis,
either from the corresponding ribonucleotide diphosphates by the
li ttle studied ribonucleotide reductase complex, or through salvage
of thymine and thymidine (Gutteridge and Coombs 1977). The
methylation of the pyrimidine ring in the formation of dTMP from dUMP
involves the thymidylate synthase cycle which, together with the
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biosynthesis of tetrahydrofolate, is of particular importance as the
target for drugs used in the chemotherapy of a number of parasitic
diseases, most notably malaria. Thymidylate synthase and
dihydrofolate reductase both occur on the same bifunctional protein
in protozoa (Garrett et al. 1984), whereas the enzymes from mammalian
cells, bacteria and yeast are distinct and readily separable (Blakely
1969)•
Little is known about the conversion of nucleotides into nucleic
acids in parasitic protozoa although there has been some work on the
the DNA polymerases of T. brucei (Dube et al. 1979) and C. fascicu-
lata (Holmes et al. 1984). DNA polymerase A, the predominant DNA
polymerase of T. brucei, is similar to the high molecular weight
enzyme found in C. fasciculata. Both of these enzymes, however, are
different,from the mammalian equivalent DNA polymerase, as judged by
the inabi lity of specific antisera that cross-reacts wi th DNA
polymerase from different mammalian species to cross-react with the
trypanosomatid polymerases (Holmes et al. 1984). A second
polymerase, DNA polymerase B, has been isolated from C. fasciculata.
It was found to be of lower molecular weight and is more easily
classified as a type similar to DNA polymerase ~ from mammalian cells
(Holmes et al. 1984).
In Leishmania, and all other members of the Kinetoplastida, DNA
is found in both the nucleus and in association with the Kinetoplast
(kDNA). kDNA is found as a giant network composed of thousands of
catenated mini circles (0.8-2.5Kb depending on species) and 20-50
identical DNA maxicircles, which in different species range from 20-
40Kb. Maxicircles are similar to, but a little larger than,
mammalian mitochondrial DNA (Englund 1981). and their major
transcripts have been found to be 9S and 12S ribosomal RNAs. As yet,
however, no translation products have ben detected (Englund et al.
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1962). The minicircles are heterogenous in base sequence and
apparently do not have a conventional coding sequence as it appears
that they are not transcribed (Challberg and Englund 1960). The
function of kDNA is still not understood, although it is likely that
the maxicircles are trypanosomatid equivalents to mitochondrial DNA.
A number of theories concerning mini circle function have been
suggested, includi ng a structural roLe in the segregation of
maxicircles equally to progeny mitochondria (Englund 1961). As well
as understanding the function of kDNA, its unique properties may also
lead to new chemotherapeutic drugs that interfere with either
replication or transcription of this satellite DNA.
1.4.1.2. Proteins
Parasitic protozoa require the same twenty amino acids for
protein synthesis as mammalian cells. In mammals ten of the common
amino acids cannot be formed de novo and must be obtained from their
food, whilst the remainder can either be synthesised de ~ from
metabolic intermediates or formed from the essential amino acids.
The precise amino acid requirements for Leishmania are not known,
although studies on L. m. mexicana (Hart and Coombs 1962),
L. donovani and L. b. braziliensis (Steiger and Meshnick 1977) give
some information for both promastigotes growing in vitro and, in the
case of L. m. mexicana, transforming amastigotes. Proline was
excreted by promastigotes of L. m. mexicana (Hart and Coombs 1962),
suggesting that this species is unlike several other kinetoplastid
flagellates including L. donovani, the insect stages of which are
reported to use proline as a major energy source (Srivastava and
Bowman 1971, Krassner and Flory 1972). The anabolism of proline in
L. donovani involves arginine, ornithine and citrulline as precursors
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(Krassner and Flory 1972, Camargo et al. 1976) and interestingly both
argenine and ornithine were consumed by L. m. mexicana promastigotes
(Hart and Coombs 1962).
The apparent importance of amino acid catabolism in the energy
metabolism of some Leishmania species has prompted studies on the
uptake of amino acids into the parasites. L. tropica promastigotes
have been shown to have an active transport system for L-proline (Law
and Mukkada 1979) and methionine (Mukkada and Simon 1977). In
addi t ion, studies with L. tropica promastigotes with the non-
metabol isable analogue of neutral ami no acids, 0< -aminoisobutyric
acid, has shown that there is a common transport system, regulated by
feedback inhibition and transinhibition, for alanine, cysteine,
glycine, methionine, serine and'proline (Lepley and Mukkada 1963).
TherB has been very little work reported on the mechanism by
wh{ch proteins are synthesised in parasitic protozoa. The first
step, the transcription of nuclear DNA to produce mRNA, is catalysed
by a DNA-dependent RNA polymerase. Trypanosoma cruzi and T. brucei
have been shown to contain unique RNA polymerases which fail to
separate into different classes, whereas C. fasciculata and L. m.
amazonensis have chromatographically distinct RNA polymerases
(Kitchin et al. 1964). Translation of the mRNA then occurs on
ribosomes found in the endoplasmic reticulum. Ribosomal structure
and the mechanism of protein synthesis have not been investigated in
Leishmania, although there has been some work on polypeptide
synthes is in Crithid ia which suggested that it is more simi lar to
other eukaryotic cells than to prokaryotes (Gutteridge and Coombs.
1977)•
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1.4.1.3. Lipids
Studies on the lipids of various species of Leishmania have
shown that in promastigotes total lipids accounted for 2-15% of the
dry weight of the cell and that neutral and polar lipids were 14-55%
and 45-66% respectively of the total lipids (Gercken et al. 1976,
Beach et ale 1979, Herrmann and Gercken 1960). In L. donovani, the
main lipids, phospholipids, sterols and acyl glycerols were found in
a ratio of 1:0.37:0.24. In the phospholipid fraction, phosphatidyl
choline (57%), phosphatidyl ethanolamine (23%), phosphatidyl inositol
(11%) and sphingomyelin (6%) were the major lipids identified
(Gercken et al. 1976). In addition, it was found that up to 50% of
phosphat idyl ethanolamine existed in the plasmalogen form (Gercken
et al. 1976), and that Leishmania were able to synthesise ether
lipids from basic metabolites such as glucose and amino acids
(Herrmann and Gercken 1960). Recently, the initial steps of
alkoxyphospholipid biosynthesis, including plasmalogens, have been
discovered in the glycosomes of bloodstream T. brucei (Opperdoes
1964a) and therefore these enzymes may also may be present in
glycosomes of Leishmania. Free sterols and sterol esters were also
found in L. donovani promastigotes in a ratio of 1:0.3. The main
sterols detected were isomers of ergosterol , similar to those found
in fungi, and the identification of squalene and lanesterol suggested
that sterols were being produced by the route typical of non-photo-
synthetic organisms such as animals and fungi (Goad et al. 1964). The
possible interference by the drug ketoconazole in the metabolism of
sterols in Leishmania (See section 1.3.2.1.)makes an understanding
of this area of lipid metabolism of prime importance.
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1.4.2. Degradation processes
The major energy producing catabolic pathways found in
trypanosomatid parasitic protozoa are glycolysis, the tricarboxylic
acid cycle (TCA cycle),the respiratory chain, amino acid catabolism
and ~-oxidation of fatty acids. The enzyme levels and in vivo
metabolic functioning of the pathways have been characterised for a
number of trypanosomatids and have been found to vary considerably
between different species and indeed between different developmental
stages of the same species (Gutteridge and Coombs 1977, Bowman and
Flynn 1976).
1.4.2.1. Substrate utilization and end products oT metabolism in
Leistmania
The ,major end products of Leishmania promastigote energy
metabolism are succinate, CO2, pyruvate and alanine (Steiger and
Meshnick 1977, Marr 1980, Hart and Coombs 1982). There is some
controversy, however, on the relative importance of glucose and amino
acids as substrates for Leismania energy metabolism, although the
variations found may be related to species differences and the length
of time that the promastigotes have been growing in culture. The
growth of L. tropica, L. donovani and L. braziliensis was found to be
similar in media with and without added glucose (Mukkada et al. 1974,
Marr and Berens 1977), nevertheless when glucose was added, this
utilization was found to be greatest in the late-log phase and
stationary phase of growth. Later studies on L. m. mexicana,
L. donovani and L. braziliensis also showed substantial glucose
utilization throughout promastigote growth (Steiger and Meshnick
1977, Hart and Coombs 1982).
The importance of glucose as an energy substrate in promas-
tigotes has prompted studies on its uptake. In studi es with
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L. tropica and L. donovani involving the non-metabolisable analogue
2-deoxy-D-glucose, it was demonstrated that glucose was actively
accumulated via a carrier-mediated transport system with a high
affini ty and speci fici ty for D-glucose (Schaefer et ale 1974,
Schaefer and Mukkada 1976, Zilberstein and Dwyer 1984). This high
affinity for glucose could be important to Leishmania promastigotes
at times when the glucose content in the environment of the parasite
is low; possibly when the promastigote is taken up into the host
macrophage or when the glucose in the insect gut, taken up in the
blood meal of the sandfly, has been used (Zilberstein and Dwyer
1984).
The catabolism of amino acids, and in particular proline, has
been suggested as a major source of energy in promastigotes of
L. donovan-i and L. tropica (Krassner and Flory 1972, Law and Mukkada
1979). High concentrations of proline and other amino acids have
been found in the haemolymph of insects (tsetse flies) (Bursell 1966)
and it has been suggested that the catabolism of amino acids by
promastigotes of Leishmania may be an adaptation to life in the
sandfly. Steiger and Meshnick (1977), however, suggested that amino
acids were not important energy sources in L. brazi liens is or
L. donovani promastigotes and these results are similar to those of
Hart and Coombs (1982) who found that both promastigotes and
amastigotes of L. m. mexicana consumed some amino acids but also
excreted others including alanine,- glycine and proline.
Although the majority of work on substrate utilization has
involved promastigotes growing in culture, the energy metabolism of
L. m. mexicana amastigotes transforming in vitro has also been
investigated (Hart and Coombs 1982). The major end-products of
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amastigote catabolism, CO2 and succinate, were the same as for
promastigotes, but the utilization of substrates was found to differ
significantly between the two forms. Glucose was catabolised by
amastigotes at a lower rate than by promastigotes, but, in contrast,
the rate of uptake and metabolism of non-esterified fatty acids was
10 fold higher in the mammalian stage (Hart and Coombs 1982). This
suggests that fatty acids are important energy substrates for
amastigotes, whereas they may only be important as substrates in
promastigote anabolism. This ability to utilize fatty acids by the
amastigote may be related to environmental conditions as macrophages
regulate the level of lipoproteins in the serum (Brown et al. 1979)
and may therefore provide a large supply of lipids for amastigote
catabolism (Hart and Coombs 1982).
1.4.2.2. Gaseous requirements of Leishmania
Relatively high 02 tensions (maximum growth at 20% v/v 02) were
found to be essential for continual growth of L. m. mexicana
promastigotes in vitro, whereas puri fied amastigotes transformed
successfully in vitro with as low as 0.4% (v/v) 02 (Hart et al.
1981c, Hart and Coombs 1981). Carbon dioxide levels in the range
0.1-5% had little effect on promastigote growth, but at 5% CO2
amastigote transformation was greatly stimulated compared with that
at 0.1%. This finding may reflect the different environments of the
two forms of the parasite as L. m. mexicana amastigotes are found in
poorly vascularised cutaneous lesions that could well be expected to
have low 02 tensions. In addition, the host cell, the macrophage,
may utilize a high proportion of the available 02 producing CO2 as an
end product. It has been suggested that the susceptability of
amastigote transformation to high CO2 levels may be the trigger
whereby transformation is initiated after ingestion of the amastigote
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into the sandfly gut (Hart and Coombs 1961), however there is no
evidence that CO2 levels are higher in the insect gut than the
parasitophorous vacuole of macrophages residing in the centre of a
poorly vacularised lesion. CO2 levels are thought to be important to
a number of parasites) they may be involved in the hatching of
coccidial oocysts, the exsheathment of nematode eggs and larvae and
are also of importance to the activity of various CO2-fixing enzymes
involved in the metabolism of many parasi tic helminths (Von Brand
1979, Barrett 1961).
1.4.2.3. Catabolism in Leishmania
Glycolysis, the TeA cycle and the pentose phosphate pathway
(PPP) are the major pathways involved in the catabolism of carbohyd-
rates in higher animals. All three pathways have been shown to be
present in many parasitic protozoa, although in some instances the
TCA cycle is absent, incomplete or even acts to a certain extent in
the reverse direction (Von Brand 1979). In addition, the TCA cycle
is a key entry point into general metabolism for the products of
protein degradation, through amino acid catabolism, and fatty acid
catabolism through ,a-oxidation. With this area of Leishmania
biochemistry, as with most other aspects, it is mainly the culture
promastigote that has been studied (See Marr 1960), although there
has been some recent work on purified amastigotes (Coombs et al.
1962, Meade et al. 1964).
1.4.2.3.1. Glycolysis and the pentose phosphate pathway
The detection of metabolic intermediates and end-products by the
use of radioactively-labelled substrates and the measurement of
enzyme activities are classic ways of confirming the presence of an
35
active metabolic pathway. The production of labelled succinate and
pyruvate from radioactive glucose in promastigotes of L. donovani
(Chatterjee and Datta 1973). together with the detection of
activities of all the glycolytic enzymes from hexokinase to pyruvate
kinase in four species of Leishmania (Martin et al. 1976). suggested
that the Embden-Meyerhoff pathway is functional in Leishmania
promastigotes. The essential enzymes of the pentose phosphate
pathway have also been found in four species of Leishmania (Martin
et al. 1976).
Many eukaryotic cells which can utilize glucose under both
aerobic and anaerobic conditions exhibit a phenomenon known as the
Pasteur effect. If oxygen is admitted to an anaerobic suspension of
cells that are utilizing glucose at a high rate by fermentation
involving glycolysis. the rate of glucose catabolism declines to a
small fraction of its anaerobic rate. This effect is mediated by the
high [ATP]I [ADP] ratios produced during oxidative phosphorylation
inhibi ting the rate of glycolysis through inhibi tion of
phosphofructokinase. In mammalian cells phosphofructokinase is an
allosteric enzyme that is stimulated by ADP and AMP and inhibited by
ATP and citrate and is a key enzyme in the control of glycolysis.
Two other enzymes. hexokinase and pyruvate kinase. are also involved
in the control of glycolysis but not to the same extent as
phosphofructokinase (Krebs 1972). There are at least two kinds of
pyruvate kinase found in mammalian cells which are classified
according to functional parameters. In cells in which both
glycolysis and gluconeogenesis occur (for example. liver cells).
pyruvate kinase is allosterically regulated by various heterotrophic•modulators. whereas in muscle cells. which are primarily concerned
with energy production. the enzyme is not allosterically controlled.
Leishmania promastigotes do not exhibit the Pasteur effect and a
number of workers have shown that there appears to be no such
regulation of glycolysis in Leishmania (Berens and Marr 1977a,b, Marr
and Berens 1977, Berens et ale 1980, Marr 1980). Partially purified
hexokinase from promastigotes of L. donovani and L. braziliensis
showed conventional Michaelis-Menten kinetics with respect to its
substrates but no inhibition or activation was found with any
glycolytic intermediates or phosphorylated nucleotides (Berens et al.
1980). Glucose-6-phosphate, the product of hexokinase, can be
metabolised further either via glycolysis or the PPP. The first
enzyme of the PPP, glucose-6-phosphate dehydrogenas~ also appeared
to be uncontrolled (Berens et al. 1980), suggesting that some other
mechanism, such as subcellular compartmentation, may be involved in
regulating the fate of glucose-6-phosphate. Phosphofructokinase from
both L. braziliensis and L. donovani promastigotes was found to be
allosterically activated by its substrate fructose-6-phosphate and
required AMP for activation, but was unaffected by other modifiers
(Berens and Marr 1977a).
Pyruvate kinase from the supernatants of crude homogenates of
L. donovani and L. braziliensis was reported to be allosteric with
respect to its substrate PEP but to be unaffected by any hetero-
trophic modifiers except H+ ions, and was therefore thought to be
similar to the mammalian muscle enzyme (Berens and Marr 1977b).
Previous studies on crude homogenates of L. tropica promastigotes
suggested that pyruvate kinase was activated by fructose-1,6-diphos-
phate and AMP (Mukkada et al. 1974). Both of these studies,
however, were performed on crude extracts that contained substrates
and other factors that could affect the function of the enzyme and so
have limited usefulness in elucidating regulation mechanisms. A
recent preliminary report by Etges and Mukkada (1983)suggested that
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purified pyruvate kinase from L. tropica was under both heterotrophic
and homotrophic allosteric regulation. The enzyme was reputed to be
activated by phosphoenolpyruvate and fructose-1,6-diphosphate and
strongly inhibited by ATP, GTP and ITP. Clearly this enzyme could be
an important regulatory point in Leishmania metabolism as phospho-
enolpyruvate may also be carboxylated to oxaloacetic acid by
phosphoenolpyruvate carboxykinase (PEP carboxykinase). These results
also bring into question the suggestion that the lack of apparent
regulation of glycolysis in Leishmania promastigotes indicates that
the aerobic fermentation of carbohydrates is of only secondary
importance to these organisms (Berens and Marr 19na,b, Marr 1980).
Control of glycolysis in Leishmania could occur by some mechanism not
found in other animal cells and microorganisms, for instance the
unique sUQcellular organisation of trypanosomatid flagellates (See
section 1.4.3.).
There is little data on glycolysis and the PPP in amastigotes of
Leishmania, although a number of glycolytic enzymes have been
detected in amastigotes of L. m. mexicana (Coombs et al. 1982) and
more recently all the enzymes of glycolys is and the PPP were
demonstrated in purified L. donovani amastigotes (Meade et al. 1984).
The activities of the glycolytic enzymes of both L. donovani and
L. m. mexicana amastigotes are generally lower than promastigotes
with pyruvate kinase especially low in L. m. mexicana amastigotes.
This suggests that glycolysis may be less important to the amastigote
than the promastigote.
1.4.2.3.2. The tricarboxylic acid cycle, respiratory chain and
glyoxylate cycle.
The two main forms of Leishmania have a well-developed mitochon-
drion with plate-like cristae, utilize oxygen in a cyanide-sensitive
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fashion and produce CO2 as a major end product (Rudzinska et al.
1954, Simpson 195B, Hart et al. 19B1a,c, Hart and Coombs 19B2). All
these facts suggest that Leishmania has a fully functional TCA cycle
and indeed all the enzymes have been detected with approximately the
same activity in promastigotes of four species of Leishmania (Martin
et al. 1975, Mukkada 1977). The acti vities of citrate synthase and
~-ketoglutarate dehydrogenase were so low in all four of the species
investigated, however, that doubt was expressed as to whether the
pathway was significant in the metabolism of carbohydrates in vivo
(Mukkada 1977, Meade et al. 19B4).
The TCA cycle is also the entry point for the products of both
protein and fatty acid degradation. When amino acids are used as
fuel in mammalian cells they undergo the loss of their amino group
and the carbon skeletons can either be converted into glucose via
gluconeogenesis or oxidized to CO2 via the TCA cycle. As Leishmania
does not appear to contain carbohydrate stores (Marr 19BO), it is
unlikely that gluconeogenesis is important in this parasite. Enzymes
involved in the two major mechanisms of amino acid utilization,
transamination and oxidative deamination, however, have been detected
in Leishmania. Three aminotransferases have been detected in L.
donovani (Von Brand 1979, Le Blancq and Lanham 19B4) and glutamate
dehydrogenase was present in four species of Leishmania promastigotes
(Martin et al. 1975) and L. donovani amastigotes (Meade et al. 19B4).
Amino acids may be provided, at least in part, by intracellular
protein degradation of abnormal proteins. This protein degradation
has been investigated in L. tropica promastigotes (Simon and Mukkada
19B3) where a labile class of proteins (molecular weight 30,000-
50,000) has been demonstrated to have a rapid turnover. L. m.
mexicana has also been shown to have high proteinase activity
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especially in the amastigote (Pupkis and Coombs 1954). Enzymes
involved in ~-oxidation of fatty acids have been reported in
L. m. mexicana promastigotes and amastigotes and the product, acetyl
CoA, can also enter the TCA cycle and be subsequently oxidized to CO2
and H20 (Coombs et al. 1952).
Leishmania is similar to many other trypanosomatids in
possessing a classical respiratory chain containing a terminal
cytochrome aa3 oxidase (reviewed Bowman and Flynn 1976, Von Brand
1979). The use of respiratory inhibitors with known mechanisms of
action have greatly helped the elucidation of the components of
trypanosomatid respiratory chains. The respiration of both
amastigotes and promastigotes of L. m. mexicana was sensitive to
cyanide, azide, antimycin A and high concentrations of amy tal
indicating similarities in the respiratory chain between both stages
of the parasite and also mammalian systems (Hart et al. 1951c).
There is no evidence for any branched respiratory chain, with
multiple terminal oxidases, in Leishmania promastigotes (Martin and
Mukkada 1979, Hart et al. 1951c), whereas cytochrome 0 has been
detected in various members of the Kinetoplastida including C. fasci-
culata and T. brucei (Hill and Cross 1973, Kronick and Hill 1974).
The two key enzymes of the glyoxylate cycle, isoci trate lyase
and malate synthase, have been reported in promastigotes of five
species of Leishmania (Mukkada 1977, Simon et al. 1975). These
findings, together with the detection of the intermediate glyoxylate,
suggested that the cycle is operative in vivo. The glyoxylate cycle
is found in many prokaryotes, fungi and plants (Hogg and Kornberg
1963, Spector 1972). The role of the glyoxylate cycle in Leishmania
is not established, but it could be important in utilizing substrates
such as fatty acids. It is not known if the cycle is present in
amastigotes, however, the high rate of utilization of fatty acids by
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transforming amastigotes of L. m. mexicana (Hart et al. 1981a,c, Hart
and Coombs 1982) suggests that this form of the parasite may benefit
from such a cycle.
1.4.2.3.3. Carbon dioxide fixation
Succinate is an important end product of many parasites and can
be formed by TCA cycle enzymes operating in either the forward or
reverse directions (Von Brand 1979). Excretion of succinate means
that oxaloacetic acid (OAA) must be regenerated in order for the TCA
cycle to continue functioning and this may occur through a number of
CO2-fixing reactions. PEP carboxykinase is the major CO2-fixing
enzyme in many succinate-excreting parasitic worms, including
Fasciola hepatica (Prichard and Schofield 1968), Hymenolepis diminuta
(Bueding and Saz 1968) and Trichinella spiralis (Ward et a1. 1969).
This enzyme, and other CO2-fixing enzymes, pyruvate carboxylase and
malic enzyme (Table 4), have been discovered in various species of
trypanosomatids (Bacchi et al. 1970, Klein et al. 1975, Martin et al.
1976, Cataldi de Flombaum et al. 1977, Cazzulo et al. 1980).
Table 4. Enzymes of CO2-fixation in Leishmania
1. Pyruvate carboxylase (EC 4.6.1.1.)
Pyruvate + HC03- + ATP ~Oxaloacetic acid + ADP + Pi
2. Malic enzyme (EC 1.1.1.40.)
Pyruvate + HC03- + NADPH Malate + NADP
3. PEP carboxykinase (EC 4.1.1.49.)
PEP + ADP + HC03-~Oxaloacetic acid + ATP
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L. donovani promastigotes incorporated 14C-labelled CO2 into the
end product succinate in the presence of glucose (Chatterjee and
Datta 1973). Pyruvate was suggested as the major CO2 acceptor
(possibly via pyruvate carboxylase), the malate produced being
subsequently converted to succinate. Radioactive assays, however,
showed tha presence in L. donovani promastigotes of three CO2-fixing
enzymes, pyruvate carboxylase, malic enzyme and PEP carboxykinase
(Chatterjee and Datta 1974). Pyruvate carboxylase was subsequently
found with low activity in promastigotes of three other species of
Leishmania (Martin et al. 1976, Berens and Marr 1977a) and more
recently in amastigotes of L. donovani (Meade et al. 1984). Neither
Martin et al. (1976) or Meade et al. (1984) assayed for PEP carboxy-
kinase, although Berens and Marr (1977a) could not detect the enzyme
using a ,spectrophotometric assay in either L. braziliensis or
L. donovani. PEP carboxykinase, however, has been reported to be the
major CO2-fixing enzyme in C. fasciculata (Bacchi et al. 1970, Klein
et al. 1975), T. cruzi epimastigotes (Cataldi de Flombaum et al.
1977, Cazzulo et al. 1980) and T. brucei procyclic trypomastigotes
(Klein et al. 1975), all of which produce substantial quantities of
succinate as an end product (Bowman 1974).
1.4.2.4. Variations in metabolism during the life-cycles of
trypanosClTEtids
Of special interest in the study of intermediary metabolism,
including energy metabolism, in digenetic trypanosomatids is the
elucidation of the ways in which different parasite forms are adapted
to the very different environments that they encounter during their
life-cycle. The changes that occur in ultrastructural morphology and
intermediary metabolism can be extreme and the most studied
transformation is that between the long slender bloodstream and the
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culture procyclic forms of T. brucei. The bloodstream form is
totally dependant on glycolysis for energy production with glucose,
entirely to pyruvate under aerobic conditions (Flynn and Bowman
1973). TCA cycle and respiratory chain enzymes and cytochromes are
absent, and the NAOH produced by glycolysis is reoxidized by a
coupled glycerol-3-phosphate dehydrogenase and glycerol-3-phosphate
oxidase system that involves oxygen as the terminal electron acceptor
but is cyanide insensi tive (See Bowman and Flynn 1976, Bowman and
Fairlamb 1976). On transformation to the procyclic stage, other
energy substrates, such as amino acids, are utilized together with
glucose and the mitochondrion is developed to contain an active TCA
cycle and a respiratory chain involving cytochrome aa3 as a terminal
electron acceptor (See Bowman 1974, Bowman and Flynn 1976). These
changes i~ morphology and substrate utilization are also paralleled
by changes in the enzyme content of the glycosome (See section
1.4.3.1.). Trypanosoma cruzi, in comparison, has little change in
mitochondrial structure and energy metabolism during its life-cycle
with respiration being cyanide sensitive in both the cultured
epimastigotes and the mammalian developmental forms of the parasite
(Rogerson and Gutteridge 1979). Leishmania experiences changes in
its environment probably as extreme as those to which T. brucei is
exposed, however, from the information presently available, there
appears to be only quanti tati ve and not quali tati ve differences in
energy metabolism between amastigotes and promastigotes (Hart et al.
1981c, Hart and Coombs 1982, Coombs et al. 1982, Meade et al. 1984).
1.4.3. The relationship between energy metabolism and subcellular
structure of trypanosanatids
The subcellular organisation of trypanosomatids has been
investigated biochemically in the last few years as an extension to
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previous ultrastructural studies using electron microscopy and
cytochemical staining. The principle techniques involved in these
studies have been differential centrifugation and isopycnic
centrifugation on linear sucrose gradients with the subsequent
detection of various enzymes that have been assigned to different
subcellular compartments of the cell. The majority of the work has
been performed on T. brucei (Opperdoes and Borst 1977, See Opperdoes
1984b), although a number of other trypanosomatids are now being
studied in detail (Cannata et ale 1982, Coombs et ale 1982). with
emphasis being given to the characterisation of glycosomes. The part
played by these organelles, however, must be considered together with
the contributions of other cell components if the whole organism is
to be understood. The mitochondrion and cytosol have been studied to
an extent with some trypanosomatids, but there is comparatively
little known about other organelles.
1.4.3.1. Glycosomes
Glycosomes are mi crobody-like organelles that were first
discovered in T. brucei (Opperdoes and Borst 1977, Oduro et al.
1980a) and have subsequently been reported to be present in Crithidia
spp. (Opperdoes et al. 1977a, Taylor et al. 1980), Leishmania spp.
(Coombs et ale 1982, Hammond and Gutteridge 1982) and T. cruzi
(Taylor et ale 1980, Cannata et ale 1982). The presence of
glycosomes in these three major representatives of the Trypanosoma-
tidae suggest that the organelles may be a general feature of this
family of protozoa (Opperdoes 1982). Glycosomes have been separated
from other subcellular components by isopycnic centrifugation
(Opperdoes and Borst 1977) and have been purified to near homogeneity
from bloodstream form T. brucei (Opperdoes et al. 1984) (See section
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1.2. for analysis of purified glycosomes). Initial enzyme analysis
of bloodstream form T. brucei fractionated on sucrose gradients
showed that a number of glycolytic enzymes (hexokinase, glucose
phosphate isomerase, phosphofructokinase, aldolase, triosephosphate
isomerase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate
kinase) together with glycerol kinase and glycerol-3-phosphate
dehydrogenase were associated with glycosomes (Opperdoesand Borst
1977). In addition, it was shown that the activity of these enzymes
exhibited latency in the presence of the detergent Triton X-100 which
suggested that the enzymes were present in an organelle and not
absorbed to particles (Opperdoes and Borst 1977). At the same time,
glycerol-3-phosphate oxidase was found to band with the mitochondrial
marker oligomycin-sensitive ATPase suggesting it was located in the
highly repressed mitochondrion of bloodstream T. brucei (Opperdoes
and Borst 1977, Opperdoes et al. 1977a).
Trypanosoma brucei was also screened for enzymes which have been
. -.....used as classical markers for other microbodies in other organisms
(mammalian peroxisomes or plant glyoxysomes). Catalase, O-amino acid
oxidase, malate synthase and isocitrate lyase were not detectable in
the bloodstream form of T. brucei and this suggested that glycosomes
are distinctly different from all other organelles previously
isolated (Opperdoes et al. 1977b). Interestingly, catalase was
detected in glycosomes of Crithidia spp. (Opperdoes et al. 1977a),
and peroxidase in those of T. cruzi epimastigotes (Oocampo et al.
1976). A number of recent advances, however, have suggested that
glycosomes and mammalian peroxisomes may in fact be related
(Opperdoes 1984a). Enzymes involved in alkoxy-phospholipid
biosynthesis have been detected in glycosomes of bloodstream
T. brucei (Opperdoes 1984a) and some enzymes of ~-oxidation of fatty
acids have been implicated with glycosomes of Leishmania
45
promastigotes (Hart and Opperdoes 1983)J both pathways are present in
peroxisomes of mammalian cells (Lazarow and De Duve 1976, Lazarow
1978).
A number of other enzymes have been found associated with
glycosomes of trypanosomatids. Adenylate kinase, which in mammalian
cells is found between the inner and outer mi tochondrial membrane
(Janski and Cornell 1980), has a dual mi tochondrial and glycosomal
distribution in both bloodstream and procyclic T. brucei (Opperdoes
et al. 1981) and was also found in glycosomes of bloodstream
T. rhodesiense (Mclaughlin 1981) and Leishmania promastigotes (Hart
and Opperdoes 1983). The last two enzymes of pyrimidine
biosynthesis, orotate phosphoribosyl transferase and orotidine
carboxylase, were also found to be associated with glycosomes of
bloodstream form T. brucei, T. cruzi culture epimastigotes, blood
trypomastigotes and intracellular amastigotes, L. m. amazonensis
promastigotes and also C. luciliae (Hammond et al. 1981, Hammond and
Gutteridge 1982, Pragobpol et al. 1984). Hammond and Gutteridge
(1982), however, were unable to detect latency of orotate
phosphoribosyltransferaseand they found that various inhibitors were
as effective against the enzyme activity of intact glycosomes as that
in broken glycosomal preparations. They suggested therefore that
both enzymes are located on the outside of the glycosome and are
freely accessible to the cytoplasm. As well as these pyrimidine
biosynthetic enzymes, the purine phosphoribosyltransferases,
hypoxanthine-guanine and xanthine, were detected in association with
the glycosomes of L. m. mexicana promastigotes (Hassan and Coombs
1984) and T. cruzi epimastigotes (Gutteridge and Davies 1982),
whereas adenine phosphoribosyltransferase was cytosolic (Gutteridge
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and Davies 1982. Hassan and Coombs 1984). The CO2-fixing enzyme PEP
carboxykinase has been found in the glycosomes of T. brucei
procyclics (Opperdoes and Cottem 1982. Broman et al. 1983). T. cruzi
epimastigotes and C. fasciculata (Cannata et al. 1982). Malate
dehydrogenase has also been detected in glycosomes of procyclic
T. brucei (Ilppertioeset ale 1981) and also epimastigotes of T. cr-uzi,
where it has a dual mitochondrial and glycosomal distribution
(Cannata and Cazzulo 1984).
In T. brucei. the large loss of mitochondrial activity that
occurs upon transformation of the insect procyclic stage to the
bloodstream trypomastigote is apparently compensated for by changes
in the metabolic activi ty of the glycosome (Hart et al. 1984).
Glycosomes of culture procyclic forms differ from those of
bloodstream forms in polypeptide and phospholipid content (Hart
et al. 1984) and analysis of the enzyme content also show a number of
differences (Outlined in Fig. 3). Firstly. the activities of the
glycolytic enzymes are considerably lower in the procyclic stage of
T. brucei (opperdoes et al. 1981). which may reflect the lesser
importance of glycolysis to this form of the parasite (Hart et ale
1984). Secondly. phosphoglycerate kinase is found in the cytosol of
procyclic forms but in the glycosome of bloodstream forms. Thirdly.
the decrease in activity of the dihydroxyacetone phosphate. glycerol-
3-phosphate shuttle in procyclics is associated with the production
of glycosomal PEP carboxykinase and malate dehydrogenase (Opperdoes
et al. 1981. Opperdoes and Cottem 1982). It has been suggested that
this malate dehydrogenase acts to reoxidize glycolytically-produced
NAoH. reoxidized by glyceraldehyde-3-phosphate dehydrogenase in
bloodstream forms. and PEP carboxykinase provides glycosomal ATP.
provided by phosphoglycerate kinase in bloodstream forms (Upper-does
and Cottem 1982). Thus redox balance appears to be maintained in the
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Fig. 3a.
Oiagramatic representation of the compartmentation of
glycolysis in Trypanosoma brucei bloodstream trypomastigotes. (from
Opperdoes 1982)
G-6-P, glucose-6-phosphateJ FOP, fructose-1,6-diphosphateJ
OHAP, dihydroxyacetone phosphateJ G-3-P, glycerol-3-phosphateJ GAP,
glyceraldehyde~3-phosphateJ 1,3-0PGA, 1,3-diphosphoglyceric acidJ 3-
PGA, 3-phosphoglyceric acidJ SHAM, salicylhydroxamic acid
Fig. 3b.
Oiagramatic representation of the compartmentation of pathways
within T. brucei procyclic trypomastigotes. (from Opperdoes and
Cottem 1982)
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glycosomes of both forms of T. brucei (Fig. 3).
The changes that occur in glycosomal contents of other
trypanosomatids during their life-cycles has not been well studied.
but they are likely to be less extreme than with T. brucei which
appears to exhibit the largest metabolic switch of any trypanosomatid
studied to date. Information presently available. however. suggests
that there is some variation in glycosomal structure between species
as well as stages of the life-cycle (e.g. glycosome densities on
sucrose gradients, see section 4.3. of the discussion). but the full
extent is still to be elucidated.
All the glycolytic enzymes except glucose phosphate isomerase
found in glycosomes of T. brucei are particulate and appear to be
associated with each other (Opperdoes et al. 1977b. Oduro et al.
1980a.b. Opperdoes 1982). These enzymes apparently behave as a
multienzyme complex. which is eluted in the void volume during Bio-
gel A-5M column chromatography of cell homogenates (Oduro et al.
1980a). The complex can be dissociated into its individual
components by 0.15M sodium chloride and this process can be reversed
by removal of the salt by dialysis (Oduro et al. 1980a. Mclaughlin
1981).
It has been shown that glycosomal enzymes exhibit latency which
was abolished by freezing and thawing. sonication or the addition of
detergents such as Triton X-100 (Visser and Opperdoes 1980). This
suggests that the glycosomal membrane is relatively impermeable to
the substrates required for enzyme activity and therefore impermeable
to certain cofactors and glycolytic intermediates. Further
experiments with intact bloodstream form T. brucei pulse-labelled
with 14C-glucose showed the presence of two separate pools of
glycolytic intermediates (Visser et al. 1981). One pool was rapidly
labelled (in 15 seconds), represented 20-30% of the total cellular
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metabolites, and was thought to be within the glycosorne,whereas the
other pool equilibrated only slowly (approximately 14 mins for
labelling 90% of the cellular contents) and probably represented the
cyt0sol (Visser eta 1. 1981)• As the glycosomal volume only
represents 9% of the cytoplasmic volume of T. brucei, but there is a
glycosomal metabolite pool of 20-30% of the total pool size, this
gives further evidence against a complete equilibration of
metabolites between glycosome and cell sap (Visser et al. 1981). If
the compartmentation of glycolysis outline in fig. 3. is to function
then a number of metabolites including glycerate-3-phosphate,
glycerol-3-phosphate, dihydroxyacetone phosphate and glucose must be
able to cross the glycosomal membrane. It has been demonstrated that
the glycosomal membrane is totally impermeable to hexose
monophosphate (Opperdoes and Nwagwu 1980), suggesting a specific
uptake mechanism for glucose. Glycerol-3-phosphate, however, unlike
most other glycosomal intermediates, is rapidly equilibrated with the
cytosolic pool, indicating that its crossing of the glycosomal
membrane is facilitated by a specific translocator (Visser et al.
1981). Dihydroxyacetone phosphate must return to the glycosome to
serve as an acceptor for reducing equivalents generated by
glyceraldehyde-3-phosphate dehydrogenase, therefore the functioning
of the shuttle would result in the rapid mixing of the
dihydroxyacetone phosphate and glycerol-3-phosphate pools as indeed
was observed (Visser et al. 1981). The presence of a mul tienzyme
complex, together with this apparent compartmentation of intermediary
metabolites and enzymes, may account for the extremely high rate of
glycolysis that is found in bloodstream T. brucei. There is no
comparable data concerning metabolite compartmentation in Leishmania.
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1.4.3.2. Other organelles
With methods currently in use, the unitary mitochondrion of
trypanosomatid flagellates is ruptured during cell lysis into
vesicles that retain some of the soluble matrix enzymes. These
mitochondrial vesicles have been found to have a lower density than
glycosomes and the two organelles can therefore be separated by
isopycnic centrifugation (Opperdoes and Borst 1977, Opperdoes et al.
1977a, Cannata et al. 1982). The inactive mitochondrion of
bloodstream T. brucei was shown to contain oligomycin-sensitive
ATPase, subsequently used as a marker for this organelle, and also
glycerol-3-phosphate oxidase, isocitrate dehydrogenase, adenylate
kinase and a particulate malate dehydrogenase. This latter enzyme
represent~ about 10% of the total cellular malate dehydrogenase, the
remainder of which was found in the cytosol (Opperdoes et al. 1977a,
Opperdoes et al. 1981). Transformation to the procyclic stage is
accompanied by the development of an extensively-branched
mitochondrion with numerous plate-like cristae and an active
respiratory chain. All the enzymes found in the bloodstream
T. brucei mitochondrion were also detected in the procyclic organelle
but in addition the TCA cycle enzymes, including succinate
dehydrogenase, sn-glycerol-3-phosphate dehydrogenase and two enzymes
involved in threonine metabolism, NAO-linked threonine dehydrogenase
and carnitine acetyltransferase were also found (Opperdoes et al.
1981) •
Trypanosoma brucei bloodstream and procyclic forms have also
been screened for enzymes to serve as markers for the plasma
membrane, flagellar pocket, lysosomes, endoplasmic reticulum and
Golgi apparatus. ~-glucosidase was found to be a good marker for the
plasma membrane of both bloodstream and procyclic T. brucei. This
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structure equibrated on sucrose gradients as a plasma membrane-
microtubule complex at a densi ty of 1.20-1.22 g/ml (Steiger et al.
1960, Opper-does and Steiger 1961). Ouabain-sensitive Na+ /K+-
stimulated ATPase, adenylate cyclase, and 5'-nucleosidase have also
been suggested as plasma membrane markers. The two former enzymes
were considered good markers in bloodstream T. brucei by Rovis and
Baekkeskov (1960), although Steiger et al. (1960) were unable to
detect ouabain-sensitive ATPase. Voorheis et al. (1979) reported the
presence of 5'-nucleosidase in T. brucei membranes, and this enzyme
also has a surface membrane localization in L. donovani
promastigotes (Dwyer and Gottlieb 1964). In addition to a 5'-
nucleosidase, a 3'-nucleosidase, an enzyme that has not been
demonstrated in mammalian cells, was also detected in L. donovani
surface membranes (Gottlieb and Dwyer 1963, Dwyer and Gottlieb 1964).
Membrane bound adenylate cyclase, which was thought to co-purify with
plasma membranes in bloodstream T. brucei (Voorheis et al. 1979), was
shown to be associated with some other membrane system, possibly the
flagellar pocket (Walter and opperdoes 1962).
Acid phosphatase was found in association with both the
flagellar pocket and the endoplasmic reticulum in T. brucei
bloodstream forms (Steiger et ale 1960), whereas in the procyclic
form it was only found associated with microsomal membranes derived
from the endoplasmic reticulum (opperdoes and Steiger 1961). Using
subcellular fractionation and ultrastructure cytochemistry, acid
phosphatase, which is usually a lysosomal marker, was shown to have
50% of its act ivi ty on the plasma membrane of L. donovan i
promastigotes, where it was distributed over the entire surface of
the parasite (Gottlieb and Dwyer 1961).
Galactosyl transferase, which is a marker for the Golgi
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apparatus of higher eukaryotes, has also been found in this organelle
of bloodstream T. brucei (Steiger et ale 1980) and also
T. congolense and T. vivax (Grab et al. 1984), suggesting that the
site of the major glycosylations of variable surface antigens is the
Golgi apparatus in these three species of trypanosomes. There is no
information at present on the enzymes of the Golgi apparatus in
Leishmania.
Lysosomes have also been investigated in T. brucei bloodstream
and procyclic forms with an acid proteinase and ()(-mannosidase being
found associated with the organelles (Steiger et al. 1980, Opperdoes
and Steiger 1981). A high cysteine proteinase activity found in
L. m. mexicana amastigotes (Coombs 1982) has recently been shown to
be located in organelles, possibly the lysosome-like "Megasomes"
(Coombs end Pupkis 1984).
The study of these hydrolytic enzymes in trypanosomatids and
their assignments to specific organelles as markers has helped to
characterise further the subcellular organisation of the digestive
systems of these parasites.
1.5. THE ATIMSOF THE PROJECT
The overall aim of this project was to investigate aspects of
the intermediary metabolism of Leishmania mexicana mexicana in order
to correlate the differences in metabolism between the insect
promastigote and mammalian amastigote stages to their respective
environments and also to discover biochemical differences between the
parasite and mammalian host. In this way it was hoped to find
systems essential to the parasite which could be suitable for
chemotherapeutic attack. The initial part of the project was to
investigate further the carbohydrate metabolism of L. m. mexicana and
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in particular the part played by CO2 in leishmanial amastigote
metabolism. A second aim was to elucidate the subcellular
organisaton of the parasites metabolism and the enzyme distribution
between glycosomal, mitochondrial and cytoplasmic compartments. A
third object was to purify and characterise two of the enzymes found
to be especially important to the amastigoteJ PEP carboxykinase and
malate dehydrogenase. An additional aim was to gain direct
information on the mechanism of antimonial action against Leishmania
and the reasons for the specificity of pentavalent antimonials for
the amastigote form
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2.0 MATERIALS AND METHODS
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2.1 PARASITES
2.1.1 Parasites and their cultivation.
The WHO-recommended strain of L. m. mexicana (code number M379)
used in this study was first isolated in 1962 in Belize and was
obtained from Or. R. A. Neal (The Well come Research Laboratories,
Beckenham, Kent) in 1972. The parasites, which were uncloned, were
routinely passaged by subcutaneous injection of 3 x 107 purified
amastigotes into the shaven rump of female NIH (Hacking and
Churchill, Huntington, Cambridge, England) or CBA (Zoology
Department, University of Glasgow) mice. The area surrounding the
point of inoculation was shaved monthly and large cutaneous lesions
developed in the mice 3 - 9 months after infection. The lesions that
developed in CBA mice were generally large and unruptured and they
grew more quickly than those in NIH mice, therefore CBA mice were
used routinely after the first 3 months of this study.
Leishmania m. mexicana promastigotes were derived by
transformation in vitro from amastigotes. A small piece of lesion
was aseptically removed from a CBA mouse, inoculated into 5ml HOMEM
medium (Berens et ale 1976) supplemented with 20% (v/v) heat
inactivated foetal calf serum (HIFCS)and 25~g/ml gentamycin sulphate
to prevent bacterial growth, and incubated at 250C for 72h. The
promastigotes produced were then routinely subpassaged into HoMEM
medium when at mid-log phase of growth (approximately every 3 days)
and incubated at 250C in sealed universals using air as the gas phase
throughout. Only promastigotes that had been subpassaged less than
11 times were used in this study.
Promastigotes of L. m. mexicana clone (2B(sub1)),isolated from
M379 promastigotes by Mrs M.Y. Ghafoor, were stored as a stabilate
in liquid nitrogen until use, when they were grown in HoMEM medium as
above. Amastigotes of the same clone were grown in female CBA mice
by inoculation of 4 x 107 promastigotes. Amastigote lesions, which
took between 5 - 7 months to grow, were harvested as described in
section 2.1.2.
Two species of Leishmania were kindly supplied by Dr. R. Stokes
(Liverpool School of Tropical Medicine). Amastigotes isolated from
mice and culture promastigotes of L. m. amazonensis (LV 76) and
cul ture promastigotes of L. donovani (LV 9). were obtained as washed
pellets frozen at -70oC and ready for use. Leishmania donovani
amastigotes were supplied in infected Cotton rats.
Procyclic T. b. brucei Antat 1.6 and T. b. rhodesiense Eatro
2340 were grown in HiLls medium at 250C (Cunningham 1977) wi th 10%
(v/v)HIFCS and 25~g/ml gentamycin sulphate and harvested in late log
phase of growth (approximately 107 cells/ml). Trypanosoma b. brucei
and T. b. rhodesiense pleomorphic bloodstream trypomastigotes,
derived from the same stock as the procyclics, were grown in NIH mice
after inoculation of 106 bloodstream forms and harvested for use 5
days later.
2.1.2 Harvesting parasites
Leishmania m. mexicana promastigotes, grown in bulk in 500ml
sealed bottles containing 200ml of medium, were harvested when at
mid-log phase of growth (1-2 x 107 cells/ml) by centrifugation at
1600g for 10 min at 40C on an MSE Chilspin centrifuge. The parasites
were washed three times in 0.25M sucrose and then either used
immediately or stored as pellets at -700C.
Amastigotes of L. m. mexicana were purified essentially as
described by Hart et al. (1961b) with the following procedure: The
lesion was aseptically excised from the mouse, placed in 20m I of
PSGEMKA buffer and cut into small pieces. The chopped lesion was
then homogenised between two gauze meshes to release the parasites
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and the suspension filtered through No 1 Whatman filter paper to
remove large pieces of debris. Saponin (0.05%w/v) was added to lyse
red blood cells, the parasites washed three times in PSGEMKA and then
gently dispersed by two strokes of a Potter homogeniser working at
low speed. The cells were then diluted with buffer to give a
parasite density of approximately 108 /ml and so minimise parasite
clumping. The cells were passed down an ion-exchange column
containing 2g of CM-Sephadex C25 to remove the contaminating host
whi te cells, washed once in PSGEMKA and then once in 0.25M sucrose.
They were either used immediately or stored as pellets at -700C.
Amastigote numbers and the percentage contamination with other cells
were determined using an improved Neubauer haemocytometer. This
procedure routinely gave preparations with less than 0.1% (cell/cell)
contamination.
Leishmania donovani amastigotes were isolated from the spleens
of Cotton rats and purified using the same method as for
L. m. mexicana.
Bloodstream forms of T. b. brucei and T. b. rhodesiense were
purified by ion-exchange chromatography using the method of Lanham
(1968). Blood was removed by cardiac puncture, collected in heparin
to prevent clotting, and the trypanosomes separated from blood cells
on a DEAE cellulose column using phosphate saline glucose buffer pH
8.05. All harvested trypanosomes were washed twice in 0.25M sucrose
before use.
Adult Schistosoma mansoni, kindly supplied by Dr. A. McGregor
(Biochemistry Department, University of Glasgow), were isolated from
Balb/c mice 60 days after infection, washed and suspended in Hanks
Saline and stored for 7-14 days at -200C.
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2.1.3 Preparation of parasite homogenates and mouse liver extracts
To prepare parasite homogenates for use in many experiments,
Leishmania amastigotes and promastigotes and trypanosomes were
suspended in 0.25M sucrose and lysed by either the addition of 0.1%
(v/v) Triton X-100 or by 4 cycles of freezing at -700C and thawing at
250C. In some experiments, as speci fied in the text, enzyme
activities were determined for parasite lysates produced in the
presence of 100~g/ml of the proteinase inhibitor leupeptin.
Parasites were lysed by mixing to a thick paste with acid-washed de-
fined alumina (Sigma type 305) for differential and isopycnic
centrifugation fractionation experiments.
Homogenates of S. mansoni were prepared by twenty strokes of a
Dounce homogeniser and used immediately. Mouse liver extracts were
prepared ,using female CBA mice. The livers were excised, washed
twice in 0.1M Tris-HCl buffer pH 7.3, and homogenised with twenty
passes of a Potter homogeniser. The homogenate produced was
centrifuged at 40C for 1h at 240,000g and the supernatant stored at -
700C until use.
2.2 ASSAYS
2.2.1Enzyme assays.
All enzyme assays were performed on either a Pye Unicam SP BODO
or a Perkin-Elmer Lambda 5 UV/VIS spectrophotometer, both
incorporating a temperature controlled cell holder. All assays
were in 1.5ml total volume unless otherwise specified. For the
determination of specific activities, all assays were carried out at
250C. For inhibitor studies, promastigote extracts were assayed at
250C, amastigote extracts at 340C and both mouse liver and S.
mansoni extracts at 370C. The following assays were used as
standard except where specified.
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Hexokinase (EC 2.7.1.2) was assayed at 340nm (Martin et al. 1976) in
a reaction mixture containing 100mMTris-HCl pH 7.3, 0.66mM EDTA,
6.6mM MgC12, 15mMglucose, 0.33mM NADP, 1.4 uni ts yeast glucose-6-
phosphate dehydrogenase and 30-50~g sample protein. The reaction was
ini tiated by 1mMATP.
Glucose phosphate isomerase (EC 5.3.1.9) was assayed at 340nM (Martin
et a1. 1976) in a reaction mixture containing 100mMTris-HCl pH B.O,
0.33mM NADP, 0.7 units yeast glucose-6-phosphate dehydrogenase and
3.3mMfructose-6-phosphate. The reaction was ini tiated by 30-60jJg
sample protein.
Glucose-6-phosphate dehydrogenase (EC 1.1.1.49) was assayed at 340nm
(Bergmeyer 1974) in a reaction mixture containing 100mMtriethanol-
amine buffer pH 7.5, 0.33mM NADP, 13.3mM EDTAand 10-20pg sample
protein. The reaction was initiated with 2mMglucose-6-phosphate.
Phosphofructokinase (EC 2.7.1.11) was assayed at 340nm (Mukkada et
al. 1974) in a reaction mixture containing 100mMTris-HCl pH 7.3,
O.lmM NADH, 6.6mM MgC12 ' 3.3mM fructose-6-phosphate, 0.2 units
rabbi t muscle aldolase, 2 units rabbit muscle triosphosphate
isomerase/~-glycerophosphate dehydrogenase and 100pg sample protein.
The reaction was started with 0.4mMATP.
Glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12) was assayed
at 340nm (Bergmeyer 1974) in a reaction mixture containing 100mM
triethanolamine buffer pH 7.5, lmM ATP, 3.3mMglycerate-3-phosphate,
O.lmM NADH, lmM EDTA, 2mMMgS04 and 3.3 units of rabbit muscle
phosphoglycerate kinase. The reaction was started by the addition
of 50-100~g of sample protein.
Phosphoglycerate kinase (EC 2.7.2.3) was assayed at 340nm (Bergmeyer
1974) in a reaction mixture containing 100mM triethanolamine buffer
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pH 7.5, 1.66mM MgSD4, D.6mM ATP, 2.66mM glycerate-3-phosphate, D.lmM
NADH and 2.5 units of yeast glyceraldehyde-3-phosphate dehydrogenase.
The reaction was started by the addition of 2D-5D)-lgsample protein.
Pyruvate kinase (EC 2.7.1.40) was assayed at 34Dnm (Bucher and
Pfleiderer, 1962) in a reaction mixture containing 8DmM Tris HCl 7.3,
8mM MgSD4' 75mM KC1, D.lmM NADH, 4mM PEP, 15 units of pig heart
lactate dehydrogenase and 3D-15D~g sample protein. The reaction was
started with ImM ADP.
Isoci trate dehydrogenase (EC 1.1.1.42) was assayed at 34Dnm (Berg-
meyer 1974) in a reaction mixture containing 1DDmM triethanolamine
HCl buffer pH 7.5, 4mM MnSD4, D.33mM NADP, and 8D-1DD~g sample
protein. The reaction was started by the addition of 3.3mM
isocitrate.
ex-Ketoglutarate dehydrogenase (EC 1.2.4.2) was assayed at 34Dnm
(Martin et al. 1976) in a reaction mixture containing 1DDmM Tris
HCl pH 7.0, D.33mM thiamine pyrophosphate, 0.1mM coenzyme A, 3.3mM
L-cysteine, D.33mM NAD and 150}Jgsample protein. The reaction was
initiated with the addition of 3.3mM oc.-ketoglutarate.
Malate dehydrogenase (EC 1.1.1.37)was assayed at 34Dnm in both the
forward and reverse directions. For oxaloacetic acid reduction
(Martin et al. 1976) the reaction mixture contained 100mM triethan-
olamine HCl buffer pH 7.5, 0.2mM NADH and 5-2D~g sample protein.
The reaction was started with D.83mM oxaloacetic acid. For malate
oxidation (Bergmeyer 1974) the reaction mixture contained 1M glycine,
D.4M hydrazine sulphate, NaDH buffer pH 9.5, 2mM NAD, and 5-2D}Jg
sample protein. The reaction was initiated with 133mM sodium malate.
Phosphoenolpyruvate carboxykinase (PEP carboxykinase) (EC 4.1.1.49)
was assayed at 34Dnm by following the oxidation of NADH after
coupling the production of oxaloacetic acid to bovine malate
dehydrogenase (Bentle and Lardy 1976). The reaction mixture
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contained 100mM imidazole buffer pH 6.6, 4mM MnS04, 20mM NaHC03,
0.1mM NADH, 4mM PEP, 15 units of bovine malate dehydrogenase (in
glycerol) and approximately 40-150)Jg sample protein. The reaction
was started by the addition of ImM ADP. In order to avoid inter-
ference from the high promastigote NADHoxidase activity that is
stimulated by Mn2+ and HC03-, promastigote PEP carboxykinase was
assayed anaerobically with the same incubation mixture as above but
wi th 0.7ml total volume. Amastigote Mn2+ stimulated NADHoxidase
was low in comparison to the PEP carboxykinase activity and was
simply subtracted to obtain the PEP carboxykinase activity.
Pyruvate carboxylase (EC 6.4.1.1) was assayed at 340nm (Martin et al.
1976) in a reaction mixture containing 100 mMHEPES buffer pH 7.B,
6.6mM MgCl2, 20mM NaHC03, 0.1mM NADH, 0.4mM acetyl CoA, ImM ATP, 11
units bovine malate dehydrogenase and 10D-15D)Jg sample protein. The
reaction was initiated with 1DmMpyruvate.
Mal ic enzyme (carboxylating) (EC 1.1.1.40) was assayed at 34Dnm
(Klein et al. 1975) in a reaction mixture containing 1DDmM
imidazole buffer pH 6.6, 4mM MnS04, D.1mM NADPH, 20mM NaHC03 and
10D-15D)Jg sample protein. The reaction was initiated with 10mM
pyruvate.
Malic enzyme (decarboxylating) (EC 1.1.1.40) was assayed at 34Dnm
(Martin et al. 1976) in a reaction mixture containing 1DDmM
triethanolamine buffer pH 7.5, 4mM MnSD4, 0.33mM NADPand 6D-15D)Jg
sample protein. The reaction was initiated with 3.3mM malate.
Glutamate dehydrogenase (Ee 1.4.1.3) was assayed at 340nm (Martin
et al •• 1976) in a reaction mixture containing 100mM Tris He1 pH B.5,
320mM (NH4)2S04 • D.2mM NADHor NADPHand 6-6D~g sample protein.
The reaction was started with 6.6mM o<.-ketoglutarate.
Glutathione reductase (Ee 1.6.4.2) was assayed at 340nm (Bergmeyer
1974) in a reaction mixture containing BDmMsodium phosphate buffer
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pH 6.6, o.lmM NAD(P)H, and 1ooj-lg sample protein. The reaction was
started with 0.3mMoxidized gluthatione.
Fumarate reductase (EC 1.3.99.1) (NADH-dependant reversal of
succinate dehydrogenase) was assayed at 340nm (Klein et al. 1975) in
a reaction mixture containing BomMTris HCl pH B.o, o.lmM NADHand
15o)-lg sample protei n. The reaction was initiated wi th 3.3mM sodium
fumarate.
Isocitrate lyase (EC 4.1.3.1) was assayed according to Dixon and
Kornberg (1959) with 100mMimidazole buffer pH 6.6, 6.6mMMgS04 or
MnS04, 0.66mM EDTA, 3.3mM isoci trate and 3.3mM phenylhydrazine
hydrochloride. The production of glyoxylate phenylhydrazone was
followed at 324nm.
Alanine aminotransferase (EC 2.6.1.2) was assayed at 340nm (8ergmeyer
1974) in a reaction mixture containing B5mMsodium phosphate buffer
pH 7.4, 13.2mM L-alanine, o.lmM NADH, 1.5 units of rabbit muscle
lactate dehydrogenase and 10-Boj-lg sample protein. The reaction was
started with 6.6mM ()(.-ketoglutarate dehydrogenase.
ATPase (EC 3.6.1.4) was determined according to Frasch et al. (197B).
In the assays~ which were performed in duplicate, approximately 50ug
of sample protein was incubated in a total volume of 1.oml containing
100mMTris-HCl pH 7.3, 4 j-lmoles MgC12 and 3)-lmoles ATP. After 30
minutes incubation, the reaction was stopped by the addition of
0.1ml 50% (w/v) trichloracetic acid, centrifuged at 1o,ooog for 5
mins at 1BoC and the supernatant estimated for phosphate by the
method of Rathburn and 8etlach (1969). o.Bml of supernatant was
added to 0.55ml of buffer (3M acetate buffer, 37% formaldehyde in a
ratio of 1 : 0.1) and mixed immediately. 50pl ammonium molybdate (2%
w/v) and 1oo~1 6.75mMstannous chloride were added, the mixture left
for 5 min and the absorbance read at 735nm. Sample phosphate
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concentrations were determined by comparison with a standard curve
prepared with 0-200,umoles (in 25J-lgsteps) of K2HP04• To assay
oligomycin-sensitive ATPase, the enzyme sample was pre-incubated with
20~g/ml of oligomycin for 10 minutes at 250C before the addition of
ATP. Controls in which trichloracetic acid was added at time zero
were included for all the ATPase assays.
2.2.2 Protein determinations
Protein concentrations were determined by one of two methods.
In the enzyme activity and fractionation studies the method of Lowry
et al. (1951) was used. 1.0ml of reagent 1 (2% (w/v) Na2C03 in 0.1M
NaOH, 1% (w/v) CuS04' and 2% (w/v) NaK tartrate mixed in the ratio of
98:1:1) was added to 0.2ml of sample and left to stand for at least
10 min at room temperature. 0.1ml of 1N Folin and Ciocalteu's phenol
reagent was then added, mixed well and the mixture left for 1 h at
room temperature and the absorbance read at 700nm. Sample protein
concentrations were determined by comparison with a standard curve
prepared with 0-50fg (in 5~g steps) of bovine serum albumin (BSA).
The Coomassie blue method of Bradford (1976) as modified by Read
and Northcote (1981) is 5-10 times as sensitive as the method of
Lowry et al.(1951) and was therefore used for determining protein
concentrations during the enzyme purifications and the digitonin
experiments. 950pl of dye (100mg Coomassie blue G-250 dissolved in
8.8% (v/v) orthophosphoric acid and 4.67% (v/v) ethanol and filtered
through Watman No 1 filter paper) was added to 50~1 of sample
protein, left for 5 min at room temperature and the absorbance read
at 595nm. Sample protein concentrations were determined by
comparison with a standard curve prepared with 0-10 j-Ig(in 0.5~g
steps) of BSA.
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2.3. INHIBITOR STUDIES WITH ANTIMONIALS AND ARSENICALS.
Melarsen and 1714 were dissolved in distilled, deionised water,
melarsen oxide in O.1M NaDH and Mel B in propylene glycol, all to
3mM. Before use melarsen oxide was diluted 1:5 in D.1M Tris-HCl pH
7.3. 5822 was prepared as a cloudy suspension in absolute ethanol at
a concentration of 3mM. Pentostam was dissolved at 1.0mg/ml (1.1mMJ
in 0.1M gluconic acid and Triostam at 2.0mg/ml (5.0mMJ in 0.01M
gluconic acid. The effect of inhibitors upon enzymes was tepted by
pre-incubation with the enzyme at the appropriate temperature for one
hour before the enzyme activity was measured. Only concentrations of
inhibitors that did not significantly effect the activities of the
linkage enzymes were used. In all cases, a cuvette containing an
equal concentration of the solvent used to dissolve the inhibitor was
assayed in parallel to measure the control enzyme activity. The
activity of the inhibitors against enzymes was expressed as the 150,
the concentration that inhibited the activity by 50%, and was
determined from a curve drawn by eye to fit a series of at least 5
inhibitor concentrations.
The effect of the inhibitors on L. m. mexicana promastigote growth
was assessed using a range of doubling concentrations with a three
day incubation period. The number of motile cells after 72 hours
were counted and the LD50 (the concentration of inhibitor that
reduced the number of parasites to 50% of the control) and the MLC
(minimum concentration that killed all the parasi t es l determined.
The time taken for Triostam (400jJg/ml),and melarsen oxide (100J..lg/ml)
to exert an effect on promastigotes in vitro was monitored by
observations of cell morphology and mobility using phase contrast
microscopy. The effects of cysteine on the growth of promastigotes
and the inhibitory action of Triostam was assessed using a range of
cysteine concentrations in the incubations.
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2.4 STUDIES ON THE SUBCELLULAR LOCATION OF LEISHMANIAL ENZYMES
2.4.1 Particulate and soluble activities.
The distribution of enzyme activities between the particulate
and soluble parts of the parasite was determined for amastigotes and
promastigotes of L. m. mexicana. Parasites were lysed by the
addition of 0.1% (v/v) Triton X-100 as described in section 2.1.3.
The homogenates were centrifuged for 2 min at 10,000g at 180C in an
Eppendorf centrifuge and the supernatant removed. After suspending
the pellet in 0.25M sucrose, to the same volume as the supernatant,
the enzyme activity in each fraction was determined and the values
expressed as the percentage of the total activity recovered in both
fractions.
2.4.2 Differential centrifugation
All procedures were performed at 40C. Washed L. m. mexicana
promastigotes and amastigotes were lysed with alumina as described in
section 2.1.3. The degree of cell breakage was assessed using phase
contrast microscopy and when >95% of the cells were lysed the paste
was resuspended in 2-3 volumes of breakage buffer (0.25M sucrose,
25mM Tris-HCI pH 7.3, 1mM EDTA). The alumina was removed by
centrifugation at 1,000 rpm (180g) for 5 min on an MSE Chilspin
centri fuge and the supernatant taken as the homogenate (H). This
was then fractionated in 3 steps: 2,100g for 10 mins to give
pellet 1 (P1); 15,800g for 10 mins to give pellet 2 (P2); 240,000g
for 1 hour to give pellet 3 (P3) and the supernatant (5). Each
pellet was resuspended in 1.0ml of breakage buffer. In most cases
the fractions were assayed immediately but on occasions they were
frozen at -70oC until use. All fractions were assayed for enzyme
activity in the presence of 0.1% Triton X-100 to ensure organelle
lysis.
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2.4.3 Sucrose density gradient centrifugation
All procedures were performed at 40C. Promastigotes of
L. m. mexicana were lysed and the alumina removed in the same manner
as described above for differential centrifugation. The post-
alumina homogenate (H) was centrifuged at 2,1oog for 3 mins and the
resul tant supernatant (H2) removed. 1.15-1.24g/ml 1inear sucrose
gradients containing 25mM Tris-HCl pH 7.3 and 1mM EDTA were prepared
using a Pharmacia P-3 peristaltic pump and an LKB gradient mixer.
33ml of gradient were layered onto t.Ornl of 2.5M sucrose and cooled
to 40C. Subsequently, 2-3ml of H2 was layered onto the pre-cooled
gradient which was then centrifuged in an MSE Prepspin 50
ultracentrifuge using a MSE titanium vertical tube rotor. The rotor
was accelerated at minimum setting to 1,000 r.p.m. and then at
maximum acce ler-ati cn to 50,000 r.p.m. (2oo,ooog). After 105 mins,
the rotor was deaccelerated with the brake on to 1,000 r.p.m. and
then without the brake to rest. The gradient was collected in 2.oml
aliquots by suction after piercing the bottom of the tube with a
needle. After mixing each fraction, 1.oml was taken and weighed to
determine the density and then assayed immediately or frozen at -
7ooC. Enzyme assays were performed in the presence of 0.1% (v/v)
Triton X-100, or by 4 cycles of freezing at -7ooC and thawing at 250C
in the case of ATPase, to ensure organelle lysis. The enzyme data
was calculated and presented essentially as described by Beaufay and
Amar-Costesec (1976) using the formula:
computed dlfference in density
% of total activity x _1100
Frequency =
In order to combine the resu 1ts of different experiments, the
density distribution histograms were normalised according to the
method of Bowers and De Duve (1967). The distribution histograms
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were divided into 1B sections with equal density increments of
0.05g/ml. Taking a starting densi ty of 1.24 g/ml, the fractional
area included in each of the 1B sections was calculated and
normalised according to the densi ty range for the individual
fractions from each experiment. As the linear gradient had a final
density of 1.15 g/ml, all the activity recovered at a lower density
than this was combined and is presented as 1 fraction consti tuting
the soluble activity (p = 1.15 - 1.07 g/ml). In the figures
presented (Fig. 7 and B), the left hand axis represents the frequency
of the enzymes on the gradient (f = 1.24 - 1.15 g/rnll, and the right
hand axis represents the frequency for the single soluble fraction(p
= 1.15 - 1.07 g/rnl ), All results were calculated and plotted using a
BASIC program written for a Commodore Pet 2 series 2001 computer and
linked to,a Watanabe WX 4671 Digiplot.
2.4.4 The release of Leishmania m. mexicana enzymes using digitonin.
The release of soluble enzymes from L. m. mexicana amastigotes
and promastigotes was studied by suspending purified amastigotes (109
parasites/sample) or washed promastigotes (2 x 10B parasites/sample)
in breakage buffer and exposing them at 250C to digitonin at a range
of concentrations and for different times. The digitonin was
dissolved in dimethylformamide and it was confirmed that controls
with the solvent did not cause enzyme release. After the
appropriate incubation period, the parasites were centrifuged at
10,OOOg for 5 mins at 1BOC, the supernatant removed, and the pellet
resuspended in breakage buffer containing 0.1% (v/v) Triton X-100.
Enzyme assays were performed immediately for each fraction and the
activity in each expressed as a percentage of the total activity
recovered in the two fractions.
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2.4.5 Isoelectric focusing
Flat bed agarose isoelectric focusing (lEF) was performed using
pH range 3.5-10 as outlined in the Pharmacia guide to lEF.
2.4.5.1 Preparation of agarose gels
Agarose lEF was performed by casting 27ml of gel onto a
hydrophilic polyester sheet (Gelbond). The gel contained the
following components:
0.275g Agarose lEF,
3.3g sorbitol;
24.75ml distilled deionized water,
1.75ml LKB Ampholine pH 3.5-10.
The agarose and sorbitol were dissolved in the water by heating
in a boil~ng water bath. When the solids were dissolved the gel was
cooled to 750C, the Ampholine added and mixed, and the solution
poured into a 114 x 185 mm mould. Once the gel was set (about 10-15
min) it was placed at 40C for at least 1hr before use.
2.4.5.2 Preparation of sample protein
2 x 109 amastigotes and 1 x 109 promastigotes of L. m. mexicana
clone 2B (sub1) were each lysed in 400~1 0.25M sucrose containing
100~g/ml leupeptin and 0.2% (v/v) Triton X-100. Both the amastigote
and promastigote samples were then split into two equal fractions.
To the first fraction was added 50~1 1M NaCl containing 10% (v/v)
ethylene glycol. After 5 min incubation at 40C, the sample was
centrifuged at 10,OOOg for 5 min at 180C and the resultant
supernatant taken as the homogenate (H). The second sample was
centrifuged at 10,OOOg for 5 min and the resultant supernatant taken
as S. The pellet was washed once in O.25M sucrose and then
resuspended in 100pl 200mM NaCI containing 10% (v/v) ethylene glycol
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and 100jJg/ml leupeptin. After 5 min incubation at 40C, the sample
was recentrifuged and the resultant supernatant taken as P.
2.4.5.3 Running the agarose gel
The gel was placed on the cooling plate of a flat bed
electrophoresis apparatus (Pharmacia FBE 3000). Electrode strips
were soaked in the appropriate electrode solutions (Anode: 0.05M
H2S04: Cathode: 1M NaOH), blotted well, and placed on the gel. 15~1
of the sample proteins were applied to filter paper applicators which
were then placed on the gel at intervals of approximately 1cm. The
constant power supply (Pharmacia ECPS 3000/150) was set to deliver a
maximum of 5W and 500 volts with the current unlimited. The sample
applicators were removed after 40 min and the electrophoresis
continued for a total of 2.5 hr by which time the haemoglobin marker
had focused.
2.4.5.4 Staining for malate dehydrogenase
Malate dehydrogenase activity in the focused gel was detected
using a zymogram technique of overlaying the agarose gel with a
reaction mixture, dissolved in agar, that forms a visible insoluble
product (formazan). The reactions involved were:
malate )( NAOH C MTT
oxaloacetate NAO') formazan
5mg NAO+, 5mg MTT (thiazolyl blue) and 2ml of 1M sodium malate
(neutralized to pH 7.0 with NaOH) were dissolved in 20ml of O.1M
Tris-HCl pH 8.0, mixed with 20ml of ?~(w/v) agar and 0.5mg phenazine
methosulphate (PMS) and poured over the gel. After the overlay had
set, the gel was placed in a 370C incubator until the blue formazan
product was visible.
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2.5 SOUBILIZATION OF LEISHMANIA M. MEXICANA PARTICULATE ENZYMES
109 amastigotes or 2 x 1DB promastigotes were lysed at 40C in
0.25M sucrose containing 0.1% (v/v) Triton X-100 and centrifuged for
5 min at 180C at 1o,000g. The pellet was resuspended in 0.25M
sucrose and aliquots exposed to different concentrations of NaCl.
After 5 min incubation at 40C, the samples were centrifuged for 5 min
at 1BoC at 1o,000g, the supernatant removed, the pellet resuspended
in 0.25M sucrose, and both fractions assayed for enzyme activity.
2.6 ENZYME PURIFICATION AND CHARACTERISATION
All procedures were performed at 40C. 5 x 1010 purified
L. m. mexicana amastigotes were lysed by 10 min incubation in 0.25M
sucrose containi ng 0.2% (v/v) Triton X-100 and 1oo}Jg/ml leupeptin,
the latter to protect the enzymes from proteolytic attack. The
resultant homogenate (H) was centrifuged at 1o,000g for 5 min and the
pellet (P1), after one wash in 0.25M sucrose, was resuspended in 4ml
of 0.12M triethanolamine buffer, pH 7.5, containing 0.5M NaCl.
After 5 min incubation, the sample was centrifuged for 30 min at
24o,000g on an MSE Prepspin 50 ultracentrifuge and the resultant
supernatant (S2) used as the source of solubilized enzyme.
2.6.1 Hydrophobic interaction chromatography.
The supernatant S2 was loaded onto a Phenyl-Sepharose Cl-48
column (1.6 x 15.5cm, bed volume 31ml) which had been pre-
equilibrated with buffer A (0.12M triethanolamine buffer, pH 7.5,
with 1.oM NaCI). Unbound protein was eluted with BOml buffer A (flow
rate 6oml/h, eluant collected in 8ml fractions) and the bound enzymes
were eluted with 150ml of a concomitantly increasing gradient of
ethylene glycol (30-70% v/v) and decreasing gradient of NaCI (700-
3oomM) with a flow rate of 30ml/h. The eluant was collected in 3ml
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fractions, and those containing malate dehydrogenase or PEP
carboxykinase and hexokinase activities were combined and
concentrated on an Amicon filtration unit (model 8010) using a YMS
Diaflow ultrafiltration membrane with an exclusion range of SOOO
daltons. The Phenyl-Sepharose Cl-48 gel was regenerated with the
following procedure:
1) 20ml 70% (v/v) ethylene glycol,
2) 2 volumes distilled water,
3) 2 volumes absolute ethanol,
4) 4 volumes distilled water.
The column was stored in 0.02% (w/v) sodium azide to prevent
bacterial growth.
2.6.2 Metal chelate affinity chromatography.
Metal chelate affinity chromatography was attempted in an effort
to separate malate dehydrogenase and PEP carboxykinase activi ties
that coeluted from the Phenyl-Sepharose column. In order not to
waste any semi-purified sample, the technique was tested with
solubilized pellet (S2). The Chelating Sepharose 68 (1.6 x 4cm, bed
volume 1oml) was charged with metal ions by washing with 20ml of
Smg/ml MnS04 or ZnC12 dissolved in buffer A (flow rate 30ml/h).
Excess ions were removed with 20ml buffer A and then O.Bml S2 was
loaded onto the column. Unbound proteins were then eluted with 20ml
of buffer A containing 1M NaCl (buffer X) and bound proteins with
either o.oSM sodium acetate buffer pH 4.0 or 0.12M triethanolamine
buffer pH 7.S containing 1M NaCl and SOmM EDT A (buffer Y). Eluant
was collected in 2ml fractions. The final elution conditions also
served to regenerate the column which was stored in 0.02% (w/v)
sodium azide.
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2.6.3 Affinity chromatography.
As the metal chelate column was unsuccessful in separating
malate dehydrogenase and PEP carboxykinase (see section 3.6), further
purification was achieved using affinity chromatography. 3ml of
concentrated enzyme preparation from the Phenyl-Sepharose column was
loaded onto a 5' AMP-Sepharose 4B column (1.6 x 3.5cm; bed volume
7ml) which had been pre-equilibrated with buffer B (0.12M triethano-
lamine buffer, pH 7.5, 200mM NaCl, 1.0mM OTT and 10% (v/v) ethylene
glycol). Unbound protein, which included PEP carboxykinase and
hexokinase, was eluted with 40ml of buffer B (flow rate 15ml/h) and
protein bound to the column was eluted with 40 ml buffer C (0.12M
triethanolamine buffer pH 7.5, 1M NaCl, 1mM OTT, 10%(v/v) ethylene
glycol). The eluants were collected in 2ml fractions and those
containing malate dehydrogenase or PEP carboxykinase and hexokinase
activities were pooled and concentrated on an Amicon filtration unit
(YM5 membrane).
The column was regenerated in three steps.
1) 10 volumes of 0.1M Tris-HCl pH B.5 + 0.5M NaCl;
2) 10 volumes of 0.1M sodium acetate buffer pH 4.5 + 0.5M NaCl;
3) 10 volumes of distilled water.
The column was stored in 0.02% (w/v) sodium azide.
2.6.4 Gel filtration chromatography.
PEP carboxykinase and hexokinase were further purified by gel
filtration. 1.5ml of concentrated eluate containing PEP
carboxykinase and hexokinase activities from the 5' AMP-
Sepharose 4B column was loaded onto a Sephadex G-100 superfine column
(2.6x 50cm; bed volume 265ml) which had been pre-equilibrated with
buffer C. The column was eluted with the same buffer in an upwards
direction (20ml/h) and 2.5ml fractions were collected. The column
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was calibrated using the low molecular weight calibration kit from
Pharmacia Ltd. The standard proteins and molecular weights were:
Blue dextran 2000,
Albumin,
Ovalbumin,
Chymotrypsinogen A,
Ribonuclease A,
2,000,ODD,
67,000,
43,000,
25,000,
13,700.
3mg of each standard protein was dissolved in buffer C, which was
also used to elute the proteins. The molecular weights of purified
enzymes were calculated from a plot of log1o molecular weight of
calibration proteins against fraction number.
The Sephadex G-1oo was also used to determine the molecular
weight of malate dehydrogenase isoenzymes from cell free homogenates
of L. m. mexicana amastigotes. 3 x 109 amastigotes were lysed by
four cycles of freeze and thawing in 1ml buffer C. The homogenate
was centrifuged for 5 min at 1o,000g at 180C and the supernatant
loaded and run on the Sephadex column as described above.
The column was stored in buffer C containing 0.02% (w/v) sodium
azide.
2.6.5 pH and temperature profiles of purified malate dehydrogenase
The activity of purified malate dehydrogenase in both forward
and reverse directions was determined in the pH range 4.5 to 11.0.
The following buffers were used for oxaloacetic acid reduction: pH
4.5 - 6.0, 0.1M sodium succinate, pH 6.0 - 7.5, 0.1M Lmi dezo le-Hr l,
pH 7.5 - 9.0, 0.1M Tris HCl; pH 9.0 - 11.0, 0.1M glycine-NaOH.
Assays for malate oxidation incorporated the following buffers, pH
4.0 - 7.0, 0.5M citric acid/0.4M hydrazine sulphate; pH 7.0 - 10.5,
1.oM glycine/o.4M hydrazine sulphate. The temperature profile was
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determined for the range 150C - 500C using the standard assay
conditions for oxaloacetic acid reduction. The enzyme was pre-
equilibrated for 5 min at the required temperature before addition of
substrate.
2.6.6 Enzyme kinetics.
Purified malate dehydrogenase was assayed in the direction of
oxaloacetic acid reduction in 1.5ml total volume with extracts
diluted 50-fold. For malate oxidation, malate dehydrogenase was
assayed in 1.5ml total volume wi th extract diluted 6-fold. The Km
and Vmax of purified malate dehydrogenase were determined in both
directions, with oxaloacetic acid and malate as substrates, using the
method of Lineweaver and Burk (1934). Double-reciprocal plots were
constructed using data for 5 NADH (0.20 - 0.03mM) or NAD (2.0 -
0.05mM) and six oxaloacetic acid (0.17 - 0.017mM) or malate (133 -
3.3mM) concentrations. The Vmax and apparent Km were determined
for each line by least squares regression analysis (Wilkinson 1961).
Plots of the intercepts of the ordinate from the double-reciprocal
plots against the reciprocals of the concentration of NADH or NAD
were used to obtain the Km NADH or Km NAD and respective Vmax' A
plot of the slope from the double reciprocal plots against the
reciprocals of the concentration of NADH or NAD was also used to
determine the ~ oxaloacetic acid and Km malate (Fromm 1975).
2.7 POLYACRYLAMIDE GEL ELECTROPHORESIS
Discontinuous SOS polyacrylamide gel electrophoresis (Disc-PAGE)
was performed according to the method of Laemmli (1970) using an
apparatus designed for microelectrophoresis (Amos 1976).
75
2.7.1 Gel preparation
Disc-PAGE relies on the casting of two gels with different pore
sizes, a large pore stacking gel and a small pore running or
separating gel. The separating gel was cast first and contained as a
final concentration in 25% separating gel buffer (see Table 5):
10% (w/v) total acrylamide (see Table 5);
0.1% (v/v) N,N,N',N'-tetramethyl-ethyl ened iami ne (TEMED);
0.1% (w/v) ammonium persulphate;
0.1% (w/v) lauryl sulphate (SOS).
Oxygen inhibits polyacrylamide polymerisation. therefore the
mixture was degassed under partial vacuum before the addition of the
ammonium persulphate catalyst. After pouring the gel into 8 x 8 cm
glass holders, separating buffer was layered on top of the gel
mixture to ensure that it set to give a smooth interface for the
stacking gel. The stacking gel, which was prepared as above except
with 4% (w/v) total acrylamide and stacking gel buffer (See table 5),
was subsequently layered over the separating gel. A nine teeth well-
former was placed in the gel. which was left for at least one hour at
room temperature to set before use.
2.7.2 Sample preparation
45ul of sample protein was incubated for 5 min at 1000e with
15)-11of sample buffer (4x) (see table 5). The low molecular weight
(LMW) gel electrophoresis calibration protein mixture was dissolved
in 3oo}Jl of sample buffer Ixll, in which the SOS concentration had
been increased to 2.5%, and heated for 5 min at 1000e to completely
reduce and denature the proteins.
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Table 5.
Solutions for discontinuous polyacrylamide gel electrophoresis.
(1) Concentrated Acrylamide: 30.B% (w/v) total wi th 2.7% cross-
linker (N,N'-Methylene-bis-acrylamide)
(2) Separating gel buffer: 1.5M Tris-HC1, pH B.B
(3) Stacking gel buffer: D.5M Tris-HC1. pH 6.B
(4) Sample buffer (4X): 60% sucrose. 40mM Tris-HCl pH B.B. 4mM
EOTA. 160mM OTT. 4mg/ml bromophenol blue. 4% SOS.
(5) Electrophoresis buffer: 0.05M Tris-HC1. 0.3B5M glycine.
pH B.3. 0.1% SOS.
Table 6.
Gel destaining procedure for discontinuous polyacrylamide gel
electrophoresis
Step 1: 40% ethanol. 3% acetic acid
Step 2: 30% ethanol. 3.5% acetic acid
Step 3: Repeat step 2
Step 4: 20% ethanol. 4% acetic acid
Step 5: 5% acetic acid
1-2 hours
1-2 hours
1-2 hours
Store
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2.7.3 Electrophoresis and staining
Either 20-30~l of denatured sample protein or 10~l LMW
calibration protein solution were gently settled into each well using
a micropipette. Anode and cathode reservoirs were filled with
electrophoresis buffer (Table 5) and the gel run at 16mA constant
current using a Volkam SAE 2761 powerpack until the tracking dye,
bromophenol blue, was close to the bottom edge of the gel
(approximately 3.5 hours). The gels were stained overnight in a
solution of 0.2% (w/v) coomassie blue R-250 in 95% (v/v) ethanol
which was diluted 1:1 before use with 10% (v/v)acetic acid. The gel
was subsequently destained using the procedure outlined in table 6.
2.7.4Molecular weight determinations
The ~olecular weights of sample enzymes were determined from a
standard curve prepared using standard proteins. The relative
migration rates (Rf) for each of the calibration proteins was
measured using the dye front as the reference point. The log10
molecular weight of marker proteins (phosphorylase b (94,000);
albumin (67,000)J ovalbumin (43,000)J carbonic anhydrase (30,000);
trypsin inhibitor (20,100); lactalbumin (14,400)) was plotted
against Rf values and a line drawn by regression analysis. The
molecular weights of sample enzymes were then determined from their
corresponding Rf values.
2.8 MATERIALS
Pentostam (sodium stibogluconate) and Triostam (sodium antimonyl
gluconate) were gifts from The Wellcome Research Laboratories,
Beckenham, Kent, UK. Sodium rne Ier-serumelarsen oxide; Melarsoprol
(Mel B); monosodium p(2,4 diamino-1,3,5 triazin-6-ylamino) phenyl-
stibonate octahydrate (1714, a pentavalent antimonial analogue of
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sodium melarsen)J 2-hydroxy-4-methylol-4.S-dihydro-1.3.2-dithia-
stibole (SB22. a trivalent antimonial analogue of Mel B) were gifts
from May & Baker Ltd. Dagenham. Essex. UK.
Growth culture medium including foetal calf serum. MEM Eagle
suspension powder. MEM (SOx) amino acids solution and MEM (100x)non-
essential amino acids solution were obtained from Gibco-Biocult.
Paisley. Scotland.
Phenyl-Sepharose Cl-4B (Cat. No. 17-0B10-01), Chelating
Sepharose 6B (Cat.No. 17-0S27-01), S' AMP-Sepharose 4B (Cat.No. 17-
0620-01). low molecular weight gel filtration calibration kit
(Cat.No. 17-0442-01). low molecular weight PAGE calibtration kit
(Cat.No. 17-0446-01), agarose IEF (Cat.No. 17-046B-01), CM-Sephadex
C2S and Gelbond were obtained from Pharmacia Fine Chemicals Ltd.
Milton Keynes. England.
Digitonin. dimethylformamide. sorbitol. alumina (Type 30S) and
Sephadex G-100 superfine (Cat.No.G-100-S0) were obtained from Sigma
Chemical Co. Ltd.. Poole. Dorset. England.
Leupeptin was obtained from The Protein Research Foundation.
Osaka. Japan.
All other chemicals and linkage enzymes were purchased from
Sigma Chemical Co. Ltd «» The Boehringer Corporation (London) Ltd••
Lewes. East Sussex. England. or BOH Chemicals Ltd•• Poole. Dorset.
England.
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3.0 RESULTS
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3.1 TIE ACTIVITIES OF GLYCOLYTIC I TCA CYCLE AND ASSOCIATED ENZYMES
IN LEISHMANIA AND TRYPANoSOMES.
The activities detected in L. m. mexicana promastigotes and
amastigotes of a number of enzymes involved in glyco lys is, the TCA
cycle and related metabolic pathways are given in Table 7. The
glycolytic enzymes hexokinase, glucose phosphate isomerase, phospho-
fructokinase and phosphoglycerate kinase were at high activities in
both forms of the parasite and this was also found for glucose-6-
phosphate dehydrogenase, the first enzyme of the pentose phosphate
pathway. The presence of TCA cycle enzymes was confirmed with
isocitrate dehydrogenase and malate dehydrogenase activities being
present, although ex-ketoglutarate dehydrogenase could not be
detected in either form. Isocitrate dehydrogenase was found to
have NAOP~linked activity but no activity was detected with NAO+ as
substrate.
One of the major differences found between the two stages of the
parasite was found in the area of phosphoenolpyruvate metabolism
and CO2 fixation. PEP carboxykinase and malate dehydrogenase were
detected at much higher activity in amastigotes than promastigotes
of L. m. mexicana (Table n. Neither of the other CO2-fixing
enzymes investigated, pyruvate carboxylase and malic enzyme (carboxy-
lating), could be detected in amastigotes although the latter
activity was found at low levels in promastigotes. Pyruvate kinase
was confirmed as having significantly higher activity in
promastigotes than amastigotes (Table 7), whilst fumarate reductase,
which functions as a reversal of succinate dehydrogenase and can be
important as a metabolic route for reverse flow of the TCA cycle to
succinate, could only be detected in amastigotes and then at low
activity.
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Table 7.
Enzyme activities of Leishmania m. mexicana promastigotes and
amastigotes.
ENZYME
SPECIFIC ACTIVITya
PROMASTIGOTE AMASTIGOTE
Hexokinase 13B + 3B (4) B9 + 15 (3)
Glucose phosphate isomerase 159 + 10 (2) 430 + 112 (3)
Phosphofructokinase 106 + 25 (3) 55 + 9 (2)
Phosphoglycerate kinase 235 (1) 102 + 7 (2)
Pyruvate kinase 100 + 10 (5) 12 + B (4)
Glucose-6-phosphate dehydrogenase 105 + 20 (2) 92 + 24 (3)
PEP carboxykinase 26 "+ 9 (4) 172 "+ 5B (7)
Malate dehydrogenase 470 + 160 (4) 3760 + 690b (5)
Isocitrate dehydrogenase 100 + 31 (6) 71 + 22 (7)
«-ketoglutarate dehydrogenase NOc <" 1.0 (2) NO <" O.B (2)
Glutamate,dehydrogenase (NAO) 9BO + 235 (5) 112 + 13 (5)
Glutamate dehydrogenase (NAOP) NO <" 1.0 (3) 33 + 6 (3)
Alanine aminotransferase 137 + 7 (2) 35 (1)
Malic enzyme (decarboxylating) 49 + 20 (5) 3 + 2 (3)
Malic enzyme (carboxylating) 3+2 (3) NO <" 0.4 (4)
Pyruvate carboxylase NO < 1.1 (2) NO < O.B (3)
Isocitrate lyase NO < 0.7 (4) NO < 0.9 (7)
Glutathione reductase NO < O.B (2) NO < O.B (2)
Fumarate reductase NO < 1.0 (3) 1.6 + 0.2 (2)----------------------------------------------------------------------
a The activities are expressed in nmoles/min/mg protein and are the
means (+ SO or range) from the number of experiments given in
parentheses. Parasites were lysed by incubation in 0.25M sucrose
with 0.1% (v/v) Triton X-100 for 10 mins at 40C.
b Assayed in the presence of 100~g/ml leupeptin
c Not detected with limit of detection given.
B2
In order to see if these large difference between the two
stages of the parasite were found in other species of Leishmania and
also in trypanosomes, the activities of PEP carboxykinase, malate
dehydrogenase and pyruvate kinase were determined for both L. m.
amazonensis and L. donovani (Table 8) and T. b. brucei and T. b.
rhodesiense (Table 9). Both malate dehydrogenase and PEP carboxy-
kinase ofL. donovani were at significantly higher activity in
amastigotes than promastigotes which was similar to the situation
found in L. m. mexicana. Pyruvate kinase from L. donovani
amastigotes, however, was higher than detected for L. m. mexicana but
still lower than the promastigote activity. Although the
promastigote acti vities of L. m. amazonens is agreed well with the
other two Leishmania species, there was only sufficient amastigote
material'for one determination. The activities detected were
similar to those of the promastigote. The procyclic stage of
T. b. brucei and T. b. rhodes iense both showed subs t.ant ielLy
higher malate dehydrogenase and PEP carboxykinase acti vities when
assayed at both 250C and 370C than the mammalian bloodstream form of
the parasite (Table 9), whereas the reverse was true of pyruvate
kinase.
Malate dehydrogenase activity in L. m. mexicana amastigote
homogenates maintained at 40C was found to be very unstable and the
addition of leupeptin had a marked effect on the enzyme's activity.
In the absence of leupeptin, only 20% of the amastigote activity
remained 30 mins after amastigote Iys is, whereas 64% remained when
amastigotes were lysed in the presence of 10qug/ml leupeptin (Table
10). In contrast, homogenate activities of PEP carboxykinase,
pyruvate kinase and hexokinase were stable, even in the absence of
leupeptin, for several hours at 40C.
Two enzymes involved in the utilization and metabolism of amino
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Table 8.
Malate dehydrogenase, PEP carboxykinase, and pyruvate kinase activities
in different species of Leishmania
Specific activitya
ISOLATE ENZYME PRoMASTIGoTE AMASTIGoTE
Malate Dehydrogenase 470 + 160 (4) 3760 + 690b(2)
L. m. mexicana PEP Carboxykinase 26 + 9 (4 ) 172+ 58 (2)
Pyruvate Kinase 100 + 10 (5) 12 + 8 (2)
Malate Dehydrogenase 222 + 100 (3) 241
Pyruvate kinase
39 + 18 (3)
60 + 35 (3)
42
(1 )
(1 )
(1)
L. m. amazonensis PEP Carboxykinase
46
Malate Dehydrogenase 219 + 73 (2) 1440 + 330 (4)
L. donovani PEP Carboxykinase 45 + 6 (2) 115 + 12 (4)
Pyruvate kinase 77 + 14 (2) 46 + 9 (4)--------------------------------------------------------------------------a The activities are expressed in nmoles/min/mg protein and are the means
(+ SO or range) for the number of experiments given in parentheses.
b Assayed in the presence of 100?g/ml leupeptin.
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Table 10.
Loss of Leishmania m. mexicana amastigote homogenate malate
dehydrogenase and PEP carboxykinase activities during incubations in
the presence and absence of 100~g/ml leupeptin.a
TIME
Leupeptin 1Gnin 30min 1hr 2hr 7hr
Malate dehydrogenase 87 20 9 6 2
Malate dehydrogenase + 100 64 45 40 NOb
PEP carboxykinase 100 108 105 130 70---------------------------------------------------------------------
a Values are expressed as a percentage of activity measured at time
zero. Homogenates were prepared by lysis with 0.2% (v/v)Triton X-100
in 0.25M sucrose.
b Not determined
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acids were also investigated. with both glutamate dehydrogenase and
alanine aminotransferase being detected in both forms of L. m.
mexicana (Table 7). The promastigote NADH-linked glutamate dehydro-
genase was 1D-fold higher in activity than the equivalent amastigote
enzyme) in contrast no NADPH-linked activity could be detected in the
promastigote. although significant activity was detected in the
amastigote. Neither isocitrate lyase nor glutathione reductase could
be detected in amastigotes or promastigotes. either in the presence
or absence of leupeptin.
The distribution of the enzyme activities between the
particulate and soluble fractions of the parasite are given in Table
11. Hexokinase. malate dehydrogenase. PEP carboxykinase. glycer-
aldehyde-3-phosphate dehydrogenase and phosphofructokinase were all
found to be particulate to a large extent. Pyruvate kinase. glucose
phosphate isomerase. glucose-6-phosphate dehydrogenase. isocitrate
dehydrogenase. glutamate dehydrogenase. malic enzyme and alanine
aminotransferase were all soluble. For most of the enzymes there was
Little difference in distribution between the two parasi te forms.
however malate dehydrogenase had a higher proportion of particulate
activity in the amastigote. When the cells were lysed with Triton X-
100 instead of freezing and thawing. the fractionation gave similar
results.
Following the discovery that the amastigote contained much
higher activities of PEP carboxykinase and malate dehydrogenase than
the culture promastigotes and because of the suggested involvement of
glycolytic kinases as targets for the antileishmanial antimonials.
these enzymes were studied in more detail. Preliminary studies on
PEP carboxykinase in parasite homogenates showed that it is ADP-
specific and has an absolute requirement for manganese that could not
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Table 11.
promastigote enzymes.a
Particulate nature of Leishmania m. mexicana amastigote and
ENZYME
Protein
Hexokinase
Glucose phosphate
isomerase
Glucose-6-phosphate
dehydrogenase
Phosphofructokinase
Phosphoglycerate kinase
Glyceraldehyde-3-phosphate 49
dehydrogenase
Pyruvate kinase
Malate dehydrogenaseb 44
Isocitrate dehydrogenase 11
Glutamate dehydrogenase 2
(NAD)
Malic enzyme
Alanine aminotransferase
PEP carboxykinase 40
PROMASTIGOTE
P S SO
80
14
91
AMASTIGOTE
P S SO
34 66 + 6 (7) 42 58 + 4 (4)
17 + 5 (3)73 + 13 (3) 83
4 (1 )
27
17 83 + 3 (2) 96
Not Done
61 39 + 2 (2)
15 85 + 3 (2)
17 83 + 3 (2)
62 38 + 5 (2)
57 43 + 4 (2)
20 ( 1 )
( 1 )
5 95 + 5 (3)
80
51
5 95 + 4 (3)
20 + 15 (4)
8 92 + 4 (3)
56 + 11 (3)
89 + 3 (3)
98 + 2 (4)
9 + 2 (3)
2 98 + 5 (5)
91
7 93 + 2 (2)
Not Done
86 (1)
60 + 5 (2) 9 + 8 (4)
a Values are expressed as the percentage of the total activity
recovered in the pellet (P) and supernatant (S) fractions after 2 min
centrifugation at 10,OOOg. The results are the mean (+ SO or range)
b
from the number of experiments shown in parentheses.
Amastigote malate dehydrogenase assayed in the presence of
100~g/ml leupeptin.
be replaced by magnesium. It was also unaffected by nucleoside
triphosphates (ATP, ITP, GTP), nucleoside diphosphates ( lOP, GOP)
and the end products malate and succinate. In addition the activity
of PEP carboxykinase was considerably higher when assayed in imida-
zole buffer pH 6.6 than Tris-HCl pH 7.5.
3.2 THE EFFECT OF ANTIMONIALS AND ARSENICALS ON GLYCOLYTIC KINASES
A number of organic antimonials and arsenicals were tested for
inhibitory activity against glycolytic kinases thought to be possible
targets for these antileishmanial chemotherapeutic agents. The
structures of the drugs used are shown in Fig. 4. The effects of
these antimonials and arsenicals on phosphofructokinase from
several sources are given in Table 12. Triostam was active only
against the schistosome enzyme, with an 150 of 200 ~ 25 ~m and 74%
inhibition at 500~m (Fig. 5), whereas the pentavalent antimonial 1714
was equally active against the enzyme from schistosome and mouse
liver (Table 12). None of the antimonials, pentavalent or
trivalent, had an inhibitory effect against the leishmanial enzymes.
Melarsen oxide was an inhibitor of all the phosphofructokinases
tested wher-ees Mel B inhibited all except the promastigote enzyme;
schistosomal phosphofructokinase was especially sensitive to both
trivalent arsenicals.
Melarsen oxide had a broad spectrum of inhibitory activity
(Table 13). It inhibited pyruvate kinase and malate dehydrogenase
from L. m. mexi cana at low }JM concentrations, with the mouse
liver pyruvate kinase being less sensitive. Leishmanial hexokinase
was also inhibited. The other compounds were found to be much
poorer inhibi tors than melarsen oxide (Table 13). Mel B inhibited
pyruvate kinase, but only at relatively high concentrations, and
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Fig. 4 The structures of the organic antimonial and arsenical drugs
used in the inhibitor studies.
ORGANIC ANTIMONIAlS
(1) (2)
PENTOSTAM TRIOSTAM
(3) (4)
M&B1714 MaS 5822
ORGANIC ARSENICALS
(6)
MElARSEN MElARSEN OXIDE
(7)
MEL B
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Fig. 5. Inhibition of Schistosoma mansoni phosphofructokinase by
Triostam.
Fig 6. The effe~t of Triostam and melarsen oxide on the growth of
Leishmania m. mexicana promastigotes.
Promastigotes were grown in HOMEMmedium for 72hr incubations
wi th 0-20Opg/ml Triostam (.) or 0-100}Jg/ml melarsen oxide ( .. ). %
growth represents the parasite numbers as a percentage of the
control with no drug.
Fig. 5
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Table 12.
Effects of antimonials and arsenicals on phosphofructokinase activitiesa•
Compound
Leishmania m. mexicana
Arnastigote Promastigote
Mouse
liver
Rabbit
muscle
Schistosoma
mansoni
Tr-i ost an NI NI NI 200 + 25 (3)
1714 NI NI 275 + 35 (3) NI 275 (1)
Melarsen
oxide
B + 1 (2) 7 + 1 (2) 9 + 2 (2) 160 + 15 (2) 0.6 + 0.2 (2)
Mel B 300 + 25 (2) NI 275 + 25 (2) 400 (1) 13 + 3 (2)
a The figures given are the 150 in ~M and are the means (+ S.D. or
range) from the number of experiments given in parentheses. The
following drugs gave no inhibition at the concentrations tested (given
in parentheses): Melarsen (400~M); pentostam (110~M).
b NI. No inhibition at the maximum concentration tested: Triostam
(600}JM)J 1714 (400J-lM);Mel B (200}lM).
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amastigote, but not promastigote, malate dehydrogenase. The penta-
valent antimonial 1714 inhibited leishmanial hexokinase, whereas
Triostam, 5822 and melarsen had no effect on hexokinase, pyruvate
kinase, malate dehydrogenase or PEP carboxykinase from any source.
The only effect of Pentostam was a slight inhibition of amastigote
PEP carboxykinase, with 34% inhibition at the maximum concentration
tested which was 366~M. The peak serum level of Pentostam obtained
in humans being treated for cutaneous leishmaniasis was reported to
be approximately 15f-lg/ml(16.5f-lM)(Berman and Wyler 1980). At this
concentration, Pentostam had no inhibitory action on PEP carboxy-
kinase.
3.3 THE EFFECT OF ANTIMONIALS AND ARSENICALS ON THE GROWTH OF
LEISHMANIA M. MEXICANA PROMASTIGOTES
The lack of a marked effect of Pentostam on Leishmania promas-
tigote growth reported by previous workers (Mattock and Peters 1975,
Berman and Wyler 1980 and Coombs et ale 1983) was confirmed, with
promastigote numbers being reduced by less than 10% by drug at
100,ug/mlin comparison with the control after a 72 hour incubation.
Neither the pentavalent arsenical melarsen nor its antimonial
analogue 1714, at concentrations of 200~g/ml, had any appreciable
effect on growth. In contrast, the trivalent analogue of
Pentostam, Triostam, had potent antileishmanial activity (Fig. 6, pg.
91); the L050 was 20f-lg/mland the MLC was 400)-lg/ml.It was found to
be almost as effective, on a weight/weight basis, as melarsen oxide
CLD50, 20)-lg/ml; MLC, 100f-lg/ml). Triostam at 400).lg/ml caused
promastigotes to round up by 4 hours and immotile parasites were
observed from 8 hours onwards: over 90% of the cells appeared dead
within 24 hours. Melarsen oxide acted less rapidly, with dead cells
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Table 14.
The effect of cysteine on the inhibitory action of Triostam against
promastigotes of Leishmania m. mexicana.
with Triost~
Cysteine
(mM) without Triostama 400}Jg/ml 2DD)Jg/ml 100)Jg/ml
10 11 + 5 41 + 2 111 + 75 105 + 37
5 1B + 2 1B + 9 41 + 1B 79 + 13
3 21 + 5 1 + 1 1B + 10 76 + 1B
1 7B + 23 o 1 + 1 20 + 9
o 100 o 0.4 + 0.2 5 + 2
a Parasite numbers as a percentage of the control minus cysteine and
Triostam after 72 hrs incubation at 250C.
b Parasite numbers as a percentage of that in cultures containing the
same concentration of cysteine but no drug. The results are the mean
(+ S.D.) from at least three experiments.
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appearing by 12 hours but only 60% of the promastigotes were killed
by 24 hours. The activity of Triostam was found to be antagonised
by cysteine (Table 14). The addition of 10mM cysteine to
promastigote cultures with Triostam at 400~g/ml reduced the
inhibitory action of the drug on parasite growth by 41% and abolished
the effect of the drug at 200~g/ml. With cysteine at this concen-
tration, however, there was only 11% growth compared to the control
with no cysteine. 1mM cysteine, which by itself reduced the growth
of L. m. mexicana by 22%, had no significant effect on the action of
Triostam at 400 or 200~g/ml, even though the molar ratio of cysteine
to drug was 1:1.2 and 1:0.6 respectively, and only antagonised the
drug at 1OO~g/ml by 15%.
3.4 STUOIES ON ENZYME LOCATIONS IN LEISH1ANIA M. ftEXICANA
3.4.1 Differential centrifugation
The distributions of enzymes and protein in the fractions of L.
m. mexicana promastigotes produced by differential centrifugation are
given in Table 15. Hexokinase, glucose phosphate isomerase,
glyceraldehyde-3-phosphate dehydrogenase and PEP carboxykinase were
recovered in large amounts in the small organelle fraction P2 and all
exhibited latency. Isocitrate dehydrogenase, malic enzyme, glutamate
dehydrogenase (NAO-linked) and alanine aminotransferase were present
at high activity in both Pl and the soluble fraction, whereas almost
70% of the malate dehydrogenase activity was recovered in Pl. A
small but significant proportion of phosphoglycerate kinase activity
was found in the pellets with the majority, 69%, in S. Glucose-6-
phosphate dehydrogenase and pyruvate kinase were found almost exclu-
sively in S.
It was found impossible to fractionate L. m. mexicana
amastigotes successfully by applying the methods used with promas-
96
(I)
+' co
0.
X
W r-, r-, ('f) N ('f) <r .q- m to .q- N m m (I)co
4- 4-
0 0 C. 0
0 ·rl(I) Z +'
C U
0 CO
·rl ~
+J 4-
U 0 ('f) <;t- m N m to 0 L11co >. ':;:'1 ':;:'1 71 ifl ~I ~I ~ ~I ~I ~ ~I ~I :;:-1 £~ C ~ +1 +1 u
4- 0 OJ ro r-, <;t- m m to to m 0 m .q- m ('f) co
·rl > 0 co m m 0 a:J 0 to m m 0 m m OJ+' 0 ~ ~ ~ ~~ co U I C
co en OJ ·rl
.-t :::J o;
:::J4- LJ
.-t ·rl 0,0 C
rl~ N :::J
OJ+J c:rl ~I ~I ifl c:rl ~I ~I c:rl ~I 'tl Cfl ~I ':;:'1 0u C 4-
.DOJ L11 to N ~ to m m to m N <r a:J L11
:::J U en .q- ~ L11 co ('f) to co N ('f) <r N ('f) (I)(I) OJ
rl co ·rl
co >. +'
OJ·rl +' ·rl£ +J ·rl
71 71 c:j?1 ~I ~I ~I ~I ~I ~I ~I c:j?1 ~I ~I >+' C > ('f) ·rlOJ ·rl Q_ .q- ~ <r N N to m co ~ ~ N L11 m +'~ +' ~ ~ U
C OJ U co
·rl 4- co
4- OJ
(I)·rl rl rn .c~:co ':;:'1 ':;:'1 71 c;l ifl Cfl ~I ~ Cfl ~I ~I ifl Cfl +'+' N +10 Q_ co co N r-, N m N m N L11 L11 r-, L11 OJ
N.o +' ~ in ('f) .q- ~ L11 N ~ ~ ~ ~ c,
C co
OJLJ 4-
OJ 0
LJ ~ ~ .
C co 0,0 Cfl Cfl ifl ~ ~I ':;:'1 c:j?1 c;l ifl ':;:'1 71 71 Cfl OJLJco 0. ~ +1 b.OOJ
OJ Q_ ('f) L11 N 0 0 N to r-, co N m 0 to C ~
C ~ N ~ ~ ~ N ~ to L11 ('l'l L11 <;t- co OJ
·rl 0. ~ >
OJ 0
+J (I) ~ Uo OJ 0 OJ
~+J ~
0.0 OJ 0
b.O (I) en>.
·rl co +'
4-+J C + I·rlo (I) OJ >
~
b.O 0 C·rl
OJ 0 c:( co+'
C 0 (I) ~ OJ Z ~
U
0 ~ co LJ +' co
·rl 0. ~ >. co OJ OJ '-'
+J OJ £ £ OJ (I) OJ (I) .-t
:::J co b OJ 0. (I) co (I) co C co.0 C LJ (I) co C co ~ OJ+J
·rl co (I) 0 c OJ OJ C OJ > 0
~ U ·rl OJ £ ·rl (I) b.O OJ 4- ·rl +J
+' ·rl +' 0. .x. co 0 b.O (I) b.O
(I) X OJ co I OJ C ~ 0 C OJ
·rl OJ +' £ ('f) OJ (I) OJ LJ ~ co (1)£o E co 0. I +' OJ co b.O >. LJ ~ OJ+J£ (I) OJ co (I) C 0 £ >. +' :::J. 0. 0 LJ OJ ~ co ·rl ~ OJ £ 0 rl4-
E (I) £ >,(1) OJ C .:L LJ LJ
~
OJ C co 0
0 0. £ co U ·rl >. >. LJ ·rl >• co OJ ..c I OJ C >. .x. x £ OJ ~ OJL11 ·rl +' (I) 0. to LJ OJ rl 0 OJ +' N OJ b.O
~ C -c co I .-t b.O b!l OJ .D LJ co C +J OJ coco OJ c C OJ OJ co 0 0 +' ~ ~ OJ ~
OJ £ +J
OJi:
C ·rl ·rl (I) (I) ~ ~ £ co co OJ +' C I- C
0 OJ .:L 0 0 OJLJ 0. > U +' ·rl U co ·rl OJ.-l(l) 0. +' 0 U U U >, (I) :::J co U ·rl +J C ulj.@ b 0 x :::J :::J >.£ 0 ~ Q_ rl 0 rl :::J co ~~ OJ rl rl rl OJ ..c W co (I) co .-t rl • OJI-__J u Q_ I CJ L.9 CJ"O Q_ Q_ Q_ ~ H ~ CJ c:( co 0.
97
tigotes. Attempts at fractionation resulted in fractions in which
there was no latency detected for either of the glycosomal markers
hexokinase or glucose phosphate isomerase. presumably due to lysis of
the organelle and consequent release and exposure of their
contents. The distributions of a number of amastigote enzymes
produced by differential centrifugation are shown in Table 16. Hexo-
kinase. which has particulate activity (Table 11). showed an even
distribution between P1 and P2 whereas glucose phosphate isomerase. a
putative soluble glycosomal enzyme. was mainly recovered in the
soluble fraction S. Glutamate dehydrogenase. which is a soluble
mitochondrial matrix enzyme and showed 50% of its activity in P1 of
promastigotes (Table 15). was recovered to the extent of only 15% of
its activity in the P1 fraction of amastigotes (Table 16). In an
attempt to fractionate amastigotes successfully. various modifi-
cations of the methods were tested. including lysis using glass
beads. the detergent digitonin. ground glass homogenisers and
hypotonic condi tions, but none proved better than the method using
alumina. Breakage buffers of different compositions (eg. replacing
sucrose with mannitol) and containing combinations of inhibitors of
proteinases (leupeptin and antipain) and phospholipases (mepacrine.
chelating agents). enzymes which were thought to be responsible at
least in part for the breakdown of the organelles. were also tested
but without success. Unfortunately, none of these methods produced
cell lysates containing intact amastigote organelles as determined by
latency of glucose phosphate isomerase and hexokinase.
3.4.2 Sucrose density centrifugation
The enzyme distribution profiles of some of the glycolytic
enzymes on 1.24 - 1.15 g/ml linear sucrose gradients are shown in
Figures 7 and B. Hexokinase. glucose phosphate isomerase. phospho-
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Figs. 7 and B.
Distribution profiles of Leishmania m. mexicana promastigote
enzymes after isopycnic centrifugation of lysates on 1.24-1.15g/ml
linear sucrose gradients. The left hand axis represents the
frequency of the gradient (p= 1.24-1.15g/ml) and the right hand axis
represents the frequency of the soluble fractions combined as one
histogram bar (f= 1.15 -1.07g/ml). Histograms show the means (~
S.E. or range) from the number of experiments in parentheses. Mean
percentage recoveries ranged from 87% (glucose phosphate isomerase)
to 138% (malate dehydrogenase).
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fructokinase, glyceraldehyde-3-phosphate dehydrogenase, and PEP
carboxykinase showed large distinct peaks with a density of 1.215 -
1.220 g/ml (Fig. 7). For each enzyme some of the activity was found
remaining on top of the gradient and in the case of glucose phosphate
isomerase this amounted to about 50% of the total activity. Small
amounts of phosphoglycerate kinase and glucose-6-phosphate dehydro-
genase activities were also detected on the gradient at a similar
density to hexokinase. Pyruvate kinase was recovered exclusively in
the soluble fraction. The distribution profile for oligomycin-
sensitive ATPase, a mitochondrial marker enzyme, shows a sharp peak
of activity at a density of 1.190 - 1.195 g/ml (Figure B). Total
ATPase acti vity, however, was spread through most of the gradient.
Malate dehydrogenase also showed a distinct but smaller peak at 1.190
- 1.195 g/ml. Glutamate dehydrogenase, alanine aminotransferase and
malic enzyme, probably all mitochondrial enzymes, showed very small
peaks at this density, with most of the activity in the soluble
fractions and spread out on the gradient.
3.4.3 Release of soluble enzymes of Leishmania m. mexicana by
digitonin.
As an alternati ve approach to the study of enzyme
locations in L. m. mexicana, the detergent digitonin was used: this
lysed the various parasite membranes at different rates and so caused
the sequential release of soluble enzymes from within the organelles.
The results of these studies with both amastigotes and promastigotes
are given in Figures 9, 10 and 11. In the amastigote, three subcel-
lular compartments were distinguished. After 10 min incubation with
digitonin at 150~g per 109 amastigotes, more (95%) of glucose-6-
phosphate dehydrogenase activity was released than the putative
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Fig. 9.
Release of soluble enzymes and protein from Leishmania m.
mexicana amastigotes treated for 10 mins with digitonin at different
concentrations. The experiment was performed twice with one
representati ve set of experimental data shown. 109 amastigotes
contained approximately 1.Bmg protein. Key to enzymes: Glucose-6-
phosphate dehydrogenase ( A ) J glucose phosphate isomerase (0 )J
phosphoglycerate kinase (. ), glutamate dehydrogenase (A ),
alanine aminotransferase ( • )J protein (0 ).
Fig. 10.
Release of soluble enzymes and protein from Leishmania m.
mexicana amastigotes treated for different lengths of time with
150~g digitonin/109 cells. The experiment was performed 3 times,
one representative set of data are shown. Legends for enzymes as
for Fig. 9.
Fig. 11.
Release of soluble enzymes and protein from Leishmania m.
mexicana promastigotes tDeated for 10 mins with digitonin at
different concentrations. 2 x 10B promastigotes contained
approximately 1.6mg protein. Pyruvate kinase (X). Legends for
other enzymes as for Fig. 9.
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glycosomal enzymes glucose phosphate isomerase and phosphoglycerate
kinase (each approximately 70%). which in turn were released to a
greater extent than the mitochondrial enzymes glutamate dehydrogenase
and alanine aminotransferase (only about 20% release) (Fig. 9).
Following the release of enzymes during 30 min incubations of 109
amastigotes with 150~g digitonin revealed even greater differences
between enzymes from different organelles (Fig. 10). 90% of
glucose-6-phosphate dehydrogenase activity was released within 2,min.
whereas only about 50% of both glucose phosphate isomerase and phos-
phoglycerate kinase activities were released within 3 min with the
remainder of the activities (up to 90% maximum) being released over
the next 20 minutes. Less than 20% of glutamate dehydrogenase and
alanine aminotransferase activities were released during the first 10
mins incupation. but between 10 and 20 mins there was a rapid release
such that greater than 90% of each activity was recovered in the
supernatant by 30 minutes. Comparative studies carried out with
L. m mexicana promastigotes produced a similar enzyme release profile
to amastigotes but there were some differences in concentrations of
digitonin involved (Fig. 11). Glucose-6-phosphate dehydrogenase was
released from both parasite forms at approximately the same digitonin
concentration (per mg protein), but the mitochondrial glutamate
dehydrogenase and alanine aminotransferase and the glycosomal glucose
phosphate isomerase were released from promastigotes at higher
digi tonin concentrations in comparison to the amastigote enzymes.
In digitonin-treated promastigotes. pyruvate kinase was released in
parallel with glucose-6-phosphate dehydrogenase (Fig. 11).
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3.4.4 Isoelectric focusing of malate dehydrogenase isoenzymes
A diagramatic representation of the zymogram of malate dehydro-
genase for various fractions of L. m. mexicana amastigote and
promastigote clones is shown in Fig. 12. The major bands were not
distinctly focused but ran together to a certain extent. This may
have been due to the 200mM NaCI which was required to solubilize all
the particulate isoenzymes. If this was removed by dialysis before
applying the samples to the agarose gel, the enzymes precipi tated
and lost activity. Despite these limitations in the use of the
technique there were clearly large differences observed between
amastigote and promastigote malate dehydrogenase isoenzymes.
Amastigote homogenate (Track 1) and solubilised pellet (Track 5)
showed 3 major bands (c,d,e,) which stained within 20 min. These
were possibly due to particulate enzymes although they also appeared
in amastigote supernatants but at much lower activity. Only one of
these bands (c) was detected in promastigote homogenates (Track 2)
and pellets (Track 6). Amastigote homogenates showed a further 2
bands which appeared after 1 hr (b and f), which were not detected in
any other sample. Amastigote homogenate and supernatant both showed
a weak band (a) very close to the cathode which only appeared after 2
h incubation and which was not found in the amastigote pellet or
promastigote fractions. The band g isoenzyme, which may also
represent a soluble isoenzyme, had higher activity in promastigote
homogenate and supernatant than those from amastigotes and was not
found in amastigote pellet. Purified malate dehydrogenase showed one
major band (mid-way between band c and d) with 2 smaller bands on
either side, however the three bands appeared to overlap.
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Fig. 12.
Diagramatic representation of isoel8ctric focusing of malate
dehydrogenase isoenzymes. Samples were run on 1mm thick rEF agarose
gels (114 x 185mm) for 2.5 hr at a maximum of 5W and 500V with
current unlimited. Gels were stained for malate dehydrogenase
acti vity with a zymogram overlay in 0.2% agar. Key to the time in
which the malate dehydrogenase stain appeared: Within 20 mins (")J
1hr (~)J 2hr (~). The shading represents the bands that ran
together to a certain extent.
Key to tracks:
1) Amastigote homogenate
2) Promastigote homogenate
3) Amastigote supernatant
4) Promastigote supernatant
5) Amastigote pellet
6) Promastigote pellet
7) Purified malate dehyd~ogenase
8) Lysed human blood cells
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3.5 SOLUBILIZATION OF PARTICULATE ENZYMES
The effect of ionic strength on particulate enzymes from
amastigotes and promastigotes of L. m. mexicana was investigated
using 0-1M sodium chloride. Malate dehydrogenase, PEP carboxykinase
and hexokinase activities sedimented from amastigote homogenates by
centrifugation at 10,000g for 2 min were found to require different
concentrations of NaCl for solubilization (Fig. 13a). Malate dehyd-
rogenase was solubilized by lower concentrations of NaCl than PEP
carboxykinase or hexokinase but all three enzymes were solubilized to
greater than 80% by 0.5M NaClj consequently this concentration of
salt was used in the subsequent purification procedure for amastigote
enzymes. In a comparative experiment promastigote particulate
enzymes were found to behave in a manner similar to those from
amastigot~s (Fig 13b) although 1M NaCl solubilized more protein from
amastigotes (65%) than promastgotes (40%).
3.6 PURIFICATION AND CHARACTERISATION OF PARTICULATE MALATE DEHYDRO-
GENASE AND PEP CARBoXYKINASE FROM LEISHMANIA M. MEXICANA AMASTIGoTES
Particulate malate dehydrogenase and PEP carboxykinase were
purified to electrophoretic homogeneity as summarised in Tables 17
and 18. Malate dehydrogenase was purified 150-fold overall with a
final specific activi ty of 1230 uni ts/mg protein and a recovery of
63% (Table 17). Most of the loss of activity occurred during the
concentration step using the Amicon filtration unit. This may have
been due in part to the process taking several hours because of the
high viscocity of the mixture containing 50% ethylene glycol, and
also possibly to non-specific adsorption to the membrane filter.
Less activity was lost when the eluates were reduced less in volume,
however the protein concentrations in these samples were too low for
SOS-gel electrophoresis. For routine purifications, the samples
109
Fig. 13a.
Solubilization of particulate enzymes of Leishmania m. mexicana
amastigotes. Parasites were lysed in 0.25M sucrose containing 0.1%
(v/v) Triton X-100, the lysate centrifuged at 1BoC for 5 min at
10,OOOg and the pellet exposed to a range of NaCl concentrations.
The supernatant and resuspended pellet from a subsequent 5 min
centrifugation at 10,OOOg were assayed for malate dehydrogenase
( • ), PEP carboxykinase (.), hexokinase ( ...) and protein ( 0 )
and the soluble activity expressed as a percentage of the total
activity recovered in both fractions.
Fig 13b.
Solubilization of particulate enzymes of Leishmania m. mexicana
promastigotes. The experimental procedures and representation of
data is as shown in Fig. 13a.
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would require less concentrating and the percentage recoveries would
be accordingly better. Partially purified and pure malate dehydro-
genase when washed free of ethylene glycol and suspended in 0.12M
triethanolamine buffer, pH 7.5, containing 200 mM NaCl and lmM OTT
were found to be very unstable at both 40C and -700C, all activity
being lost within 24 hr. Solubilised particulate malate dehydro-
genase (S2) lost 78% activity when stored at 40 for 5.5 hr. When the
enzyme was kept in 1% (v/v) ethylene glycol, there was still a loss
of 70% of the enzyme activity in 5.5hr at 40C, whereas in 5% (v/v)
ethylene glycol 35% of the activi ty was lost under the same
conditions (Table 19). It was found, however, that full activity was
maintained when the enzyme was stored in 10% (v/v) ethylene glycol at
-700C fo~ up to 3 months or overnight at 40C; consequently 10%
ethylene glycol was included in all buffers used for further purifi-
cation procedures.
PEP carboxykinase was purified 132-fold overall with a final
specific activity of 30.3 units/mg protein and a recovery of 20%
(Table 18). The percentage recovery from the Phenyl-Sepharose
column was lower in the experimental example presented (57%) than in
other similar experiments (80-90%). In all cases, however, the
majority of the enzyme loss occurred during Amicon filtration.
Malate dehydrogenase, hexokinase and PEP carboxykinase co-eluted
from the Phenyl-Sepharose Cl-48 column when the gradient had reached
50% ethylene glycol and 500mM NaCl. Glyceraldehyde-3-phosphate
dehydrogenase was eluted earlier (Fig. 14).
Metal chelate affinity chromatography was attempted in an effort
to separate PEP carboxykinase from the enzymes that co-eluted with it
from the Phenyl-Sepharose Cl-48 column. The separation method is
based on the differing ability of sample proteins to bind heavy metal
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Table 19.
The effect of ethylene glycol on the loss of Leishmania m. mexicana
amastigote solubilised particulate malate dehydrogenase activity.a
TIME (Hours)
% Ethylene glycol o 0.5 1 2 5.5
o 100 69 76 64 22
1 100 74 60 64 30
5 100 83 93 91 65
10 100 91 83 85 100
20 100 104 112 104 131
a The values represent the percentage of the activity present at time
zero remaining after incubation at 40C. The solubilised enzyme (S2)
was prepared as described in section 2.6 of the methods.
114
Fig. 14.
Purification of Leishmania m. mexicana amastigote enzymes using
hydrophobic interaction chromatography. Solubilized particulate
enzyme (52) was applied to a column (1.6 x 15.5cm) of Phenyl-
5epharose CL-4B pre- equilbrated with O.12M triethanolamine buffer
pH 7.5 and 1MNaCI (Buffer A). The column was then washed with BOml
of buffer A (flow rate BOml/hr, 8ml fractions collected) followed by
150ml of an increasing gradient of ethylene glycol (30-7~~ v/v) and
a decreasing gradient of NaCl (700-300mM) in O.12M triethanolamine
buffer pH 7.5 (flow rate 30ml/hr, 3ml fractions collected).
Fractions were assayed for malate dehydrogenase ( • ), PEP
carboxykinase (.), hexokinase ( • ) and glyceraldehyde-3-phosphate
dehydrogenase ( 0). Protein (----) was measured at 2BOnm. The
malate dehydrogenase activity was approximately BD-fold higher than
the other enzymes assayed and is represented on a separate scale.
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ions. The binding to the column is pH dependent and can be reversed
by reducing the pH, increasing the ionic strength or using a
chelating agent such as EOTA. A chelating Sepharose 6B column loaded
with Zn2+ showed separation of the test sample (solubilised pellet
S2) into three protein peaks under different elution conditions (Fig.
15a), however the column was not suitable for purification of the
enzymes under study as both PEP carboxykinase and malate dehydro-
genase, which are inhibited by O.5mM ZnC12 by 93% and 95% respec-
tively, were inhibited by ZnC12 from the column. Leishmania m.
mexicana PEP carboxykinase is manganese dependent and a Chelating
Sepharose column loaded with Mn2+ might therefore be expected to give
a good purification of PEP carboxykinase. However M n2+ only binds
poorly to the Chelating Sepharose (Porath et al. 1975) and it was
found that only a small concentration of protein bound to the column,
the majority, including all malate dehydrogenase and PEP
carboxykinase activities, was washed straight through (Fig. 15b).
7% of the malate dehydrogenase activity was eluted immediately
from the 5' AMP-Sepharose column, together with all detectable PEP
carboxykinase and hexokinase activities (Fig. 16). The 93% of
malate dehydrogenase activity that remained bound to the column was
eluted with 1M NaCl in D.12M triethanolamine buffer pH 7.5 and was
shown to be electrophoretically homogeneous on SOS polyacrylamide
gels (Fig. 17). This purified enzyme preparation was used in the
characterisation studies.
PEP carboxykinase, hexokinase and the 7% of malate dehydrogenase
activi ty which did not bind to 5' AMP-Sepharose were subsequently
separated by gel filtration on Sephedex G-100 (Fig. 15). The eluted
PEP carboxykinase and hexokinase both appeared to be homogeneous on
SOS polyacrylamide gels} however due to the very low protein concen-
tration loaded onto the gels the bands were too weak to be reproduced
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Fig. 15a.
Attempted purification of Leishmania m. mexicana PEP carboxy-
kinase using metal chelate affinity chromatography (MCAC) with Zn2+.
O.Bml of solubilized pellet (S2) was applied to a column (1.5 x 4cm)
of Chelating-Sepharose 5B charged with 5mg/ml ZnCl2 and pre-
equilibrated with buffer A. The column was washed with 20ml of the
same buffer (flow rate 50ml/hrJ 2ml fractions collected). Bound
enzymes were subsequently eluted with 20ml buffer X (0.05M sodium
acetate buffer pH 4.0. 1M NaCI) and 20ml buffer Y (0.12M triethano-
lamine buffer pH 7.5. 1M NaCI. 50mM EOTA). Protein was determined
at 2BOnm (------).
Fig. 15b.
Attempted purification of Leishmania m. mexicana PEP carboxy-
kinase using MCAC with Mn2+. Procedure was as outlined above except
that the column was charged with 5mg/ml MnS04. Malate dehydrogenase
(."0"). PEP carboxykinase ( 0 i. protein (------).
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Fig. 16.
Purification of Leishmania m. mexicana malate dehydrogenase
using affinity chromatography. The concentrated sample from the
Phenyl-Sepharose Cl-4B column was applied to a column (1.6 x 3.5cm)
of 5' AMP-Sepharose 4B pr-e-aquiLtbr-e'ted with 0.12M triethanolamine
buffer pH 7.5, 200mM NaCl, lmM OTT and 10% (v/v) ethylene glycol.
The column was washed with 20ml of the same buffer, 2.5ml fractions
being collected. Bound enzyme was subsequently (arrowed) eluted
with 20m I of buffer containing 1M NaCl and the fractions collected
assayed for malate dehydrogenase ( • ), PEP carboxykinase ( •
and hexokinase (A ). Protein (----) was measured at 280nm.
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a) SOS gel electrophoresis of samples from different stages during
the purification of malate dehydrogenase. Key to tracks (protein
applied): 1, low molecular weight (LMW) marker proteins (20~g)J 2,
homogenate H (6Jlgh 3, pellet P1 (B.5}Jg)J 4, supernatant S2,
(6.1Jlg)J5, unbound protein eluted from 5' AMP-Sepharose column
(1.3)Jgh 6, purified malate dehydrogenase (O.32)Jgh 7, LMW marker
proteins (20}-lg).
b) Molecular weight determinations using a calibration curve of low
molecular weight protein markers. 1, phosphorylase b. 2, albumin.
3, ovalbumin. 4, carbonic anhydrase. 5, trypsin inhibitor.
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Fig. 18.
Purification of Leishmania m. mexicana enzymes using gel
fil tration. 1.7ml of unbound protein from the S' AMP-Sepharose 48
column was concentrated and applied to a column (2.6 x SOcm) of
Sephadex G100 equilibrated with 0.12M triethanolamine buffer pH 7.S
with 10% (v/v) ethylene glycol, 1MNaCI and 1mMOTT. The column was
eluted in an upwards direction (20ml/hr) and 2.Sml fractions were
collected and assayed for malate dehydrogenase ( • ). PEP carboxy-
kinase ( • ) and hexokinase ( .6 ).
Insert: Molecular weight determination using a calibration
curve of low molecular weight (MWt) protein markers. 1,
ribonuclease A - 13,700, 2, chymotryps inogen A - 2S,OOO, 3,
ovalbumin - 43,000, 4, albumin - 67,000.
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3.6.1 Molecular weight determinations
The molecular weights of the purified enzymes were estimated by
two methods: Chromatographic mobility on Sephadex G-100 (Fig. 18),
which gave molecular weights of 39,800 for malate dehydrogenase,
63,100 for PEP carboxykinase and 83,000 for hexokinase, and SOS
polyacrylamide gel electrophoresis, which gave molecular weights of
33,300 and 65,100 for malate dehydrogenase (Fig. 17) and PEP carboxy-
kinase, respectively.
The molecular weights of all malate dehydrogenase isoenzymes
were investigated using Sephadex G-100. A homogenate of L. m.
mexicana amastigotes containing all the isoenzymes of malate dehydro-
genase, including solubilized particulate enzyme, eluted as a single
peak during gel filtration (Fig. 19) with a molecular weight of
39,800.
3.6.2 pH and temperature profiles
The pH profiles for malate dehydrogenase assayed in both
directions (oxaloacetic acid (OAA) reduction and malate oxidation)
are shown in Fig. 20(a). The former reaction was active over a
broad pH range (6.0 - 9.5) with a maximum at pH 7.5. For malate
oxidation, the optimum pH was 8.5. The enzyme, assayed with OAA as
substrate, increased in activity as the temperature was increased
from 150C up to 400C (Fig. 20b) but was inactivated by higher
temperatures.
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Fig 19.
a) Molecular weight determinations using Sephadex G-100 of
malate dehydrogenase in Leishmania m. mexicana amastigote total
homogenate solubilized with 0.12M triethanolamine buffer pH 7.5 with
10% Iv/vl ethylene glycol, 1MNaCI and 1mMOTT. The column was run
as described in Fig. 18.
b) Calibration curve of low molecular weight markers (ses fig.
18)
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Fig. 20.
a) pH profile for purified malate dehydrogenase assayed in both the
malate oxidation (.) and oxaloacetic acid reduction (0 )
directions.
b) Temperature profile for purified malate dehydrogenase assayed in
the direction of oxaloacetic acid reduction.
a) -E- 40 r-. 8en-c: -~
/0 . "" E- -enZ 0-0 0 -0 0/ • 6 c:._
0",,- -.
~-o Z~
O,~O \
0 0 0w
/ • ._Cl: 2 / 4 «w 0._ \ . X« 0._ 0 •w / /. 0 wo 10 \ 2
._
~ «0
o • ...J...J / ./ «« ~x __ ./
0............0
5 6 7 8 9 10 11
pH
b)
050 /-E- /0en-c: 0~
/->-._ 30>._ 0 0o /«w
~ 0
>- /N
Z 0
w
10
o
10 20 30 40 50
TEMPERA TURE CoC)
60
123
3.6.3 Enzyme Kinetics
The Vmax (OAA reduction) and apparent Km OAA values for
malate dehydrogenase for a range of NAOH concentrations are given in
Table 20. The results are shown graphically as Lineweaver-Burk
plots, which intercepted to the left of the x-axis suggesting a
single displacement reaction (Fig. 21). A plot of the intercepts
with the ordinate against the reciprocal of NAOH concentration gave
an apparent Km NAOH of 41~M, and a Vmax (oxaloacetic acid reduction)
of 576 units/mg protein (Fig. 22a) and a plot of the slope against
the NAOH concentration gave a Km OAA of 38)-lM(Fig. 22b). The Vmax
(malate oxidation) and apparent Km malate values for a range of NAO+
concentrations are given in Table 21. The resu 1ts are shown
graphically as Lineweaver-Burk plots in Fig. 23. From plots of the
reciprocal of NAO+ concentration against the intercepts (Fig. 24a)
and the slope (Fig. 24b) taken from Fig. 23, the apparent ~ NAO+ was
0.79mM, the Km malate 3.6mM and the Vmax (malate oxidation) 165
units/mg protein.
The activity for malate oxidation with both the pure or crude
preparations of malate dehydrogenase was reduced 3-fold by the
omission from the assay mixture of the high concentrations of
hydrazine sulphate, which reacts with the end product oxaloacetic
acid. Oxaloacetic acid exhibited substrate inhibition at concen-
trations greater than 0.83mM (Fig. 25) and malate was found to act as
a product inhibitor at high concentrations with 82% inhibition at
399mM and 27% inhibition at 33mM (Table 22).
Metabolic intermediates, cofactors and ions were tested as
possible modifiers of enzyme activity for malate dehydrogenase
assayed in the oxaloacetic acid reduction direction. PEP, glucose-
6-phosphate, fructose-6-phosphate, fructose-1,6,-diphosphate,
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Table 20.
The Vmax and apparent Km oxaloacetic acid (OAA) for purified
amastigote malate dehydrogenase with different NAOH concen-
trations.a
NAOH (rrf'l) bVrnax Apparent Km OAA (~M)
0.2 0.89 50.9
0.1 0.84 53.2
0.075 0.81 60.9
0.05 0.69 64.6
0.04 0.51 63.0
0.03 0.50 74.0
a Taken from fig. 21.
b Units= mmoles/min.
Table 21.
The Vmax and apparent ~alate for purified amastigote malate
dehydrogenase with different NAO+ concentrations.a
NAO (rrf'l) Apparent ~ malate (rrf'l)
2 1.15 4.9
1 0.90 7.3
0.5 0.60 9.0
0.2 0.40 12.7
0.1 0.24 31.1
0.05 0.11 22.4
a Taken from fig. 23.
b Units= mmoles/min.
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Fig. 21.
Lineweaver-Burk plots for the activity of purified malate
dehydrogenase at a range of oxaloacetic acid and NAOH
concentrations.
Fig. 22.
a) Secondary plot of the reciprocals of NAOH concentrations
against the intercept of the ordinate from Fig. 21.
b) Secondary plot of the reciprocals of NADH concentrations against
the slope of the lines from Fig. 21.
Fig. 23.
Lineweaver-Burk plots for the activity of malate dehydrogenase
at a range of malate and NAO+ concentrations.
Fig. 24.
a) Secondary plot of the reciprocals of NAO+ concentrations against
the intercept of the ordinate from Fig. 23.
b) Secondary plot of the reciprocals of NAO+ concentrations against
the slopes of the lines from Fig. 23. Key: mal•• malate.
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Fig. 25.
The effect of the substrate oxaloacetic acid on malate
dehydrogenase activity.
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Table 22.
Inhibition of L. m. mexicana amastigote malate
dehydrogenase by malate.a
Concentration
(rrM)
Activity
(Units/ml)
% inhibition
o 19.0 o
33 13.9 27
66 10.5 45
133 7.5 61
266 4.8 75
399 3.4 82
a Assayed in the direction of oxaloacetate reduction.
131
fumarate, succinate, alanine, citrate, NAD+, 5'AMP, ATP, ADP, GTP and
GOP (all at 1mM) showed no effect, whereas 1mM CuS04 and ZnS04
inhibited the enzyme activity by 90% and 91% respectively.
Leishmania m. mexicana amastigotes contain high particulate
malate dehydrogenase activity compared with PEP carboxykinase and
hexokinase, consequently large amounts of malate dehydrogenase were
recovered with this procedure which allowed the enzyme to be charac-
terized in some detail. Only small quantities of PEP carboxykinase
and hexokinase could be isolated, however, and so characterisation of
these enzymes was not possible in the time available in this study.
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4.0 DISCUSSION
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4.1 STUDIES ON THE GLYCOLYTIC SEQUENCE. THE TRICARBOXYLIC ACID CYCLE
AND ASSOCIATED ENZYMES IN LEISHMANIA
The vast majority of work on Leishmania carbohydrate metabolism,
and indeed the general biochemistry of Leishmania, has been performed
on the promastigote stage of the parasite as it can easily be
cultured in large numbers axenically in vitro (see Gutteridge and
Coombs 1977, Marr 1980). The recent development of techniques to
isolate, free from host cell contamination, amastigotes which had
been grown in mice has made possible comparative studies of the
biochemistry of the amastigote, the cultured promastigote and the
host cell, the macrophage (Hart et al. 1981a,b,c, Hart and Coombs
1982, Coombs et al. 1982, Meade et al. 1984).
Previous studies on some enzymes involved in the intermediary
metabolism of L. m. mexicana showed that glycolytic enzymes were
generally lower in activity in amastigotes than promastigotes whereas
the reverse was true for some enzymes involved in the p-oxidation of
fatty acids. (Coombs et al. 1982). The first part of my study,
therefore, was to investigate further the metabolism of the mammalian
form of the parasite by comparing the amastigote activities of
enzymes involved in central metabolism with those of the
promastigote.
The detection of the high PEP carboxykinase activi ty together
wi th the confirmation of the low pyruvate kinase activi ty in
amastigotes of L. m. mexicana, which is the reverse of the situation
found in culture promastigotes (Table 7, pg. 82), suggests that CO2
fixation in the conversion of PEP to oxaloacetic acid is a key
reaction in the metabolism of the mammalian form of L. m. mexicana.
This correlates well with the observation that high CO2 levels
stimulate the transformation of L. m. mexicana amastigotes to
promastigotes but have no effect on the growth in vitro of
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promastigotes (Hart and Coombs 1981).
The suggested importance of PEP carboxykinase in CO2 fixation in
the amastigote is reinforced by the apparent absence from this stage
of two other CO2-fixing enzymes, pyruvate carboxylase and malic
enzyme (carboxylating) (Table 7). Pyruvate carboxylase has been
reported to be present at low levels in culture promastigotes of
four species of Leishmania (Chatterjee & Datta 1974, Martin
et al. 1976) as well as amastigotes of L. donovani (Meade et al.
1984). It is likely that these apparently contradictory resul ts
are due to differences in methodology or possibly the parasite
strains. Chatterjee and Datta (1974) detected PEP carboxykinase
activi ty in L. donovani using a radioactive assay method, but they
were unable to demonstrate spectrophotometrically oxaloacetate
,
production from PEP. Berens and Marr (1977a) were also unable to
detect PEP carboxykinase spectrophotometrically in L. donovani or
L. braziliensis cell-free extracts using the method of Bacchi et al.
(1970). Both groups, however, were using an assay system with a
buffer at pH 7.4 which favours the reverse decarboxylation reaction
(Klein et al. 1975). In this study L. m. mexicana, L. m. amazonensis
and L. donovani had large PEP carboxykinase activities when assayed
wi th imidazole buffer at pH 6.6. (Table 8, pg. 84). Limitations in
the continuous spectrophotometric assay for PEP carboxykinase have
been reported in crude extracts of muscle (Duff and Snell 1982) where
NADH oxidation, attributed to the PEP carboxykinase assay, was found
to be caused by a linked pyruvate kinase and lactate dehydrogenase.
Lactate dehydrogenase, however, has not been detected in Leishmania
(Martin et al. 1976), therefore this problem should not arise in PEP
carboxykinase assays in Leishmania. Berens and Marr (1977a)
attributed the small PEP carboxykinase activity detected in
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promastigotes of L. donovani by Chatterjee and Datta (1974) to a
linked pyruvate kinase and pyruvate carboxylase. Although pyruvate
kinase has high activity in L. m. mexicana promastigotes, and may
compete for substrates, it is considerably lower than the PEP
carboxykinase activity detected in amastigotes. In addition, no
pyruvate carboxylase activity was detected in either amastigotes or
promastigotes of this strain of L. m. mexicana (Table 7), suggesting
that the PEP carboxykinase activity detected lS a true representation
of the enzyme in this organism.
The results for L. donovani (Table B) suggest that this
metabolic switch involving PEP metabolism may be a general feature
of the leishmanias, even though the data for L. m. amazonensis does
not show marked differences between amastigotes and promastigotes.
There was~ however, only one set of experimental data for amastigotes
of L. m. amazonensis due to the lack of material, therefore the
amastigote result cannot be interpreted with confidence. The
activity of PEP carboxykinase detected in L. donovani in this study
was considerably higher than the activity of pyruvate carboxylase
detected by Meade et al. (1984), who did not assay PEP carboxykinase,
suggesting that it may be the most important CO2-fixing enzyme in
L. donovani as well as L. m. mexicana.
The high PEP carboxykinase acti vities detected in the cu1ture
procyclic forms of T. b. brucei and T. b. rhodesiense (Table 9, pg.
85) are in good agreement with previous reports on the importance of
this CO2-fixing enzyme in other trypanosomatids (Klein et al. 1975,
Cataldi de Flombaum et al. 1977, Cazzulo et al. 1980, Opperdoes and
Cottem 1982). It is interesting to note that CO2 fixation appears to
be more important in the mammalian amastigote than the cultured
promastigote form of Leishmania, in contrast to the trypanosomes in
which PEP carboxykinase is found at high activity only in the insect
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procyclic stage of T. b. brucei and the epimastigote form of
T. cruzi (Table 9, Cataldi de Flombaum et al. 1977, Opperdoes and
Cottem 1982, Cannata et ale 1982). This difference is difficult to
explain in terms of our present knowledge of environmental factors,
as the Leishmania-infected gut of a sandfly could be expected to be
similar to a trypanosome-infected gut of a tsetse fly or kissing bug.
The trypanozoon trypanosomes such as T. brucei, however, undergo a
much more dramatic metabolic swi tch between mammalian and insect
stages in comparison to the changes that occur in Leishmania (see
section 1.4.2.4). It seems likely, therefore, that the various
changes in PEP metabolism that occur are related to the abili ty of
each of the trypanosomatids to transform and adapt to their new
environment. In addition, there is an assumption that the metabolism
of culture forms is a true representation of the parasites which live
in the gut of the insect and are not an adaptation to the medium in
which they are grown. This is yet to be confirmed.
The possible routes of PEP metabolism in Leishmania are outlined
in fig 26. The presence of very high malate dehydrogenase activities
in amastigotes of L. m. mexicana (Table 7) suggests that this enzyme
may act in conjunction with PEP carboxykinase, fumarase and fumarate
reductase to bring about the conversion of phosphoenolpyruvate to
succinate. a major end product of amastigote metabolism (Hart &
Coombs 1982). In contrast. conversion of phosphoenolpyruvate to
pyruvate by pyruvate kinase appears to be the more important
catabolic route in culture promastigotes of L. m. mexicana. The
reasons for the change in metabolism between the two forms of
Leishmania are not known. but it is possible that the amastigote
metabolism is an adaptation to an environment containing high CO2
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Fig. 26 Phosphoenolpyruvate catabolism in Leishmania m. mexicana.
1Phosphoenolpyruvate Pyruvate
Acetyl eoAOxaloacetic
sit
Malate
6ll
Fumarate
7b t!7a
Succinate ~-ketoglutarate
~ Succinyl eoA ~
Isocitrate
l11
Key to enzymes: 1) pyruvate kinase, 2) pyruvate dehydrogenase, 3)
citrate synthase, 4) PEP carboxykinase, 5) malate dehydrogenase,
6) fumarase, 7a) fumarate reductase, 7b) succinate dehydrogenase 8)
pyruvate carboxylase, 9) malic enzyme, 10) aconitase, 11) isocitrate
dehydrogenase, 12) 0( -ketoglutarate dehydrogenase, 13) succinyl eoA
synthetase.
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concentrations but low 02 levels. In a number of parasitic helminths
including Ascaris lumbricoides and Fasciola hepatica the NADH-linked
reduction of fumarate to succinate is coupled to the electron
transport chain resulting in the formation of ATP (see Barrett 1951).
It is possible that a similar mechanism occurs in Leishmania and
other trypanosomatids, although there is at present no evidence to
support this theory (Klein et al. 1975). Fumarate reductase was only
detected with low activity in amastigotes of L. m. mexicana (Table 7)
and no activity was found with promastigotes. CO2 fixation may playa
part in maintaining the CO2 concentration at an acceptably low
level, as has been postulated for some intestinal helminths (See
Barrett 1981). In addition, the switch in the metabolism of PEP may
be related to the observed differences in substrate uti lization by
the two forms of L. m. mexicana (Hart and Coombs 1982). Transforming
amastigotes utilize fatty acids at 10 times the rate of promastigotes
growing in vitro (Hart and Coombs 1982). CO2 fixation may then
provide C4 intermediates, such as oxaloacetic acid, in order to
replenish the C4 compounds removed in the production of the end-
product succinate from the extra acetyl CoA produced from fatty acid
metabolism.
The discovery of the rapid loss of malate dehydrogenaie activity
in extracts of L. m. mexicana amastigotes and the protective effect
of leupeptin on the enzyme (Table 10, pg. 86) confirms that this
stage of the parasite contains high proteolytic activity and
emphasizes the importance of taking precautions to limit proteolysis
when stUdying amastigote proteins (Pupkis & Coombs 1984). Although
other enzymes have been shown to be susceptable to proteolytic
degradation in homogenates of L. m. mexicana amastigotes (Hassan and
Coombs 1984), malate dehydrogenase appears to be the only enzyme in
139
this study that was degraded. Malate dehydrogenase activity in
L. m. mexicana amastigote homogenates was also found to be unstable
even in the presence of 100~g/ml leupeptin, in that 55% of the
activity was lost during a 1 hour incubation at 40e (Table 19, pg.
114). This loss of activity was found to be greatly reduced by the
addition of 10% (v/v) ethylene glycol, however, a procedure which was
found to be essential for maintaining enzyme activity during the
purification procedure (See section 4.4).
The detection of several TeA cycle enzymes including isocitrate
dehydrogenase and malate dehydrogenase in both amastigotes and
promastigotes of L. m. mexicana, together with previous data on the
respiration of L. m. mexicana (Hart et al. 1981c), indicate that the
TeA cycle is probably functional in both amastigotes and
promastig~tes of this species. It has been suggested previously that
this is the case with culture promastigotes of several other species
(Martin et al. 1976, Mukkada 1977), and also purified L. donovani
amastigotes (Meade et ale 1984). Even though 0( -ketoglutarate
dehydrogenase could not be detected in this study, it seems likely
that this enzyme was present but only at levels below the limi t of
detection; Martin et ale (1976) found it at very low levels in
culture promastigotes of L. m. mexicana and 3 other species of
Leishmania.
Under conditions of low oxygen tension the TeA cycle would
be inoperative due to a build up of reduced coenzymes that could not
be reoxidized by the respiratory chain. In this case, a partial
reversal of the TeA cycle could occur with NADH being reoxidised by
malate dehydrogenase and fumarate reductase. The extremely low
activities in L. m. mexicana of a number of TeA cycle enzymes
suggests that the TeA cycle and respiratory chain may not cope even
with the flux of reduced coenzyme produced by glycolysis under high
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oxygen tensions. Thus, succinate may be produced by either the
forward or reverse cycle depending on the efficiency of the TCA cycle
and respiratory chain and the level of oxygen available to the
organism. Succinate excretion potentially results in the depletion of
TCA cycle intermediates and so the cycle being stopped, therefore
oxaloacetic acid must be replenished if the TCA cycle is to continue
function in the forward direction.
The production of pyruvate, either from pyruvate kinase, the
decarboxylation of malate by malic enzyme or transamination of
alanine, and the regeneration of oxaloacetic acid through one of the
CO2-fixing enzymes or aspartate-glutamate transaminase is clearly an
important area of intermediary metabolism in Leishmania and one which
1S presumably under rigorous control.
The regulation of glycolysis has been extensively studied in
mammalian cells where control is maintained by a complex system that
involves substrate availability, levels of enzyme activity, and
allosteric control of individual enzymes with activation and feedback
inhibition by metabolic intermediates (see Newsholme and Start 1973).
Initial studies on Leishmania promastigotes suggests that glycolysis
is not regulated in the same way as mammalian systems as several key
glycosomal glycolytic enzymes including hexokinase and phosphofructo-
kinase are apparently not tightly regulated (see section 1.4.2.3.1).
Subcellular compartmentation of both enzymes and metabolic inter-
mediates, together wi th the organisation of these enzymes in a
multienzyme complex within the glycosome, therefore are likely to be
essential elements in the control of glycolysis in trypanosomatids
(see section 4.4).
The fate of phosphoenolpyruvate is clearly a key branch point in
leishmanial intermediary metabolism and it would be expected that
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control of metabolic flux may be mediated by regulation of the first
two enzymes past the branchpoint. PEP carboxykinase is thought to be
the rate-limiting enzyme in glyconeogenesis in mammalian cells where
it catalyses the first step of the pathway, the decarboxylation of
oxaloacetic acid to PEP (Newsholme and Start 1973, Hers and Hue
1983). Its intracellular distribution varies between species; in rat
and mouse liver it is exclusively cytosolic, in rabbit liver totally
mitochondrial, and in man equally distributed between the cytosol and
mitochondria (Utter and Kolenbrander 1972, Hers and Hue 1983). There
is apparently no modulation of PEP carboxykinase activity in mammals
by feedback inhibition, although a protein factor, that has been
isolated from rat liver, is required for optimal activation of the
enzyme by low concentrations of ferrous ions (Bentle et ale 1976).
There is ~ore long-term control of the enzyme, however, at the level
of enzyme synthesis, where the level of PEP carboxykinase mRNA is
regulated by hormonal and environmental stimuli including insulin and
glucagon (Cimbala et al. 1981). In Leishmania no activators or
inhibi tors of PEP carboxykinase an crude homogenates of
L. m. mexicana amastigotes were found, but it seems likely that CO2
concentration is an important regulatory factor. The role of PEP
carboxykinase in Leishmania clearly differs from that in mammalian
cells; it is possible that the ways in which it is regulated are also
distinct.
It has been reported that various species of Leishmania possess
isocitrate lyase and malate synthase, two of the enzymes involved in
the glyoxylate cycle, and also the intermediate glyoxylate (Mukkada
1977, Simon et al. 1978). The glyoxylate cycle has been found in the
microbodies of higher plants (Beevers 1979), in bacteria and fungi
(Kornberg 1966, Spector 1972) and also in the protozoan Tetrahymena
(Hogg and Kornberg 1963), where it is important in providing
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oxaloacetic acid for gluconeogenesis from 2 carbon units such as
acetyl coenzyme A. Isocitrate lyase could not be detected in either
the procyclic or bloodstream forms of T. brucei (Opperdoes et al.
1977b, Opperdoes and Cottem 1982). The functional significance of a
glyoxylate cycle in Leishmania is not clearly understood, and
although the enzymes fructose-1,6-bisphosphatase and glucose-6-
phosphatase have been detected in both forms of L. m. mexicana at
approximately the same activity (Coombs et al. 1982), it is not clear
if gluconeogenesis occurs in vivo in Leishmania. The presence of a
glyoxylate cycle, however, could correlate with the reported use of
fatty acids as an energy substrate by the amastigote (Hart and Coombs
1982). My inability, however, to detect isocitrate lyase (Table 7),
a key glyoxylate cycle enzyme, in L. m. mexicana suggests that, at
least in this species of Leishmania, the cycle plays little part.
Other large differences between enzyme activities in amastigotes
and promastigotes of L. m. mexicana were found with glutamate
dehydrogenase and malic enzyme (decarboxylating). The latter enzyme
is present in promastigotes and possibly functions in anapleurotic
reactions, possibly as a source of NAOPH and pyruvate, whereas it
appears to have little role in amastigotes. The high promastigote,
NAD-specific glutamate dehydrogenase activity suggests that the
catabolism of amino acids may be of importance to this form of the
parasite. Previous investigations with L. m. mexicana gave no
evidence of the use of any amino-acids as a major energy substrate
(Hart and Coombs 1962), however the enzyme may be responsible, at
least in part, for the high rate of ammonia excretion from the
parasite (Coombs and Sanderson, 19B4). It has been postulated that
this excretion may playa part in protecting the parasite against the
antimicrobial activity of the host macrophages (see section 1.1.3.2).
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The presence of both NAD- and NADP-specific glutamate dehydrogenase
activities in the amastigote but the absence of a NADP-specific
activity in promastigotes suggests that two distinct enzymes are
present in the amastigote. This is similar to T. cruzi, which
contains two enzymes with different specificities and kinetic
properties (Juan et al. 1976), and in contrast to mammalian cells,
where the enzyme is coenzyme unspecific (Frieden 1963).
The detection of high activities of an enzyme is not proof of an
active metabolic pathway and confirmation that the pathways discussed
operate in vivo in Leishmania await further studies on the fate of
intermediate substrates in each developemental form.
4.2 STUDIES ON THE MODE OF ACTION OF ANTIMONIALS AND ARSENICALS.
The lack of activity of Pentostam against Leishmania growing in
vitro is well established (Mattock and Peters 1975, Berman and Wyler
1960, Coombs et al. 1963) and for this reason Triostam, the
trivalent analogue of Pentostam, and melarsen oxide, a trivalent
arsenical were included in this study. Both of these drugs were
found to be active against culture promastigotes (Fig. 6, pg. 91).
The reason for the differences in susceptabili ty of L. m. mexicana
promastigotes to the pentavalent and trivalent antimonial drugs is
not known although there may be some differences in uptake or
metabolism (possibly to an active trivalent form) of Pentostam. The
intracellular amastigote, however, is sensitive to Pentostam in
vitro when incubated in monocyte-derived macrophages with the drug
(Berman and Wyler 1960) as are amastigotes transforming in vitro
(Coombs et al. 1963). In an attempt to explain both the anti leish-
manial activity of antimonials and arsenicals and the specificity of
Pentostam to the amastigote, the relative sensitivities of L. m.
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mexicana amastigote and promastigote enzymes and mammalian
isofunctional enzymes to inhibition by these drugs were
investigated. The antileishmanial activi ty of antimonials could
not, however, be correlated with any enzyme inhibitory activity
(Tables 12 and 13, pgs. 92,93). Neither Pentostam nor Triostam
inhibited any of the five leishmanial enzymes tested (hexokinase,
phosphofructokinase, pyruvate kinase, malate dehydrogenase and PEP
carboxykinase) suggesting that these antileishmanial drugs may have a
target other than glycolysis, a conclusion suggested previously
because of the failure of Pentostam to interfere with the catabolism
of glucose to CO2 (Hart and Coombs 1982). This appears to contrast
with the situation found with Schistosoma mansoni where Triostam, but
not Pentostam, markedly inhibited schistosomal phosphofructokinase
(Table 12). This confirms the results of Mansour and Bueding (1954)
using the trivalent antimonial Stibophen (sodium antimony bis
(pyrocatechol-2,4-disulphonate)) who suggested that phosphofructo-
kinase was the primary site of action of antischistosomal
antimonials. Thus antimonials may act in different ways against
Leishmania and schistosomesj alternatively the drugs may have a
similar, as yet undiscovered, target in both groups of parasites, a
target unrelated to the glycolytic kinases. The relatively long
time taken for Triostam to exert its leishmanicidal effects against
promastigotes (immotile parasites were not observed until 8 hrs after
the addi tion of the drug) suggests that anabolic reactions such as
DNA replication cannot be excluded from being a primary target. The
antagonistic effect of cysteine on the action of Triostam (Table 14,
pg. 95) may have been due simply to a direct interaction with the
drug, but possibly the effect was mediated through cysteine
protecting thiol groups in the parasites that are primary targets for
145
the drug. Thus, it is feasible but still to be confirmed that
thiol groups are involved as primary targets of antiparasitic
antirronials.
The finding that Triostam had no effect on either mouse liver or
rabbit muscle phosphofructokinase confirms that there are differences
in susceptability of the mammalian and schistosomal enzymes to the
drugs that may be the basis of the selective toxicity towards
schistosomes. In addition the pentavalent antimonial 1714 was found
to inhibit mouse liver, but not leishmanial, phosphofructokinase and
leishmanial, but not mouse liver, hexokinase (Tables 12 and 13).
This suggests that the structure of the organic moiety of the
antimonial drugs is important in determining their effects against
these glycolytic enzymes.
S'ti bop han also has been found to inhibit T. rhodesiense
phosphofructokinase (Jaffe et al. 1971), although the drug had an
150 of 0.5mM, five times that against the schistosomal enzyme.
In contrast to the trivalent arsenical oxophenarsine, however, this
action was not nullified by the addition of mercaptoethanol,
suggesting that its action on this enzyme was not dependant on
binding thiol groups.
Arsenical drugs, such as melarsen, Mel B and tryparsamide, have
been used in the treatment of sleeping sickness in man, even though
they have a low chemotherapeutic index (the ratio of toxic to
curative dose), as they are one of the few groups of drugs available
which can cross the cerebrospinal membrane and so control the later
stages of the disease. The pentavalent arsenicals are believed to be
reduced to the trivalent forms in vivo before the drug is active
(Crawford 1947). therefore both melarsen and melarsen oxide were
included in this stUdy. The antitrypanosomal action of these drugs
has been studied to some extent. When whole cells of T. brucei were
146
exposed to concentrations of melarsen oxide that have little effect
on glucose utilization or respiration, phosphoenolpyruvate was shown
to accumulate wi thin the cells (Flynn and Bowman 1974). It was
suggested therefore that the mode of action of melarsen oxide against
bloodstream T. brucei was through inhibition of pyruvate kinase. A
number of other enzymes, including glycerol kinase, glycerophosphate
oxidase, pyruvate and o<..-ketoglutarate decarboxylases , however,
were shown to be more sensitive than pyruvate kinase to inhibition by
the drug (Flynn and Bowman 1974, Bowman and Flynn 1976, Fairlamb
1982). It is presumed that the membranes of the glycosome and mito-
chondrion present a permeability barrier to the drug that leaves
pyruvate kinase, a cytosolic enzyme, the most susceptable target.
In this study, melarsen was found to have no effect on L. m.
mexicana promastigotes growing in culture. Melarsen oxide, however,
was found to be more toxic to L. m. mexicana culture promastigotes
than Triostam (MLCs: 100,ug/ml and 400,ug/ml, respectively), although
at these concentrations the antimonial had a more rapid effect than
the arsenical. Melarsen oxide was found to be an inhibitor of all
the enzymes tested except mouse liver hexokinase and L. m. mexicana
amastigote PEP carboxykinase. Phosphofructokinase, malate dehyd-
rogenase and pyruvate kinase from Leishmania were about equally
sensi ti ve (I50s, 4-8}-lM),although mouse liver pyruvate kinase (150
165)JM) and rabbit muscle phosphofructokinase (150 160}-lM)were less
sensitive to the drug. Mel B was also inhibitory, but higher concen-
trations were required than for melarsen oxide. The different
sensi tivi ties of the host and leishmanial enzymes, especially
pyruvate kinase, to melarsen oxide suggests that, if pyruvate kinase
was the primary target, the drug could have some specificity for the
parasite in leishmaniasis. The results also agree with those found
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previously with T. brucei (Flynn and Bowman 1974) and although
phosphofructokinase, malate dehydrogenase and pyruvate kinase from
L. m. mexicana appeared to be equally susceptable to inhibi tion by
melarsen oxide, pyruvate kinase is probably the only leishmanial
enzyme tested that is not contained within an organelle and so is
likely to be more susceptable to inhibition by the drug. The high
sensitivity of some mammalian enzymes to melarsen oxide and the fact
that glycolytic enzymes are cytosolic in mammalian cells, probably
accounts for the high toxicity of this drug to man.
One of the characteristics of arsenic is its ability to form
metallo-thiol bonds with sulphydryl groups, thus accounting for the
inhibition of various sulphydryl enzymes by arsenical drugs (Peters
et ale 1946, Flynn and Bowman 1974). For this reason, glutathione
metabolism in the rodent filaria Litosomoides carinii has been
investigated as the possible target for arsenical drugs that affect
this organism (Bhargava et al. 1983). Arsenicals were found to
readily inhibit glutathione reductase from L. carinii but had no
effect on the mammalian host enzyme, and administration of Mel B to
filaria infected gerbils caused decreases in filarial, but not host,
glutathione reductase and reduced glutathione levels. Glutathione
reductase could not, however, be detected in amastigote or
promastigote homogenates of Leishmania m. mexicana with either NADPH
or NADH as the reduced cofactor (Table 7, pg. 82). Recently, a
preliminary report showed that glutathione reductase in the trypano-
somatids T. brucei and C. fasciculata required a soluble cofactor for
activity that was heat stable with an apparent molecular weight of
400 (Fairlamb and Cerami 1983). This cofactor could not be replaced
by FAD, FMN, riboflavin or various pterins. It is possible that this
cofactor is a general feature of trypanosomatids and may therefore be
present in Leishmania species as well. A possible explanation of why
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this enzyme was not detected in this study is that the cofactor was
either denatured under the lysis conditions used or that it was too
dilute in the assay mixture to have its effect. A more detailed
investigation is therefore required to elucidate if glutathione
metabolism is a target for arsenical and possibly antimonial drugs in
Leishmania.
4.3 INVESTIGATIONS INTO THE SUBCELLULAR ORGANISATION OF LEISHMANIA
The glycosomes of T. brucei and T. cruzi have been studied in
some detail (see section 1.4.3.1)and the enzyme contents of the
organelles investigated wi th respect to the changes in metabolism
that occur during the life-cycle of these trypanosomatids (see
Opperdoes 1982, 1984b, Cannata et al. 1982, Hart et ale 1984).
Previously there has been little work on the glycosomes of
Leishmania, although the presence of the organelles has been
suggested from simple fractionation studies (Coombs et al. 1982), the
recovery of hexokinase and two pyrimidine biosynthetic enzymes on
sucrose gradients (Hammond et al. 1981) and electron microscope
studies. In order to confirm the presence of glycosomes in
Leishmania and to establish how they differ in the two main forms of
the parasite and the parts they play in their metabolism, the
subcellular organisation of the culture promastigote of L. m.
mexicana was investigated and compared to that of the amastigote.
The results obtained from differential centrifugation (Table 15, pg.
97) and isopycnic centrifugation on linear sucrose gradients (Figs.
7 and 8, pgs. 100,101) confirm the existence of glycosomesin
Leishmania promastigotes.
Fractionation studies with amastigotes using the same techniques
of cell breakage as used for promastigotes, that is mixing the
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parasites to a thick paste with de-fined alumina, were unsuccessful,
apparently due to lysis of the organelles. The presence of
"Megasomes", organelles found only in the amastigote, together with
the presence of high amastigote proteinase activity (Coombs 1982),
suggested that lysosomal type enzymes may be degrading the organelles
and releasing their contents before fractionation could take place.
The inclusion of various proteinase inhibi tors (leupeptin and
antipain) and phospholipase inhibitors (mepacrine and chelating
agents) in the breakage buffers during amastigote lysis and the use
of different breakage techniques were all without success. Putative
amastigote glycosomal enzymes such as hexokinase and glucose
phosphate isomerase exhibi ted no latency after alumina lysis, and
hexokinase, a particulate enzyme (Table 11, pg. 88) which was
,
recovered mainly in pellet 2 (P2) during promastigote differential
centrifugation fractionation (Table 15), was spread throughout the 3
pellets after centrifugation (Table 16, pg. 99). If these
"Megasomes" are indeed involved in the failure of the amastigote
fractionation technique, then the use of Leishmania species that do
not have such developed "Megasomes", for example L. donovani (Coombs
and Pupkis 1984), may be more successful.
In this study as an alternati ve approach, L. m. mexicana
amastigotes were treated with digitonin to lyse the parasite
membranes and release soluble enzymes at different rates. Digitonin
has been used to separate particulate and soluble components of rat
liver cells (Zuurendonk and Tager 1974) and also to investigate
metabolite compartmentation in isolated hepatocytes (Brocks et al.
1980); both based on the fact that the cholesterol content of plasma
membranes is in general higher than that of intracellular membranes
(Colbeau et al. 1971) and that digitonin specifically binds ~-
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hydroxysterols. Digitonin has also been used to investigate the
activation of glycolytic enzymes in the bloodstream forms of T.
brucei (Visser and Dpperdoes 1960). The trypanosome plasma membrane
was completely disrupted at 0.05mg digitonin/mg protein, as judged by
the release of the cytosolic enzyme alanine aminotransferase, whereas
the glycosomal membrane required considerably higher digitonin
concentrations to fully activate the glycosomal enzyme glycerol-3-
phosphate dehydrogenase (1-3mg digitonin/mg protein) (Visser and
Opperdoes 1960). Digitonin was reported to be less useful as a
method of cell disruption for T. brucei in fractionation studies
(Oduro et a1. 1960b). This was confirmed for L. m. mexicana
promastigotes in this study, where the high concentrations of
digitonin (400pg/mg protein) required for cell lysis of the majority
of the cells was found to abolish all hexokinase latency, presumably
an indication of damaged organelles. Digitonin was found, however,
to be effective in enzyme release studies, as treatment of L. m.
mexicana amastigotes with the detergent distinguished 3 subcellular
compartments (Fig. 9 and 10, pgs. 103,104) and gives the first bio-
chemical evidence to support the ultrastructural evidence for the
presence of glycosomes in amastigotes (Tetley et a1. 1963). The
results presented support the suggestion that glycosomes may be
present in all trypanosomatids (Taylor et al. 1960, Opperdoes 1962,
Opperdoes 1964b).
The finding that the glycolytic enzymes hexokinase, glucose
phosphate isomerase, phosphofructokinase, and glyceraldehyde-3-
phosphate dehydrogenase of L. m. mexicana promastigotes banded at a
density of between 1.215-1.220g/ml on sucrose density gradients (Fig.
7, pg. 100) indicates that promastigote glycosomes are of a lower
density than the equivalent organelles in bloodstream and pr-ocyclic,
forms of T. br-ucei , which were reported to have dens ities of 1.250
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and 1.228g/ml respectively (Opperdoes and Borst 1977, Opperdoes ~
al. 1981), and C. fasciculata (dens ity 1.26g/ ml, Cannata et al.
1982). The glycosomes of T. cruzi culture epimastigotes, however,
were found to have a lower density (1.20g/ml, Cannata et al. 1982).
There was found to be a fairly disperse distribution of
glycosomal enzymes on sucrose gradients in this study (Fig. 7) in
comparison to the distribution reported for bloodstream and procyclic
T. brucei (Opperdoes and Borst 1977, Opperdoes et al. 1981) and also
T. cruzi (Cannata et al. 1982). Analysis of purified glycosomes of
bloodstream T. brucei showed that the organelles were extremely homo-
geneous in size. The overall recovery for glycosome purification was
28% and it is possible that the purification technique could have
selected a specific type of microbody, even though isolated
glycosomes were similar in size to those analysed in situ (Opperdoes
et al. 1984). When enzymes distributions were compared on sucrose
gradients, however, T. brucei glycosomes certainly appear to be more
homogeneous than those from L. m. mexicana promastigotes.
The mitochondrial marker oligomycin-sensitive ATPase, which is a
particulate enzyme, banded at a density of 1.190g/ml (Fig. 8) and
gave a sharp peak in comparison to the soluble putative mitochondrial
enzymes, glutamate dehydrogenase, alanine aminotransferase and malic
enzyme, all of which showed only small peaks at 1.190g/ml and a more
disperse distribution. Presumably much of the soluble enzyme
activities were lost from the matrix of the mitochondrion upon its
breakage into vesicles.
The relatively low density of the glycosomes of L. m. mexicana
promastigotes meant that they banded close to the peak of the
mitochondrial vesicles on the sucrose gradient. Separation of these
two organelles was achieved, however, by using a shallow sucrose
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gradient 'r: 1.15-1.24) and this showed that the main location of
the enzymes PEP carboxykinase, hexokinase, phosphofructokinase and
glyceraldehyde-3-phosphate dehydrogenase was in the glycosome,
whereas malate dehydrogenase, glutamate dehydrogenase, malic enzyme
and alanine aminotransferase had mitochondrial activity.
The finding of glyceraldehyde-3-phosphate dehydrogenase in the
promastigote glycosome fractions suggests that the initial enzymes of
glycolysis, up to and including glyceraldehyde-3-phosphate dehydro-
genase, are located in the organelle. With phosphoglycerate kinase
mostly, and pyruvate kinase totally, cytosolic it is likely that the
last few steps of glycolysis occur wi thin the cytosol. The
recovery of approximately 50% of the glucose phosphate isomerase
activity in the soluble fractions with both differential centrifug-
ation and sucrose density gradients was probably due to enzyme
leakage from damaged glycosomes, although the possibility that some
of the early glycolytic enzymes are present in the cytosol of the
parasite cannot be excluded.
Glucose-6-phosphate dehydrogenase was found to be a mainly
cytosolic enzyme, but there was a small but significant activity
associated with the glycosome (Fig. 7). Pyruvate kinase was not
detected on the gradient, however, which indicates that the apparent
glycosomal activity of glucose-6-phosphate dehydrogenase is unlikely
to be caused by non-specific trapping in the organelle fractions.
Glycosomal glucose-6-phosphate dehydrogenase could be important in
obtaining glucose-6-phosphate produced by hexokinase within the
glycosome for the pentose phosphate pathway, whereas the cytosolic
enzyme may be involved in using the substrate produced from other
sources, or possibly glycosomal glucose-6-phosphate that leaves the
organelle. The release profile of glucose-6-phosphate dehydrogenase
from amastigotes and promastigotes treated with increasing digitonin
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concentrations (Fig. 9 and 11, pgs. 103,105) differ from those for
glycosomal glucose phosphate isomerase, suggesting that the cytosol
is the main location for glucose-6-phosphate dehydrogenase in both
stages of the parasite. A small amount of glycosomal activity could
not be detected with confidence using this method, although the
slightly higher digitonin concentration required for the total
release from promastigotes of glucose-6-phosphate dehydrogenase in
comparison to pyruvate kinase (Fig. 11) was presumably a reflection
of the presence of some enzyme in glycosomes. Amastigote pyruvate
kinase activity is so low that such comparisons were not possible in
the amastigote digitonin experiments.
Leishmania m. mexicana culture promastigotes have only low PEP
carboxykinase and malate dehydrogenase activities in comparison to
amastigotes, (Table 7). Promastigote PEP carboxykinase showed a
glycosomal distribution on sucrose density gradients (Fig. 7),
whereas malate dehydrogenase peaked at the density of the
mitochondrial marker enzyme, oligomycin-sensitive ATPase (Fig. B).
A small amount of glycosomal malate dehydrogenase activity, however,
cannot be discounted. This apparent difference in the main location
of these two enzymes in promastigotes of L. m. mexicana is
interesting as it contrasts wi th the si tuation found in T. brucei
culture procyclic trypomastigotes, where both enzymes are mainly
glycosomal (Opperdoes et al. 1981, Opperdoes and Cottern 1982), and
T. cruzi culture epimastigotes (Cannata and Cazzulo 1984), where
there is a dual mitochondrial and glycosomal distribution of malate
dehydrogenase. Neither PEP carboxykinase nor malate dehydrogenase are
detectable in the glycosomes of the bloodstream forms of T. brucei
but are produced on transformation to the procyclic form and this is
thought to be one of the adaptations of the parasi te to life in the
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midgut of the insect vector (Opperdoes et al. 19B1, Opperdoes and
Cottem 19B2). There appear to be similar major differences in malate
dehydrogenase with L. m. mexicana. The isoenzyme pattern for malate
dehydrogenase shows marked differences between amastigotes and
promastigotes of a L. m. mexicana clone. The 3 major bands in
amastigote homogenates were also found in the pellet and to a much
lesser extent in amastigote supernatant (bands c,d,e, in fig. 12, pg.
10B). The latter supernatant activities were presumably particulate
enzymes that were not removed in the 5min, 10,OOOg centri fugation
step. There was only one major band (c) in the promastigote pellet
fraction with also a minor band, presumably a soluble enzyme
contaminant. The results suggest that the large increase in activity
observed upon transformation of L. m. mexicana promastigotes to
amastigotes is mainly due to the production of two particulate iso-
enzymes not found in promastigotes, enzymes possibly associated with
the glycosome.
One of the explanations suggested for the changes that occur to
glycosomes of T. brucei upon transformation between bloodstream and
procyclic trypomastigotes was the maintenance of energy and redox
balance (Opperdoes et al. 19B1, Opperdoes and Cottem 19B2). It was
found with purified glycosomes from T. brucei procycl ics that
externally provided ATP was as efficient as PEP for promoting
glycolysis (The ATP produced by PEP carboxykinase used in the initial
steps of glycolysis), infering that the glycosome must be permeable
to ATP (Broman et al. 19B3). NAO+ was found to stimulate glycerol-3-
phosphate and 3-phosphoglycerate formation by isolated glycosomes so
this cofactor may also be permeable to the glycosomal membrane
(Broman et al. 19B3), as has been suggested previously for NAOH in
bloodstream T. brucei glycosomes (Oduro et al. 19BOa). The degree of
damage to the glycosomes during the purification procedure is
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difficult to assess and the permeability of these cofactors may be an
arti fact produced wi th damaged organelles. Nevertheless, the fact
that glycosomal enzymes show high degrees of latency indicates that
there is some substrate compartmentation involved within these
organelles. It has been suggested, however, that the permeabi lity
barrier in T. brucei glycosomes is not absolute and a slow equili-
bration of glycosomal and cytosolic intermediates occur (Visser and
Opperdoes 1980, Visser et ale 1981, Broman et al. 1983) (See section
1.4.3.1 of the introduction). If the same was true for Leishmania
glycolytic intermediates and nucleotides, there may be no requirement
to balance energy and redox levels within the glycosome as a distinct
enti ty from the cytosolic pool. Anyway, the association with
leishmanial glycosomes of several enzymes not involved in glycolysis,
including enzymes involved in fatty-acid oxidation and plasmalogen
biosynthesis (Hart and Opperdoes 1983), pyrimidine biosynthesis
(Hammond et al. 1981) and purine salvage (Hassan and Coombs 1984),
makes it impossible, as yet, to fully elucidate how energy and redox
balance would be maintained even if these organelles did represent a
self-contained energetic unit within the cell.
The results obtained from this study, together with enzyme
distribution data from other workers (Coombs et al. 1982, Hammond and
Gutteridge 1982, Hart and Opperdoes 1983, Hassan and Coombs 1984),
has enabled the construction of theoretical schemes that represent
the apparent relationship between the glycosome, mitochondrion and
cytosol in Leishmania promastigotes and amastigotes (Figs. 27 and
28) •
It is likely that in promastigotes glucose is catabolised within
the glycosome as far as 3-phosphoglyceric acid (3-PGA) which crosses
the glycosomal membrane into the cytosol (Fig 27). Cytosolic 3-PGA is
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Fig. 27
Schematic representation of the compartmentation of metabolism
in Leishmania promastigotes.
Major pathways are indicated with thick arrows ( ........)J
Minor pathways are indicated with thin arrows --)J
Movement of intermediates across membranes (major routes)
( ••• ) J
Movement of intermediates across membranes (minor routes)
The pathways enclosed within a double line in the glycosome
represent enzymes that are possibly associated with the outside of
the glycosomal membrane.
To avoid confusion not all cytosolic or mitochondrial enzymes
have been included in the scheme.
Key to the abbreviations: G-6-P, glucose-6-phosphateJ F-6-P
fructose-6-phosphateJ 6-PG, 6-phosphogluconateJ FOP, fructose-1,6-
diphcaphe tar OHAP, dihydroxyacetone phosphet e, 1,3-0PGA, 1,3-
diphosphoglyceric ac id, 3-PGA, 3-phosphoglyceric ac i.dr G-3-P,
gLycer-ol+Sr-phcaphat ar PEP, phcaphceno lpyr-uvet a, OAA, oxaloacetic
acidJ NEFA, nonesterified fatty acids) Hypoxanth, hypoxanthineJ
PRPP, phosphoribosylpyrophosphateJ 2-PGA, 2-phosphoglyceric acidJ
Ala, alanineJ Resp chainJ respiratory chain.
Fig. 28
Schematic representation of the compartmentation of metabolism
in Leishmania amastigotes.
Key as described in fig. 27.
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then metabolised to PEP and further converted to pyruvate by pyruvate
kinase. A small amount of PEP may cross back into the glycosome
where it is converted to oxaloacetic acid by PEP carboxykinase. The
low activity of PEP carboxykinase suggests that it has only a minor
role in promastigote catabolism, being involved only in the
metabolism of any PEP produced in, or which permeates into, the
glycosome. It is possible that the small glycosomal activity of
phosphoglycerate kinase may serve to regenerate some ATP within the
glycosome for maintaining energy balance, and indeed PEP carboxy-
kinase may also serve the same function. Pyruvate produced in the
cytosol may either cross into the mi tochondrion and enter the tri-
carboxylic acid cycle or be converted to alanine by transamination.
The acetyl CoA produced by ~-oxidation of fatty acids within the
glycosome, could also cross into the mitochondrion and enter the TCA
cycle (Fig. 27).
The high PEP carboxykinase and malate dehydrogenase activities
produced upon transformation of L. m. mexicana promastigotes to
amastigotes are balanced by a concomitant reduction in the level of
pyruvate kinase activity (Table 7, pg. 82). In addition, it appears
from the digitonin release experiments (Fig. 9 and 10, pgs. 103,104)
that there is considerable phosphoglycerate kinase activity within
the amastigote glycosome. This contrasts with promastigotes with
which it was found, albeit using a different technique, that less
than 5% of promastigote phosphoglycerate kinase activity was
recovered in the glycosomal fractions on sucrose gradients (Fig. 7,
pg.100). A possible interpretation of these results is that glucose
catabolism proceeds entirely within the amastigote glycosome as far
as PEP, whi ch is then carboxylated to oxaloacetic acid by PEP
carboxykinase and reduced to malate by malate dehydrogenase wi thin
the glycosome (Fig. 28). As amastigotes of L. m. mexicana utilize
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fatty acids at 10 times the rate of promastigotes (Hart and Coombs
19B2), the j3-oxidation of fatty acids has been suggested as a major
pathway of amastigote catabolism. The intracellular location of the
enzymes involved in ,a-oxidation, pyrimidine biosynthesis and purine
salvage in amastigotes, however, has not been investigated, although
the presence of these pathways in promastigote glycosomes implies
that they may also be present in the glycosomes of amastigotes. It
is possible therefore that the greatly elevated amastigote malate
dehydrogenase and PEP carboxykinase activities (Table 7) may serve to
reoxidize the additional glycosomal NADH produced by ~-oxidation of
fatty acids (Fig. 28). Some of the glycolytically produced NADH
could also be reoxidized by glycerol-3-phosphate dehydrogenase; the
glycerol-3-phosphate produced being oxidized by the respiratory chain
in the mitochondrion. The ATP required for the first step of B-
oxidation could be provided by glycosomal PEP carboxykinase.
Unfortunately as many of these enzyme acti vi ti es are largely
particulate in the amastigote (Table 11, pg. BB), the location of
the enzymes cannot be determined by the digitonin enzyme release
experiments. Nevertheless, it is clear that the changes in the enzyme
contributions of the glycosome that occur upon transformation from
insect to mammalian stage are quite different for L. m. mexicana and
T. brucei.
Glycolytic enzymes are found in the cytosol of eukaryotic and
prokaryotic cells and it is generally assumed that the macromolecular
components are freely dissol ved wi thin this cellular environment.
The possible existence of a glycolytic complex with its inherent
metabolic advantages, however, has been suggested in a number of
systems (Green et al. 1965, Reed and Cox 1966, Mowbray and Mosses
1976). Studies on glycolytic components in skeletal muscle extracts
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has shown the existence of a complex that is dependent on high
protein concentrations, pH and ionic strengthJ conditions that have
possible physiological significances (Clarke and Masters 1974). A
mUltienzyme aggregate of all the enzymes of glycolysis was also
detected in Escheri~ia coli (Mowbray and Moses 1976), and in the
glycosomes of bloodstream form T. brucei (Dduro et a1. 19BOa). The
clear advantage of such an arrangement is that high local
concentrations of intermediates would be created in the
microenvironment of the enzyme complex thus allowing an extremely
high rate of glycolysis to take place. The particulate nature of a
number of glycolytic enzymes wi thin the glycosomes of Leishmania
(Table 11, pg. BB) and other trypanosomatids suggests that the
mUltienzyme complex may be a general feature of the trypanosomatids.
The ~resence of a mUltienzyme complex within the glycosome, the
lack of allosteric control of glycosomal glycolytic enzymes, and the
possible permeability barrier to metabolic intermediates produced
outside the organelle, suggests that the control of glycolysis is
very different in Leishmania than mammalian cells. It is likely that
a certain level of control is maintained through the regulation of
the uptake of substrates, e.g. glucose into the glycosomes, and also
the transport of glycosomal end products such as 3-phosphoglycerate
acrosS the membrane.
The results presented suggest that the energy metabolism of
L. m. mexicana amastigotes and promastigotes differ to some
degree, however the full extent of the changes that OCcur in the
enzyme content of leishmanial glycosomes during transformation and
their functional significance are yet to be determined. Apparently
the changes are less dramatic than those reported for T. brucei, but
this correlates well with the findings of this and previous studies
showing similarities in energy metabolism of the two forms of
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Leishmania (Coombs et al. 1982, Hart and Coombs 1982). The detection
of an enzyme activity in a parasite does not imply that it is
involved in the metabolism of that form, it may simply remain from,
or be a preadaptation to, another stage. This could be the
situation with L. m. mexicana and confirmation of the pathways
operating in vivo awaits further studies on the fate of substrates in
each form.
4.4 PURIFICATION OF PARTICULATE PEP CARBOXYKINASE AND MALATE
DEHYDROGENASEFROM LEISHMANIA M. MEXICANA AMASTIGOTES.
The particulate nature of malate dehydrogenase and PEP
carboxykinase, their substrate and cofactor specificities and the
location.in glycosomes of the latter, demonstrates that there are
significant differences between the leishmanial and host enzymes and
similarities between PEP carboxykinase from Leishmania and other
trypansomatids (Bacchi et al. 1970, Klein et al. 1975, Cataldi de
Flombaum et al. 1977). These characteristics of the enzymes,
together with their high activity in leishmanial amastigotes, makes
them potential chemotherapeutic targets. For this reason, and the
fact that PEP appears to be a key branch point in amastigote
metabolism, particulate PEP carboxykinase and malate dehydrogenase
were purified with the aim of characterising the enzymes in more
detail. The described procedure also allowed the purification of
particulate hexokinase, and it is probable that with a few
modifications other particulate leishmanialenzymes also could be
isolated.
In mammalian cells PEP carboxykinase is a soluble enzyme that is
found in either the cytosol or mitochondrion (or both), depending on
the species (Utter and Kolenbrander 1972). In trypanosomatids,
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however, a particulate PEP carboxykinase has been demonstrated in
glycosomes of C. fasciculata and T. cruzi epimastigotes (Cannata
et al. 19B2) as well as procyclic T. brucei (Opperdoes and Cottem
1982, Broman et al. 1983).
Most higher eukaryotic cells contain two malate dehydrogenase
isoenzymes (Banaszak and Bradshaw 1975), the cytoplasmic form (s-MOH)
and the mitochondrial form (m-MOH), which are involved in the malate
shuttle and the TCA cycle. Some plants and free-living protozoa are
known to have a third malate dehydrogenase isoenzyme, which is
located in glyoxysome microbodies (mb-malate dehydrogenase) and 1S
involved in the glyoxylate cycle (Rocha and Ting 1971, Walk and Hock
1976),whereas prokaryotes appear to have only one isoenzyme (Murphey
et al. 1967a). A fourth cellular location for malate dehydrogenase
has been found recently in the glycosomes of T. brucei and T. cruzi
(Opperdoes et al. 1981, Cannata and Cazzulo 19B4). Evidence from
the fractionation studies (section 3.4) suggest that L. m. mexicana
promastigotes possess s-MOH, m-MOH and possibly also a glycosomal
enzyme. The amastigote total malate dehydrogenase activity is much
higher than that of the promastigote (Table 7, pg. B2), largely due
to an increase in particulate activity (Table 11, BB) which may
possibly be associated with the glycosome. It is this isoenzyme that
was purified in this study.
The m-MOH from pig heart has been shown not only to have soluble
matrix activity but also a particulate activity strongly associated
wi th the inner membrane of the mitochondrion that could be
solubilised with high ionic strength (3M KCl) (Compte and Gautheron
197B). Particulate glycosomal enzymes, but not including malate
dehydrogenase or PEP carboxykinase, of the bloodstream forms of
T. brucei have been released from the membrane with high ionic
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strength (Misset and Opperdoes 1983). The finding in this study that
particulate malate dehydrogenase, PEP carboxykinase and hexokinase
also were released from L. m. mexicana amastigote membranes with
500mM NaCl (Fig. 13a, pg, 110) suggests that the procedure may have
broad applications in the purification of particulate glycosomal
enzymes. In both this study on Leishmania and that on T. brucei
(Misset and Opperdoes 1983), a Phenyl-Sepharose Cl-48 column was
found to be a useful initial step in the purification of these highly
hydrophobic glycosomal proteins. The presence of 10% ethylene glycol
in all the buffers during the purification procedure had the
disadvantage of slowing down flow rates from the columns, however it
was found to be essential for maintaining malate dehydrogenase
activity.
Metal chelate affinity chromatography (MCAC) was attempted in
the purification procedure in an effort to separate malate
dehydrogenase and PEP carboxykinase. This technique is based on the
differing ability of sample proteins to bind heavy metal ions. The
binding can be reversed by reducing the pH and increasing the ionic
strength or using chelating agents such as EOTA which bind the metal
ions. The technique has been used to fractionate serum proteins on
Zn2+ and Cu2+ columns linked in tandem (Porath et al. 1975) and also
to purify the enzyme nucleosidediphosphatase from rat liver on a
single Cu2+ column (Ohkubo et al. 1980). PEP carboxykinase from
L. m. mexicana amastigotes is manganese dependent and its binding to
a Mn2+ loaded gel might be expected to achieve a good purification.
Only a small percentage of the total protein was retained on the
column, however, and all PEP carboxykinase and malate dehydrogenase
activity was eluted with the initial loading buffer (Fig. 15b, pg.
117). Mn2+ has been reported to have a lower binding capacity to the
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chelating Sepharose gel than Zn2+ (Porath et al. 1975), therefore a
Zn2+ loaded column was attempted. Although this separated the sample
into three protein peaks under different elution conditions (Fig.
15a) the procedure was not suitable for purification of these enzymes
as both were inhibited by zinc ions.
The lack of success with MCAC prompted the use of a different
affinity chromatography technique; 5' AMP-Sepharose which binds NAO+-
dependent dehydrogenases and ATP-dependent kinases. Cytosolic,
mitochondrial and glyoxysomal isoenzymesof malate dehydrogenase from
water melon cotyledons have been separated previously using affinity
chromatography on a 5' AMP-Sepharose column, with the two particulate
isoenzymes m-MOH and mb-MOH being bound whilst s-MOH was not (Walk
and Hock 1976). m-MOH and s-MOH of Schistosoma mansoni have also
been sucGessfully separated and purified using 5' AMP-Sepharose
(Rotmans 1978), s-MOH not binding whilst the bound m-MOH was eluted
with a 0-200mM gradient of KCl or low NAOH concentrations. Amastigote
malate dehydrogenase showed two peaks of activity using 5' AMP-
Sepharose with 7% of the activity eluted immediately in the presence
of 200mM NaCl with the remaining 93% of bound activity eluted with 1M
NaCl (Fig. 16, pg. 118). It is unclear whether the 2 peaks of malate
dehydrogenase activity eluted from 5' AMP-Sepharose were due to the
presence of different isoenzymes, possibly from the mitochondrial and
glycosomal compartments, or whether there was a small contaminating
cytosolic activity remaining from the initial centrifugation step.
The latter suggestion, however, seems unlikely as the pellet (P1)
from the first step of the purification was washed well.
Leishmania m. mexicana malate dehydrogenase is unusual as it binds to
the 5' AMP-Sepharose even in the presence of 200mM NaCl, a
concentration of salt that usually dissociates bound enzymes from the
column (Walk and Hock 1976, Rotmans 1978). This binding may have been
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due to a hydrophobic interaction with the 6-carbon spacer arm which
couples the 5' AMP ligand to the Sepharose gel, rather than the 5'
AMP ligand binding to a substrate sit a, Rotmans (197B) found that
the S. mansoni m-MOH which bound to the column was inhibited 75% by
20mM 5' AMP, whereas the non-binding s-MOH was unaffected. Neither
of the Leishmania amastigote malate dehydrogenase enzymes eluted from
the 5' AMP-Sepharose column, however, showed any inhibition by 3.5mM
5'AMP, the highest concentration tested.
The malate dehydrogenase which bound to the 5' AM P-Sepharose
coIurnn, and was subsequently eluted wi th 1M NaCl, was shown to be
homogeneous on SOS polyacrylamide gels (Fig. 17, pg. 119).
Isoelectric focusing, however, showed one major and two minor malate
dehydrogenase isoenzymes, the former of which banded mid-way between
2 of the major: isoenzymes in amastigote homogenates (Fig. 12, pg.
10B). The purified enzyme may have been modified in some way during
the purification procedure so that it behaves differently during
isoelectric focusing and it is unclear if the 2 minor bands are due
to malate dehydrogenase isoenzymes which have co-purified or again
one enzyme that has undergone some procedural modification.
The malate dehydrogenase isoenzymes m-MOH and s-MOH from a
wide range of organisms have been found to have similar MWts of
around 67,000, being dimeric with sub-units ranging from 32-35,000
(Murphey et al. 1967b, Banaszak and Bradshaw 1975). The enzyme has
either a dimeric or tetrameric structure, MWts 67,000 and 117,000, in
prokaryotes (Murphey et al. 1967a), whi 1st both mitochondrial and
glycosomal malate dehydrogenase from T.cruzi have been reported to
have MWts of around 60,000 (Cannata and Cazzulo 1984). Purified
particulate malate dehydrogenase from L. m. mexicana amastigotes
appeared to have a MWt of 33,300 as determined by SOS-gel
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electrophoresis (Fig. 17, pg. 119), whereas the enzyme that was not
bound to the 5' AMP-Sepharose column was found to have a MWt of
39,800 from gel filtration (Fig. 18, pg. 120). In addition, malate
dehydrogenase of L. m. mexicana amastigote crude homogenates
containing all isoenzymes, including solubilized particulate malate
dehydrogenase, eluted as a single peak (MWt 36,100) from Sephadex
G100 (Fig. 19, pg. 122), similar to the MWt found for the purified
particulate enzymes. These resul ts suggest that, suprisingly,
malate dehydrogenase isoenzymes occur as single polypeptidBs in
L. m. mexicana. It is possible, however, that the conditions under
which the Sephadex column was run in order to maintain full enzyme
activity (0.12M triethanolomine buffer pH 7.5, 10% (v/v) ethylene
glycol, 1M NaCl and 1mM OTT) caused the dissociation of the enzyme
into sub~units which nevertheless retained their full catalytic
potential.
The molecular weights of 65,000 and 63,100 determined for L.m
mexicana amastigote PEP carboxykinase by the two methods used agree
well with the MWts of 66,000 - 75,000 for PEP carboxykinase isolated
from vertebrate sources (Utter and Kolenbrander 1972) and from
parasitic helminths (Cornish et al. 1981, Wilkes et al. 1982). The
lack of material did not allow any further characterisation of PEP
carboxykinase in this study, however the technique allows the
purification of the enzyme in sufficient quantities for
investigations in the future.
There have been studies on the enzyme kinetics of malate
dehydrogenase from a wide range of sources including human erythro-
cytes, ox heart, Neurospora crassa (Munkres and Richards 1965),
Eschericia coli (Murphey et al. 1967a, S. mansoni (Rotmans 1978) as
well as the parasitic protozoa Trichomonas gallinae (Dowda and
Betterton 1974), Trypanosoma cruzi (Juan et al. 1976, Cannata and
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Cazzulo 1984) and T. brucei (Falk et al. 1980). The ~ oxaloacetic
acid of 39)JMand the Km NAOH of 41}-lMfor L. m. mexicana amastigote
particulate malate dehydrogenase fall within the range of Michaelis
constants found with these other organisms. Similarly the inhib-
ition of L. m. mexicana malate dehydrogenase by oxaloacetate is a
feature found with many malate dehydrogenase isoenzymes (Ouproque and
Kun 1969, Rotmans 1978). The concentration of oxaloacetate required
to produce inhibition, however, was higher with the amastigote enzyme
than for many m-MOH isoenzymes, with which the reaction procedes in
the malate oxidation direction. The finding in this study that the
activity of malate dehydrogenase in the direction of malate oxidation
proceded optimally at high pH (8.5)has also been reported for other
organisms (Munkres and Richards 1965). The high activity of oxalo-
acetate reduction at neutral pH, together with the observed high Km
values for malate and NAO+ (3.6mM and 0.79mM, respectively) in
comparison with many other organisms (Murphey et al. 1967b, Banasak
and Bradshaw 1975) again suggests that the major physiological
activity of L. m. mexicana amastigote particulate malate dehydrog-
enase activity is the reduction of oxaloacetic acid. The very high
malate concentration required to inhibit oxaloacetic acid reduction
suggests that such inhibition is not relevant to the in vivo
situation, and the lack of any apparent regulation by glycolytic
intermediates and nucleotides implies that the enzyme is not tightly
regulated by allosteric control.
The precise role of malate dehydrogenase in L. m. mexicana
amastigotes is still unclear, but its necessity is suggested by the
extremely high malate dehydrogenase activity in this form of the
parasite. Such an enzyme is a potential target for chemotherapeutic
attack, the results presented here, however, show that the
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particulate amastigote enzyme is similar in many respects to
mammalian enzymes. Nevertheless, its apparent association with PEP
carboxykinase and the glycosome, together with its activity as a
single polypeptide chain. demonstrate that there are distinct
differences from the mammalian enzymes. The methods developed in
this study will allow a more detailed characterisation of purified
amastigote enzymes which should clarify these differences further and
help to elucidate the functional significance of these enzymes to the
mammalian stage of this important human parasite.
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